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Preface 
The general theme of this thesis has been the interactions between proteins and lipids. This has 
been done both by looking at the inner membrane protein DsbB but also the single alpha helix 
peptides Novicidin and Pardaxin and the β-sheet peptide SerAdan.  We have investigated the 
folding and lipid insertion of these proteins with the aim of seeing how this affects the secondary 
structure and activity of the proteins but also the changes that the proteins induce in the lipids. 
The thesis has been submitted to the faculty of science and engineering at Aalborg University, 
Denmark as a part of the requirement for obtaining the PhD degree. It is divided into 3 parts. The 
First part is an introduction to the Anti microbial peptides, bacterial and model membranes 
leading over to a summarizing discussion of the Peptides Novicidin, Pardaxin and SerAdan 
which all display membrane perturbing features. The Second part is a report on the dynamic 
AFM measurements performed on the inner membrane protein DsbB. The report includes an 
introduction to DsbB, Dynamic AFM, the motivation for the initiation of the study and the 
results we obtained plus a discussion of these results. The Third part contains the three articles 
which  that have been published or are ready to be published in peer reviewed international 
papers based on part of the work done in this thesis.  
The work of this PhD study has been carried out in the lab of Professor Dr Daniel E. Otzen 
(Interdisciplinary Nanoscience Center (iNANO), Centre for Insoluble Protein Structures, 
Department of Molecular Biology, University of Aarhus, Aarhus C, Denmark) and also in the lab 
of professor Ole Mouritsen (MEMPHYS - Center for Biomembrane Physics Department of 
Physics and Chemistry, University of Southern Denmark, Odense M, Denmark) where most of 
the atomic force microscopy experiments were conducted. The PhD study was funded by 
BioNET, a Danish research network for experimental and theoretical biophysics. The center is 
supported by the VILLUM KANN RASMUSSEN FOUNDATION and constitutes a nation-wide 
collaborative effort involving the biophysics groups at the University of Copenhagen, the 
University of Southern Denmark, and the University of Aalborg 
Finally I would like to acknowledge the following persons: 
I would like to thank Novozymes for supplying Novicidin and D-Novicidin and elaborating on 
the minimal inhibitory concentrations of these, and Jan Mondrup Pedersen (Interdisciplinary 
Nanoscience Center, iNANO) for synthesizing Novicidin and the acyl/dansyl derivatives.  
Thanks to Daniel Otzen for inspiring supervision and for always being a pillar of knowledge, 
when things got confusing. 
Thanks to my supervisor Ole Mouritsen and the entire Memphys group at SDU for supervision 
and sharing their unrivaled expertise in the field Membrane Biophysics.   
Loads of thanks to the protein biophysics group, for keeping science fun, helping with 
stimulating scientific discussions and for sharing their expertise in different fields. 
Finally I would like to thank my wife and daughter for countless moments of laughter and joy 
even when things were not all that funny. 
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Summary 
The main theme of this thesis is the study of protein lipid membrane interactions. This may be 
divided into two subcategories. Firstly, the mode of interaction and degree of membrane 
perturbation by 3 peptides with very different origins and structure/charge properties, namely 
SerAdan, Pardaxin and Novicidin. Secondly, an attempt to characterize the mechanical stability 
of the inner membrane DsbB the amphipatic environment in which in it is situated be it lipids or 
detergents. 
SerAdan Adan is derived from the Adan peptide but is designed not to be oxidized by replacing 
the Cysteins at position 5 and 22 with the amino acid Serine [1]. SerAdan is produced in humans 
due to a decamer duplication of the Bri gene which produces a prepro protein that after furin 
cleavage results in the 36 AA peptide SerAdan. There have been some studies on the disruption 
of neuronal cells but none that have looked into the specific mode of interaction of SerAdan with 
membranes. We did a study of the interaction of SerAdan with model lipid membrane and have 
shown that SerAdan has a very pronounced membrane perturbing effect which is comparable to 
that of Anti microbial peptides, being active at 1/500 molar ratios. The binding and the 
subsequent perturbation of lipid vesicles was linked to the surface charge of the vesicles as we 
could observe a higher degree of perturbation with anionic vesicles and we could completely 
prevent binding by the addition of high concentrations of Sodium Chloride. Interestingly the 
membrane perturbing effect of SerAdan was found to very time dependent. The time dependence 
of membrane could be linked to the time profile for fibril formation by SerAdan with the 
prefibrillar species being the membrane active component. 
Pardaxin is a 33 amino acid residue peptide derived from the red sea mose´s sole Pardachirus 
Marmoratusa, a fish which secretes it as a milky substance from the base of its dorsal and anal 
fins. It uses it as a mode of defense against sharks as it very irritating to sharks gills and locks the 
jaws presumably due to calcium release in the muscle tissue. There have been a lot of studies on 
the mode of interaction of Pardaxin both with live cells and with model membranes and this has 
been shown that the orientation Pardaxin in membranes is influenced by the length of lipid acyl 
chain. We wanted to investigate whether Pardaxin would also be dependent on the charge 
interactions between Pardaxin and membranes. Pardaxin and lipid charge interactions have been 
looked at previously but with inconclusive results due to limitations in the methods used. We 
decided to combine three different methods in order to shed more light on these interactions, 
namely a vesicle disruption assay, carbon abundance NMR and a visualization technique 
combining Laser confocal scanning microscopy and Giant unilamellar vesicles. We showed with 
the vesicle disruption assay that there is a pH/charge dependent of disruption of vesicles with 
respect to the time profile and possibly the mode of action.  The Abundance carbon NMR 
showed an increased degree of order in the acyl chain of zwitterionic lipids upon addition of 
Pardaxin. In the presence of anionic lipids we only observed an increase in the disorder of the 
lipid headgroup upon binding of Pardaxin showing that there was clear dependence of lipid 
charge in the orientation of Pardaxin in lipid membranes. By LSCM it was unequivocally 
demonstrated that the presence of negative charged lipids changes the mode of action from pore 
formation to total vesicle disruption.  
The AMP Novicidin is a variant of the 18-residue Novispirin, which in turn is derived from the 
N-terminal region of the cathelicidin peptide SMAP-29 from sheep. We had demonstrated in a 
previous study on the parental peptide Novispirin that it did not fold into an alpha helix upon 
adsorption and disruption of zwitterionic vesicles and found this to be the case for Novicidin as 
well. There is only one reported study of Novicidin at present, which does not look into the mode 
of interaction with this protein. In order to further investigate the link between folding and 
membrane permeabilization, we have studied the effect of acylating the N-terminus of the 
antimicrobial peptide Novicidin with C8, C12 and C16 chains. Acylation was chosen because an 
earlier study with the AMP Magainin showed that acylation changes the secondary structure of 
the peptide in solution. The Acylation of Novicidin increased the ability to form α-helical 
structure in the presence of zwitterionic vesicles but actually reduced the ability to permeabilize 
these vesicles as well as intact E. coli cells, even at concentrations sufficiently low to prevent 
formation of peptide micelles. Surprisingly, this decrease in permeabilising ability is not so 
marked in mixed vesicles containing 20% anionic lipids, confirmed by microscopy studies that 
show  wt-Novicidin’s and acylated versions preference for vesicles containing 20% anionic 
lipids among populations of different vesicles. Stopped flow fluorescence measurements of 
Novicidin labeled with the environmental sensitive probe dansyl indicated that Novicidin binds 
to zwitterionic vesicles in a more peripheral manner which was more effective at disrupting the 
membrane integrity. Our data suggest that induction of α-helical structure, rather than facilitating 
membrane disruption, may inhibit it. They also reveal multiple modes of interaction between 
AMPs and simple model membranes, hinting that interactions may be even more varied in the 
complex environment of live bacterial membranes. 
The second part of the study was trying to make a systematic study of the mechanical stability of 
a membrane protein and trying to link this to the properties of either the membrane or the 
detergent in which it was situated. The parameters we intended to vary in order to understand 
their influence were key lipid/detergent components like the acyl chain length, degree of 
saturation, the headgroup charge and geometry. The model protein which we chose for our 
studies is the inner membrane protein DsbB from E. coli.  DsbB is a 176–residue protein which 
consists of 4 transmembrane helices and 2 large cytoplasmic loops. We established the procedure 
for routinely incorporating DsbB in lipid vesicles without losing its activity and to a great extend 
retaining its secondary structure. We were also able to covalently link detergent-solubilized 
DsbB onto a mica substrate. Dynamic AFM was measured on DsbB in detergent and in lipids 
with two different modes of binding to the cantilever either unspecific binding to a silicium 
nitrate cantilever or thiol gold bond between a free cystein and a gold covered cantilever.   
Preliminary measurements leading to ~1800 dynamic force spectra for each of the four different 
setups were performed.  A program was made for semiautomatic analysis of the force spectra 
was run on the data sets which yielded somewhere between 2 and 8% spectra containing force 
peak events. Less than 0.25 % of the spectra contained spectra with unfolding lengths 
corresponding to that of the full length protein. The lack of sufficient data meant that no 
conclusions with regards to the mechanical stability of the structural elements cold be drawn on 
the basis of this work, but it forms a platform on which to continue further investigations in this 
area. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Resume 
Hovedtemaet i denne afhandling har været studiet af protein lipid interaktioner. Under dette 
hovedtema er afhandlingen delt op i to underafsnit. Først er der interaktionsmåde og grad af 
membranpertubering af 3 peptider med meget forskelligt ophav og struktur/ladnings egenskaber, 
SerAdan, Pardaxin og Novicidin. Den anden del af afhandlingen beskriver et forsøg på at 
karakterisere den mekaniske stabilitet af det indre membranprotein DsbB opløst enten i lipider 
eller i detergent. 
SerAdan stammer fra Adan peptidet, men er designet til ikke at blive oxideret ved at erstatte 
cysteinerne i position 5 og 22 med aminosyren Serine.[1][1][1] SerAdan bliver produceret i 
mennesker på grund af en decamer kopiering af Bri genet som producerer et præpro protein som 
efter Furin kløvning resulterer i det 36 aminosyre lange peptid SerAdan. Der er lavet studier af 
den neuron ødelæggende effect af SerAdan, men der ikke nogen studier der specifikt har kigget 
på den måde som SerAdan interagerer med lipidmembraner. Vi har foretaget et studie af 
SerAdans interaktion med model lipid membraner og vist at SerAdan har en udpræget membran 
pertuberende effekt som er sammenlignelig med den der observeres for antimikrobielle peptider 
altså aktivitet ved 1/500 i molært ratio. Bindingen og den efterfølgende pertubering af lipid 
vesikler er forbundet med ladningen af de anvendte lipider. Der var en markant højere 
pertubering af anioniske vesikler og denne binding kunne forhindres fuldstændigt ved tilsætning 
af høje koncentrationer af natriumklorid. Den membran pertuberende effekt af SerAdan viste sig 
at være meget afhængig af tidsfaktoren. Denne tidsafhængighed kunne kædes sammen med 
tidsprofilen for SerAdans fibril dannelse hvor den præfibrillede specie var den membran aktive 
komponent.  
Pardaxin er et peotide bestående af 33 aminosyrer og stammer fra røde havs flynderen 
Pardachirus Marmoratusa, en fisk som sekreterer en hvid mælket substans fra kirtler som 
befinder sig ved roden af dens finner. Dette sekret bliver brugt som et forsvar imod hajer som 
finder det meget irriterende, da det angriber dens gæller og får dens kæbemuskler til at låse 
sandsynligvis på grund af frigivelse af calcium i muskelvævet. Der har været en del studier der 
har kigget på måden hvorpå Pardaxin interagerer både med levende celler men også med model 
lipid membraner, hvilket har vist at orienteringen af Pardaxin i membraner er påvirket af 
længden af lipid acyl kæden. Vi ønskede at undersøge hvorvidt interaktionen mellem Pardaxin 
og lipid membraner også var påvirket at ladningen af lipid hovedgruppen. Pardaxin og lipid 
ladnings interaktioner er blevet undersøgt før, men resultaterne har været inkonklusive på grund 
af begrænsninger i målemetoden. Vi besluttede at kombinere tre forskellige metoder til at 
undersøge disse interaktioner nemlig et vesikel ødelæggelses assay, Carbon abundance NMR og 
en visualiseringsteknik der kombinerer Laser confocal scanningsmikroskopi og gigantiske 
unilaminære vesikler. Med vesikel ødelæggelses assayet viste vi at der var pH/ladnings betinget 
ødelæggelse af vesikler både med hensyn til tidsprofilen og virkemåden. NMR forsøgene viste 
en højere grad af orden i acylkæden af zwitterioniske lipider ved tilsættelse af Pardaxin. I 
tilstedeværelse af anioniske lipider kunne der kun observeres en højere grad af uorden i lipid 
hovedgruppen ved binding af Pardaxin. Dette indikerer en klar indvirkning af lipid 
hovedgruppens ladning på orientering af Pardaxin i lipidmembraner. Med Laser confocal 
scanningsmikroskopi var det muligt utvetydigt at vise at tilstedeværelsen af anioniske lipider 
ændrede pardaxins virkemåde fra poredannelse til vesikel ødelæggelse.  
Det antimikrobielle peptid Novicidin er en variant af det 18 aminosyre lange peptid Novispirin 
som stammer fra den N-terminale ende af cathelicidin peptidet SMAP-29. Vi har demonstreret i 
et tidligere studie af Novispirin, at det ikke folder til en α-helix ved adsorbtion og pertubering af 
zwitterioniske vesikler og fandt at dette også var tilfældet for Novicidin. Der er på nuværende 
tidspunkt kun publiseret et studie af Novicidin og dette kigger ikke på virkemåden af Novicidin. 
For bedre at kunne undersøge forbindelsen imellem proteinfoldning og membran 
permeabilisering har vi acyleret N-terminus af Novicidin med C8, C12 og C16 kæder. Acylering 
blev valgt fordi tidligere studier med AMPét Magainin har vist at acylering ændrede peptidets 
struktur i opløsning. Acyleringen af Novicidin forøgede evnen til at danne α-helix i 
tilstedeværelsen af zwitterioniske vesikler, men kontrært til dette sænkede det peptidets evne til 
at permeabilisere både vesikler og intakte E. coli celler. Dette fænoment blev observeret langt 
under de koncentrationer som ville give anledning til formation af peptidmiceller. Overraskende 
var denne sænkning af permebiliseringsevnen ikke så udpræget ved anioniske vesikler. Dette 
blev bekræftiget ved mikroskopistudier, hvor vi viste at i en blanding af anioniske og 
zwitterioniske vesikler var der en klar præference for anioniske vesikler også selvom Novicidin 
var acyleret. Stopped flow fluorescence målinger af lablet Novicidin med den miljøsensitive 
probe Dansyl indikerede at Novicidin binder mere perifært til zwitterioniske vesikler, hvilket var 
mere membrane pertuberende end bindingen der blev observeret med anioniske vesikler. Vores 
data indikerer at induktionen af α-helix inhiberer membran permeabilisering snarer end fremme 
den. Dataene afslører forskellige grader af interaktion mellem AMPér og simple lipidmembraner 
hvilket kan tolkes som at interaktionerne muligvis er endnu mere kompleks i bakterielle 
membraner. 
Den anden del af afhandlingen er et systematisk forsøg på at karakterisere den mekaniske 
stabilitet af et membranprotein og prøve at forbinde det til egenskaber af den lipidmembran eller 
detergent hvori det befinder sig. De parametre vi varierede var kerne egenskaber for 
lipid/detergenter såsom acylkæde længde, mætningsgrad og hovedgruppeladning og geometri. 
Modelproteinet som vi valgte til vores studie er det indre membran DsbB fra E. Coli, som er et 
176 aminosyre protein som består af 4 transmembrane helixer og to store cytoplasmiske løkker. 
Vi etablerede en procedure til inkorporering af DsbB i lipid vesikler uden at miste dets aktivitet 
og i høj grad også beholde dets sekundære struktur. Vi var også i stand til covalent at binde 
detergent opløst DsbB på et mica substrat. Dynamisk AFM blev målt på DsbB i detergent og 
lipid med to forskellige bindingsmåder til cantileveren enten uspecifik binding til en silicium 
nitratcantilever eller kovalent binding med et thiolbinding til en guldcantilever. Foreløbige 
målinger førte til 1800 unikke kraft spektra for hver af de 4 forsøgsopstillinger. Der blev lavet et 
databehandlingsprogram for at gøre analysen semiautomatisk og hvert datasæt resulterede 
imellem 2-8 % spektra indeholdende kraft spektra. Mindre end 0,25 % af spektra indeholdt 
spektra med udfoldningslængder der svarede til den fulde længde af proteinet. Den 
utilstrækkelige datamængde betyder, at der ikke kunne drages nogen endelige konklusioner 
vedrørende den mekaniske stabilitet af strukturelle elementer på baggrund af arbejdet i denne 
afhandling, men udgør en platform fra hvilken vi vil foretage yderligere undersøgelser. 
  
Abbreviations: 
 
2D: Two dimensional 
oC:  Degrees Celsius 
AFM: Atomic Force Microscopy 
AMP: Anti microbial Peptide 
ATP:  AdenosinTriPhosphat 
Au: Arbitrary units 
CCD: Charge Coupled Device 
CD: Circular Dichroism 
CMC: Critical Micelle Concentration 
Cys: Cystein 
CHAPS: 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate 
DsbB: Disulfide bond protein B 
DCD-1: Dermaceptin 1 
DDM: Dodecyl maltoside 
DNA: Deoxyribonucleic acid 
DPC: Dodecylphosphocholine 
DMSO: Dimethyl Sulphooxide 
DOPC: Dioleyl Phosphocholine 
DOPG: Dioleyl phosphatidylglycerol 
EDTA: ethylenediaminetetraacetic acid 
HIV:  Human immunodeficiency virus 
IPTG:  Isopropyl β-D-1-thiogalactopyranoside, 
E. coli: Escherichia coli 
EYL:  Egg yolk lipid extract 
KDa:  KiloDalton 
KDO: 2-keto-3-deoxyoctonoic acid 
LB: Luria-Bertani Broth 
LD50: 50% lethal dose 
LSCM: Laser scanning confocal microscope 
LPS: Lipopolysaccharides 
LUV:  Large Unilamellar Vesicles 
MD:  Molecular Dynamics. 
MIC:  Miniamal Inhibitory concentration 
MLV:  Multilamenar vesicles 
NaCl:  Sodium Chloride 
NMR: Nuclear Magnetic resonance 
Nc: Novicidin wt 
NcC8: Novicidin with a 8 carbon acyl chain 
NcC12: Novicidin with a 12 carbon acyl chain 
NcC16: Novicidin with a 16 carbon acyl chain 
Nm: Nanometers 
OG: Octylglucoside 
PC: PhosphoCholine 
PE: phosphatidylethanolamine 
PG: phosphatidylglycerol 
pN: pico Newton 
PS: Phosphotidyl Serine 
QCM: Quartz Crystal Microbalance 
RNA: Ribonucleic acid 
Rh: mean radius 
SDS: Sodium dodecyl sulfate 
SM: SpingeoMyelin 
SUV: Smal unilamellar vesicles 
TM: TransMembrane 
Wt: Wildtype 
 
  
Contents 
Part I: Studies on protein - lipid interactions using antimicrobial peptides Novicidin 
and Pardaxin and the membrane perturbing peptide SerAdan as model 
proteins. 
 1 Introduction to lipids – the fats of life    11 
1.1 The mammalian cell     11 
1.2 The bacterial membrane     12 
1.3 Model Membranes      13 
1.4 Model Membrane preparation    14 
1.4.1 Multi laminar vesicles    14 
1.4.2 Small unilamellar vesicles   15 
1.4.3 Large unilamellar vesicles   15 
1.4.5Giant Unilamellar vesicles   16 
1.5 The physiochemical properties of lipids   17 
1.6  The properties and forces governing lipid bilayers 21 
1.6.1 The membrane pressure profile   21 
1.6.2 Membrane electrostatics   22 
1.6.3 Membrane phases    22 
1.6.4 Membrane thickness    23 
1.6.5 Membrane dynamics    23 
2 The role of antimicrobial peptides    25 
   2.1 Cationic peptides enriched in specific amino acids 25 
    2.1.1 Example: Indolicidin    26 
   2.2 Linear cationic helical peptides    27 
    2.2.1 Example: Mellitinin    29 
   2.3 Anionic and cationic peptides that contain cystein   
bridges       30 
    2.3.1 Example: Human betadefensin‐ 2    31 
   2.4 Anionic antimicrobial peptides    31 
    2.4.1 Example: Dermacidin    32 
   2.5 Anionic and cationic peptide fragments of larger 
 Proteins       32 
    2.5.1 Example: Lactoferrin    33 
   2.6 Mechanisms of bacterial resistance   34 
2.7 Experimental methods for characterizing AMP and  
 lipid membrane interactions     35 
 2.7.1 Nuclear Magnetic resonance   35 
 2.7.2 X-ray diffraction    36 
 2.7.3 Fluorescence spectroscopy   37 
 2.7.4 Circular Dichroism    38 
 2.7.5 Molecular dynamics    39 
 2.7.6 Atomic force microscopy   40 
 
3 Discussion of papers I, II and III 
3.1 Paper I: Kinetic partitioning between aggregation and 
 vesicle permeabilization by modified Adan   42 
3.2 Paper II, The anti microbial peptide Pardaxin displays 
 a charge dependent orientation in lipid bilayers  43 
3.3 Paper III, Divorcing folding from function: How  
acylation affects the membrane-perturbing properties  
of an anti-microbial peptide    43 
3.4 Perspectives and outlook     46 
4 References       49 
 
 
Part II:    
5 Investigating the mechanical stability of an inner membrane protein by 
atomic force spectroscopy  
5.1 Introduction      58 
5.2 Material and methods     62 
5.3 Results       66 
5.3.1 Expression, purification, reconstitution and functional 
characterization of DsbB    66 
5.3.2 The immobilization of DsbB on solid  
Substrates      68 
5.3.3 Measuring Dynamic AFM on DsbB in DDM and Anionic 
lipid membranes     71 
5.4 Discussion       74 
5.4.2 The reconstitution of DsbB in lipids  74 
5.4.3 Evaluating the morphology of DsbB on 
 a solid substrate    74 
5.4.4 Dynamic AFM of DsbB reveal patterns in the unfolding 
events      74 
5.4.5 Perspectives and future work   75 
  6 References       77 
 
 
 
 
Part III :  Papers 
Paper I: Kinetic partitioning between aggregation 
 and vesicle permeabilization by modified Adan   79 
 
Paper II: The anti microbial peptide Pardaxin displays a  
charge dependent orientation in lipid bilayers   89 
 
Paper III: Divorcing folding from function: How acylation 
 affects the membrane-perturbing properties of an 
 anti-microbial peptide      120 
  
 
 
 
 
 
 
 
 
 
Part I 
Studies on protein - lipid interactions using Novicidin and 
Pardaxin and the  SerAdan as model proteins. 
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Introduction 
This introduction is meant a general overview over the very diverse field of antimicrobial 
peptides and what are the features that distinguish them from other proteins in terms of their 
structure, interactions with membranes and internal cell components. There is also an 
introductory part on lipids, including their location but also how they influence the structure and 
qualities of naturally occurring membranes. Furthermore, this part also emphasis on how lipids 
are used in model systems when we try to make sensible emulations of in vivo systems. 
 
1 Introduction to Lipids – The fats of life 
Lipids are the main constituent of biological membranes. Lipid layers have many features such 
as controllable flexibility and water impermeability. The membranes serve not only as barriers 
towards the extracellular space but also for internal compartmentalization [2, 3] and additionally 
they can be used as energy storage [4]. The lipid molecules are a highly varied group and more 
than a thousand different lipids have been isolated from a single cell [5]. The composition of 
lipid membranes varies greatly from species to species but in multi cellular organism there is 
also some variances between different tissues [6, 7]. This chapter will focus on naturally 
occurring membranes and the model membrane systems that are used to emulate these. Given the 
rich complexity of the lipid family I will in this thesis only focus on the general membrane 
compositions of mammalian and bacterial cells as these the most relevant for this study 
1.1 The Mammalian cell 
The most commonly used example of the membrane from Mammalian cells is those of the red 
blood cells which largely consist of lipids. The distribution of lipids between the two leaflets of 
these membranes is asymmetric [8, 9]. The leaflet facing the cytoplasm consist primarily of the 
amino phospholipids phosphatidyl Serine (PS) [10] and phosphatidylethanolamine (PE) [11] The 
outer leaflet consist mostly of the phosphocholines, phosphatidyl choline (PC) [12] and 
spingeomyelin [13]. This asymmetric distribution of phosphocholines and amino phospholipids 
is mainly regulated by an ATP dependent aminophospholipid translocase [14, 15] but it has also 
been shown that the leaflet asymmetry is aided by a subset of proteins that are characterized by a 
few transmembrane helices. When the asymmetry is lost it is often a sign of significant cell 
genesis events and for example the exposure of PS in the outer leaflet will trigger coagulation 
cascades and cell scavenging processes [16-18]. It should also be noted that PS has been shown 
12 
1 Introduction to lipids  
12 
 
to be present on the surface of cancerous and other pathological cells [19]. From species to 
species there is interestingly a larger difference in the PC-SM distribution of the outer leaflet (see 
table 1.1) of red blood cells. This presumably means that there is a large difference in how these 
cells interact with membrane active peptides as increasing amounts of SM will result in a more 
rigid membrane. 
Table 1.1: The total lipid content of the red blood cells from different species. The Choline phospholipids are 
primarily found in the outer leaflet while the amino phospholipids are found in the inner leaflet. 
Organism PC SM Total choline 
phospholipids 
PE PS Total amino 
phospholipids 
Others 
Rat 47.5 12.8 60.3 21.5 10.8 32.3 7.4 
Rabbit 33.9 19.0 52.9 31.9 12.2 44.1 2.0 
Human 34.7 20.1 54.8 28.0 14.3 42.3 2.9 
Pig 23.3 26.5 49.8 29.7 17.8 47.5 2.7 
Sheep - 51.0 51.0 26.2 14.1 40.3 8.7 
 
1.2 The Bacterial membrane 
With regards to the buildup of the membrane wall bacteria are 
divided into two subgroups known Gram Positive and Gram 
negative bacteria. The gram positive bacteria are the simpler of the 
two with only one membrane bilayer (see figure 1.1) and it 
includes many well-known genera such as Bacillus, Listeria, 
Staphylococcus, Streptococcus, Enterococcus, and Clostridium. 
The membrane of gram positive bacteria is stabilized by a peptide-
glycan-techtoic acid network which stains positive for the Gram 
staining, hence the name. The phospholipids make up 80 % of the 
cytoplasmic membrane and they consist primarily of PG but also 
the amino acyl derivatives of these making it very negatively 
charged. There is a greater divergence in the phospholipid make 
up of different species within the Gram positive group compared 
to the gram Negative.  
Figure 1.1: A schematic view of the membrane architecture of gram negative and gram positive bacteria. In the 
outer membrane (blue) specific for gram positive bacteria we have the asymmetric LPS network indicated in red and 
porins shown in yellow. In magenta colors we can see the peptido glycan layer which is found either in the 
periplasmic space of gram positive or the outer layer gram negative bacteria. The peptido glycan layer helps to 
stabilize the inner or cytoplasmic membrane shown in green. 
The architecture of the gram negative bacteria differ a lot from the gram positive with an 
additional outer membrane composed primarily of PE combined with a negatively charged lipid 
polysaccharide moiety protruding from it. The LPS Layer plays a stabilizing part in the outer 
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membrane of but also works as an endotoxin, and induces a strong response from normal animal 
immune system[20]. The gram negative bacteria also have the stabilizing peptido glycan layer in 
between the outer membrane and the cytoplasmic membrane. The Cytoplasmic membrane 
consists primarily of PE and also some PG making it negatively charged[21]. 
Table 1.2: The phospholipid contents of different Gram negative and Gram positive bacteria. The lipids have been 
divided into those that constitute the Outer Membrane [11] and those that make the Cytoplasmic Membrane [22] 
Bacteria species  PG DPG L-lysyl PG PE Others 
Gram-negative       
Erwinia 
carotovora 
OIM 14 8 0 78 0 
Eschericha coli OM 3 6 0 91 0 
 CM 6 12 0 82 0 
Salmonella 
typhimurium 
OM 17 2 0 81 0 
 CM 33 7 0 6 0 
Pseudomonas 
cepacia 
OM 13 0 0 87 0 
 CM 18 0 0 82 0 
Gram positive       
Bacillus 
megaterium 
CM 40 5 15 40 0 
Bacillus subtilis CM 29 47 7 10 6 
Micrococcus luteus CM 26 67 0 0 7 
Staphylococcus 
aureus 
CM 57 5 38 0 Trace 
 
1.3 Model Membranes  
With this enormous complexity and huge diversity of lipids not only between species but also in 
different membranes in one cell it is clear that for understanding the key parameters in the 
protein lipid interactions we are tempted simplify our experimental conditions. First off we can 
define the curvature of the membranes we look at by preparing our membranes by different 
techniques. It is possible producing vesicles ranging from 30 to 200000 nm, we can produce 
uniformly flat bilayers and even single bilayer leaflets if it is desired, examples of this the can be 
seen in figure 1.2. Normally we limit the experiments to certain essential lipid headgroups 
namely phosphatidylcholine (PC), phosphatidylserine (PS), phosphatidylglycerol (PG) and 
phosphatidylethanolamine (PE). By mixing these lipids in ratios that are comparable to those in 
natural membranes we have an easy way of testing for example species specificity of a 
membrane active protein. One can also look at the effects of different acyl chain lengths and 
different degrees of saturation to see how if the protein lipid interaction is dependent on the lipid 
packing. Finally people have also looked at the effects of adding Lippopolysaccharides and 
cholesterol which are very specific for gram positive bacteria and eukaryotic cells respectively. 
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In the following section we will go through the physiochemical properties of these compounds. 
In thesis we have limited ourselves to two lipids namely DOPC and DOPG which we have 
mixed in different ratios. The rationale for choosing these two lipids is to make the simplest 
emulators of mammalian and bacterial cells when the primary focus is the charge interactions. 
The pure DOPC is used as an emulator of the zwitterionic bacterial membranes and when DOPG 
is included it is to reproduce the negative charge of bacterial cells. When the Di oleic moiety is 
chosen as the lipid acyl group the reason is twofold, one is that we are above the phase transition 
when working at ambient temperatures. The second reason is that this will result in perfect 
mixing of the two lipids and one does not have to take into account the formation of negatively 
charged islet in the membrane.  
  
Figure 1.2: It is possible prepare vesicles (A) with different techniques such as sonication, extrusion and 
electroporation which will result in vesicles with approximate sizes of 30nm, 200 nm and 30 µM respectively. It is 
possible to collapse vesicles on a substrate giving a uniformly flat bilayer (B) or even producing a single bilayer 
leaflet (C) by spreading an oil emersion on an air water interface. 
 
1.4 Model Membrane Preparation 
Prior to preparation of membranes usually the lipids that are to be used will be used are dissolved 
in an organic solvent. This is both for reducing possible hydrolysis and especially when dealing 
with saturated lipids but also because some lipids will not mix homogeneously when dissolved in 
an aqua’s phase. Usually chloroform is used because of its low vapor pressure and contrary to for 
example methanol it does not form hydrogen bonds with the polar head groups making it easier 
to evaporate. When preparing vesicles one should make sure that the lipids are above the phase 
transition temperature both while preparing but also after as this is essential for vesicle size 
distribution[23]. 
1.4.1 Multi laminar vesicles 
This type of vesicles is the easiest to produce but the sizes of the vesicles will vary greatly and 
like the name implies they will consist of multiple layers of vesicles. This might cause problems 
with absorption in spectroscopic experiment. These types of vesicles are the starting material for 
some of the other vesicle types. MLV´s are made by drying out a thin film of the lipids usually in 
a glass container to avoid leakage of pollutants from the container into the sample. The film is 
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the hydrated and with agitation the lipid films will be sheared off into large disk or myelin 
structures. The exposed hydrophobic edges will then try to reseal resulting in the formation of 
vesicles. Additional agitation by shaking, swirling or vortexing will produce a heterogeneous 
solution of MLV´s that will make the suspension milky white.  
1.4.2 Small unilamellar vesicles 
This group of vesicles is the smallest vesicles that can be produced, due to limitations induced by 
the curvature stress of the membranes. Because of the inherent frustration in this type of vesicles 
a lot of energy has to be put into the formation of them so sonication is usually the preferred 
technique. The use of sonication for lipid sample preparation was reported as early as 1967 [24] 
and is hence one of the first mechanical formation of vesicles. One advantage of this technique is 
that due to local heating high energy output the samples need not be heated above the phase 
transition temperature. The starting material is MLV´s prepared as was described above. There is 
then two ways of preparing the samples either by insertion of a tip sonicator into the sample or 
by emerging the sample in a bath sonicator, the rod sonicator is the most commonly used of the 
two. The outcome is a homogeneous group of unilamellar vesicles with a diameter below 40 nm 
which means the solution is essentially clear. These SUV´s are usually meta stable, the high 
energy curvature will by relaxed by fusing of vesicles into 60 to 80 nm vesicles over a matter of 
days[25].  
1.4.3 Large unilamellar vesicles 
Large unilamellar liposomes refer to vesicles that are larger than a 100 nm and consist of only a 
single bilayer membrane. They have the advantage of having less curvature pressure than the 
SUV´s and still being able to give reasonably low noise levels in spectroscopic experiments. 
Usually these are prepared by extrusion where a lipid solution by application of pressure is 
forced through a polycarbonate filter with predefined pores sizes or removal of detergents from 
lipid detergent mixture. The extrusion method gives the best vesicles with regards to the 
homogeneity of the size distribution. Again the starting material is MLV´s which are then put 
through 10-15 cycles of freeze thawing. This is done to make the MLV´s unilamellar as contrary 
to LUV´s they will break up during the freeze thaw process [26]. After this step the vesicles can 
be extruded but the technique will work best within the size range 100 – 500 nm. Usually the 
vesicles will end being slightly bigger than the pore size as the lipids change their morphology, 
to an extended shape allowing them to squeeze through the pores. Shear stress within the pore 
will then break the vesicles into smaller vesicles that fit the interior of the pore. This means the 
vesicle size is determined not only by the pore geometry, but also by the velocity of the 
suspension through the pore, the number of extrusion cycles and the mechanical properties of the 
bilayer membrane[27]. When preparing LMV´s by the detergent depletion method we start by 
mixing the lipid of choice in the form of MLV´s with detergent in a detergent/lipid molar ratio of 
2/10 taking into account that the final detergent concentration should be above the CMC. This 
will dissolve the MLV´s and produce a homogeneous solution of mixed micelles. The following 
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detergent depletion can be achieved by either dilution[28], dialysis, size filtration or adsorption. 
The size and homogeneity of the vesicles produce will greatly depend on the detergents and the 
rate of detergent removal but in general the faster the detergent removal, the smaller the vesicle 
size. The reason for this is that residual detergent in slow removal will increase the vesicle size 
and heterogeneity.[29] For an overview of the different vesicle sizes obtained using different 
detergents and detergent removal methods see table 1.3. 
 
Table 1.3: The size distribution of vesicles as function of detergent and the detergent removal rate. 
 
Detergent Phospholipid Vesicle diameter [Å] Detergent removal 
CHAPS EYL 2900 Very slow (dialysis) 
OG EYL 2400 Very slow 
CHAPS EYL 2080 Slow (gel chromatography) 
Triton X-100 EYL-EPA 1500 Slow (adsorbent beads) 
GCh EYL 1300/380 Fast(dilution): gel state/liquid 
crystalline state 
C12 E8 EYL 600 Medium(adsorbent beads) 
OG EYL 610 Fast (dilution) 
C12 E8 EYL 560 Fast (adsorption) 
OG EYL 300 Extremely fast (dilution) 
SCh EYL 300 Medium (gel chromatography) 
 
 
1.4.4 Giant Unilamellar vesicles 
Giant Unilamellar vesicles are vesicles with diameters between 5 – 200 µm [30] which gives 
them two very clear advantages their sizes are comparable to those for naturally occurring cells 
and it is possible to visualize them with normal light microscopy. There are three main methods 
for the formation of GUV´s, gentle hydration, Solvent evaporation and electroformation which 
all start out with an organic solvent suspension of lipids. In the gentle hydration method the 
lipids are deposited on either a glass[31] or Teflon slide[32] and allowed to hydrate for up to 36 
hours. After this time a white “cloud” will rise from the deposited and with some agitation this 
can be solubilized. This method will give a rise to a slightly heterogeneous solution with up to 15 
µm vesicles there will however be a tendency to some degree multi laminarity with this 
method[33]. The second method is solvent evaporation in an aqueous solution originally 
described by Mosho and coworkers[34]. The clear benefit of this method compared to the gentle 
hydration is that it takes much less time as GUV´s can be prepared within 2 min the drawback is 
the possible organic solvent residues that will be present in your sample. It works by putting an 
organic solvent solution of lipids in a glass flask, adding appropriate amounts of Millipore water 
and then evaporating the organic solvent by reduced pressure. This will result in an opalescent 
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fluid that contains GUV´s with a diameter of up to 50 µm, but again with some degree multi 
laminarity. 
The final method is the one described by Angelova and Dimitrov in 1986[35] using an 
oscillating electrical field to mediate the formation of vesicles. A lipid solution in chloroform is 
spread out on two platinum wires in a Teflon chamber. The organic solvent is then evaporated by 
pressure reduction for a few hours. The buffer of choice is then added (max 10 mM) and a low 
frequency AC field of 10 hertz is then applied for a couple of hours. This will result in GUV´s 
that are more or less bound to the platinum wires, depending on the lipid, which can be 
solubilized by gentle pipetting. This method is more time consuming than the solvent 
evaporation method but this is compensating by a higher degree of homogeneity of the samples 
with a size distribution between 30 – 60 µm in diameter and also a reduced occurrence of multi 
laminarity. 
 
1.4.5 Supported Bilayers 
The planar supported lipid bilayers are interesting as cell membrane mimickers and have been 
used for a wide variety of techniques such as Confocal laser microscopy[36], QCM [37], Atomic 
force microscopy [38] and Surface Plasmon resonance [39]. The method of choice is spreading 
small vesicles on a hydrophilic support. This method was originally pioneered by McConnell et 
al [40] and is now routinely used for creating supported lipid bilayers which allows for free 
diffusion and rotation of lipid molecules. The substrate used is for deposition is most commonly 
freshly cleaved mica [41] or silica where an aqueous solution of lipids is deposited for roughly 
30 minutes and subsequently washed with buffer to remove any additional layers of lipid. An 
important factor is also the presence of calcium ions which greatly facilitates the formation of 
SLB. There are several suggested pathways for going from vesicles to an adsorbed lipid bilayer, 
the spontaneous rupture of vesicles due to vesicle deformation as they adsorb, the fusing of 
neighboring adsorbed vesicle, edges of already formed bilayers causing rupture of adsorbed 
vesicles and a critical coverage of the surface that starts a cascade rupturing event. 
 
 
1.5 Physiochemical properties of lipids 
Lipids can generally by subdivided into three mayor groups: glycerolbased lipids, cholesterol 
and ceramide based sphingiolipid. The subgroup of the glycerol based lipids are composed of 
two subgroups where is referred to as glycosylglycerides and the other more commonly known is 
the phospholipids. The phosphor lipids are composed of a glycerol backbone onto which there 
are two acyl chains attached at the sn1 and sn2 position at the sn3 in the Para position there is 
phosphate group that has been esterified to simple organic molecule containing a carbohydrate 
group. The acyl chains are often referred to as the tail and the molecule attached to the phosphate 
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group as the “headgroups”. The tail is the hydrophobic part of the lipids and the headgroup is the 
hydrophilic part. The length of the acyl chains vary in natural lipids between C14 and C18. Most 
phophatidylcholines have a Cis unsaturated fatty acid acyl chain making them fluid at room 
temperature.  
 
Figure 1.3: In this figure we see the four different headgroups of the most commonly used glycerol based lipids for 
preparation of model membranes, phosphatidylcholine (PC), phosphatidylserine (PS), phosphatidylglycerol (PG) 
and phosphatidylethanolamine (PE). In the three dimensional representation the carbon groups are shown in green, 
hydrogen white, oxygen red, phosphate purple and Nitrogen in blue. They are all shown with di-oleic acid as the 
acyl moiety for ease of comparison.  
As mentioned previously there are several naturally occurring headgroups like choline, 
ethanolamine, serine and glycine which all have different properties (see figure 1.3).  
 The choline glycerophospholipids (PC) have a pKa value of around 13.9 and produces a polar 
head group with a strong zwitterionic character over the entire pH range. In animal cells, the 
fatty acid from the sn1-position is frequently 16:0 and that from the 2-position is 18:1 or 18:2 but 
in rare instances choline glycerophospholipids with a higher degree of unsaturation is found. The 
head group and of phosphatidyl cholines have roughly the same dimensions as the tail giving it a 
cylindrical shape in a lipid bilayer with tails facing each other and the headgroups facing the 
aqua’s environment.  
Ethanolamine glycerophospholipids (PE) are zwitterionic over the pH range of 2-7 and is in the 
anionic form in the pH range 7-10. The smaller size of the ethanolamine head group gives it a 
Phosphatidylglycerol (PG) 
Phosphatidylcholine (PC) 
Phosphatidylethanolamine (PE)
Phosphatidylserine (PS) 
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conical shape that imposes a curvature stress which is utilized by cells for budding, fusion and 
fission [42, 43]. While ethanolamine glycerophospholipids only occurs in small amounts in 
mammalian and plant cells it is the major constituent of Bacterial membranes. The pattern of 
fatty acid distribution in ethanolamine phospholipids generally shows a higher degree of 
unsaturation than what is found in choline phospholipids.  
The phosphatidyl glycerol’s (PG) have a second glycerol attached to the phosphate at the sn3 
position. The phosphate group has a pKa of ~ 1 giving it a net charge of -1 at physiological pH 
conditions. This lipid occurs widely but very low amounts are found in animal tissues (mainly in 
mitochondria), in plants it forms 20 to 30 % of total phospholipids (mainly in the chloroplast). In 
bacteria it is the second most abundant lipid, for example Escherichia coli, has up to 20% 
phosphatidylglycerol in its membranes while phosphatidyl ethanolamine makes up much of the 
rest (see table 1.2).  
Serine glycerophospholipids (PS) are the only lipids in animal cells that contain an amino acid. It 
possesses three ionizable groups: a diester phosphoric acid, an amino group and a carboxyl. The 
pKa of the carboxyl group of PS is around 3.6 and the pKa of its amino group is around 9.8 Thus 
at pH 7, the phosphate and the carboxyl functions are in anionic form and the amino group is 
positively charged which means that it is zwitterionic but will have a net negative charge. The 
head group shape of PS is similar to that of PC and will also spontaneously form vesicles in an 
aqueous solution. 
Cholesterol is not really a lipid but rather a waxy alcohol that is found in the plasma membrane 
of all animals where it greatly modulates the membrane properties. It consists of a bulky steroid 
group and a hydrocarbon tail. The hydroxyl group on cholesterol interacts with the phosphate 
head of the membrane, and the bulky steroid and the hydrocarbon chain is embedded in the 
membrane. Cholesterol is minimally soluble in water but does not form vesicles in the absence of 
lipids. When as can be seen from the structure Cholesterol (see figure 1.4) is uncharged which 
means that it does not play a role with regards to electrostatic mediated interactions of membrane 
active proteins. 
 
Figure 1.4: The three dimensional structure (left) and the Fisher projection of Cholesterol derived from sheep’s 
wool. It consists of a sterol head group with an OH group shown in red and a C6 acyl chain with the carbon groups 
shown in green. 
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LPS typically consist of a hydrophobic domain known as lipid A (or endotoxin), a nonrepeating 
“core” oligosaccharide, and a distal polysaccharide (or O-antigen) (see figure 1.5) and is the 
largest of the lipid molecules that we know with a MW of around 10 KDa. The lipid A part 
contains the hydrophobic, membrane-anchoring region of LPS that allows it to pack together 
with the other lipids in outer membrane forming the characteristic outer layer of gram negative 
bacteria seen in figure 1.1. Lipid A consists of a phosphorylated N-acetylglucosamine [44] dimer 
with 6 or 7 fatty acids (FA) attached. Usually 6 FA are found and they are all saturated. Some 
FA is attached directly to the NAG dimer and others are esterified to the 3-hydroxy fatty acids 
that are characteristically present. The structure of Lipid A is highly conserved among Gram-
negative bacteria. The Core polysaccharide is attached to the 6 position of one NAG. Two 
unusual sugars are usually present, heptose and 2-keto-3-deoxyoctonoic acid (KDO) The KDO is 
unique and invariably present in LPS and so has been an indicator in assays for LPS. 
 
  
Figure 1.5: To the left is the fisher projection of a lipid A moiety and on the right the schematic structure of LPS 
with the O Antigen at the outer end, the core polysaccharide in the middle and at last the membrane bound Lipid A.  
With minor variations, the core polysaccharide is common to all members of a bacterial genus, 
but it is structurally distinct in other genera of Gram-negative bacteria. The O antigen or O side 
chain is attached to the core polysaccharide. It consists of repeating oligosaccharide subunits 
made up of 3 - 5 sugars. The individual chains vary in length ranging up to 40 repeat units. The 
O polysaccharide is much longer than the core polysaccharide and it maintains the hydrophilic 
domain of the LPS molecule. A major antigenic determinant (antibody-combining site) of the 
Gram-negative cell wall resides in the O polysaccharide. Great variation occurs in the 
composition of the sugars in the O side chain between species and even strains of Gram-negative 
bacteria. At least 20 different sugars are known to occur and many of these sugars are unique 
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dideoxyhexoses, which only occur in Gram-negative cell walls. Variations in sugar content of 
the O polysaccharide contribute to the wide variety of antigenic types of Salmonella and E. coli 
and presumably other strains of Gram-negative species. Particular sugars in the structure, 
especially the terminal ones, confer immunological specificity of the O antigen, in addition to 
"smoothness" (colony morphology) of the strain. Loss of the O specific region by mutation 
results in the strain becoming a "rough" (colony morphology) or R strain. The overall net charge 
of LPS is negative due to the phosphate and ethanol amine groups found at the core region. This 
charge addition may facilitate some protein lipid interactions but the mesh of the outer 
polysaccharide will to some degree counter this effect by simple steric hindrance [45-47]. 
 
  
1.6 The properties and forces governing lipid bilayers. 
 
1.6.1 The membrane pressure profile 
As mentioned previously the cell uses the phospholipids as a 
way of compartmentalizing different components primarily 
because it is their inherent nature to form two dimensional 
bilayers in aqueous environments with physiological pH and 
ionic strength. Some lipids however do form nonlamellar 
structures but they can also be used by cells for mediating 
specific events that involve changing the morphology of the 
membrane. This feature of spontaneous curvature is 
intimately linked to the lateral surface pressure of the 
membrane. There are several forces involved in the 
modulation of the lateral surface. The most prominent of these 
are the electrostatic interactions between the hydrated 
headgroups, there is the restriction of contacts at the top of the 
Figure 1.6: Lateral pressure profile of a cross section of a lipid membrane 
with the different forces responsible. 
 acyl chains caused by the hydrophobic effect, hydrophobic interactions between the acyl chain 
and then there is steric repulsion headgroups and acyl chains. Because these forces are restricted 
to defined zones, the pressure can be up to several hundred atmospheres. 
For an overview of the lateral pressure through the membrane see figure 1.6. The lateral pressure 
profile can also be influenced by several external factors like the temperature, ionic strength and 
small molecules partitioning into the membrane. The lateral pressure profile plays an important 
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role not only in the lipid – lipid interactions but also the protein- lipid interactions and one must 
assume that these are very stringently controlled by the cells.  
1.6.2 Membrane Electrostatics 
The surface electrostatics play an important part of the assembly of the lipid membranes hence 
also in lipid protein interactions. The association of cationic proteins to anionic lipids is a very 
well studied phenomenon and is naturally driven by the positive electrostatic interactions. It has 
been shown that a cell can have anionic patches on the membrane driving the proteins to a 
specific location on the cell and the proteins can also have different modes of interaction 
depending on the charge density. Cationic lipids have also been found and studies show that they 
associate with anionic lipids and subsequently regulate peripheral lipid - protein interactions and 
also lipid – small molecule interactions. The size of these membrane domains can vary from 
several molecules up to several microns and have life spans that range the microsecond scale up 
to hours. Especially in the longer lasting domains the constituents may be changing all the time 
much as we imagine it for a micelle. A way for the cell to manipulate the membrane to form 
these domains of specific charge densities can be by phase separation.  
1.6.3 Membrane Phases 
The naturally occurring bilayer forming lipids can exist in several different phases which are 
defined by the diffusion rate of the individual lipids and the acyl chain order parameter. For 
example lipid bilayers combined with different amounts of cholesterol will show three distinct 
phases, liquid disordered, liquid ordered and solid gel. The liquid disordered phase is 
characterized by a low degree of acyl chain order and a fast diffusion rate while the liquid 
ordered phase also has a fast diffusion rate but the acyl chain order is also very high. The third 
and final phase is the solid gel which as the name indicates has a very slow diffusion rate and is 
bestowed with a high degree of acyl chain order [48]. See figure 1.7.  
 
 
Figure 1.7 : The three most relevant phases for biological membranes - the liquid disordered (left), the gel phase 
(middle) and the liquid ordered [1]. The liquid disordered is characterized by low degree of acyl chain order and a 
fast diffusion rate, the gel phase very slow diffusion rate and a high degree of acyl chain order and the liquid ordered 
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phase by fast diffusion rates and high acyl chain order. The latter is often induced by the presence of cholesterol 
molecules shown in light green. 
1.6.4 Membrane Thickness 
The thickness of the membrane is off course also a very important parameter since this is a key 
determining factor in how membrane active proteins interact with the lipid bilayer. The thickness 
is given by the length of the acyl chains with an increase in chain length we naturally see an 
increase in the bilayer thickness but also an increasing degree of saturation will thicken the 
bilayer. There are also physical parameters that will influence the bilayer for example the degree 
of hydration and temperature. A decrease in hydration will make the lipid head groups come 
together forcing the acyl chains to stretch out while an increase in temperature will make them 
contract. The latter is especially apparent around the phase transition temperature were you can 
observe large changes in bilayer thickness. But small membrane associating molecules can also 
change membrane also greatly affect bilayer thickness. The most well known example is 
cholesterol which increases the acyl chain order and hence membrane thickness. The 
hydrophobic sterol structure of cholesterol which has a natural affinity for the solid gel phase as 
this gives a closer hydrophobic packing. And yet the stiff and bulky structure of it would fit 
better in the liquid disordered phase which means the bilayer becomes “frustrated”. This is 
resolved by the induction of the third phase liquid ordered which stretches the acyl chains 
thickening the membrane. It should also be noted that unsaturated lipids greatly reduces this 
ordering and rigidifying effect of cholesterol.  
1.6.5 Membrane Dynamics 
The bilayer itself is by no means a static entity as there is a continuous movement of the 
individual lipids. There are several ways in which the lipids can move from the minute 
movements around the carbon bonds to larger scale movement such as rotation, lateral diffusion, 
protrusion from the bilayer and flip flopping from either side of the membrane leaflets see figure 
1.8. 
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Figure 1.8: Schematic overview of a lipid membrane and the different modes of movement that the phospholipids 
undergo in the membrane. Movements are indicated by arrows showing protrusion from the bilayer (A), rotation 
around its own axis (B), flip-flopping from either side of the membrane (C) and lateral diffusion (D). 
The timescale of these movements, range from picoseconds to hours, with a natural correlation 
between the scale of movement and time course. To illustrate this we can see in figure 1.9 how 
the different parts of lipid are at fixed positions but are given as bell shaped distributions with 
regard to their position relative to the bilayer center. This movement is something which is 
naturally also very dependent of the temperature of the system; with a decrease in temperature 
we observe an increase in the timescale. In the in vivo situation there are also other factors to 
take in to account, you can have different phases in which the movement is restricted to and you 
also have obstacles in the form of different membrane components that are immobilized for 
example by binding to the cytoskeleton. This will also affects the mobility of membrane proteins 
as they swim through this sea of lipids.  
 
Figure 1.9: The Trans bilayer density map of a DOPC bilayer which has been obtained x-ray and neutron scattering. 
The curves show the probability of finding the different segments of the lipid molecules. Starting from the center of 
the bilayer we find the terminal CH3 in green, the CH2 in dark blue, the carbon double bond in orange, the COO 
group in yellow, Glycerol in red and bound water in light blue. 
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2 The role of Anti Microbial Peptides  
There are many classes of anti microbial peptides all of which have been divided into subgroups 
on the basis of their amino acid composition and their secondary structure. Here we will 
introduce the largest and most well known of these with regards to their general features and how 
they work as. For a full list of these see table 2.1.  
Table 2.1: The table includes the five most well established groups of antimicrobial peptides with examples of 
proteins belonging to these subgroups. 
  Classes of antimicrobial peptides   
 
Anionic peptides 
Cationic peptides 
enriched for 
specific amino 
acids 
 
Linear cationic α-
helical peptides 
Anionic and 
cationic peptides 
that contain 
disulphide bonds 
Anionic and 
cationic peptide 
fragments of larger 
proteins 
Maximin H5 from 
amphibians 
Proline containing 
peptides from honeybees 
Cecropins, andropin 
ceratoxin and melittin 
from insects 
Peptides with 1 disulphide 
bond include brevinins 
Lactoferricin from 
lactoferrin 
Small anionic peptides 
rich in glutamic and 
aspartic acids from sheep, 
cattle and humans 
Proline and phenylalanine 
containing peptides 
including prophenin from 
pigs 
 
Cecropin p1 from Ascaris 
nematodes 
Peptides with 2 disulphide 
bonds include protegrin 
from pigs and tychpesins 
from horseshoecrab. 
Casocidin I from human 
casein.  
 
 
Dermicidin from humans 
Glycin containing 
peptides including 
hymenoptaecin from 
honeybees 
 
Pleurocidin from the 
winter flounder 
 
 
Insect defensins 
Antimicrobial domains 
from bovine α-
lactaalbumin, Human 
hameoglubin, lysozyme 
and ovaalbumin 
 Tryptophan containing 
peptides including 
indolicidin from cattle 
Seminalplasmin, BMAP, 
SMAP, PMAP from 
cattle, sheep and pigs 
Peptides with >3 
disulphide bonds include 
drosomycin from fruitflies 
and plant antifungal 
defensins 
 
 Small histidine rich 
salivary polypeptides 
including histatins from 
humans and other higher 
primates 
 
 
CAP 18 from rabbits 
Α- defensins from 
humans, rabbits and rats. 
Β-defensins from humans, 
cattle, mice, rats, pigs, 
goats and poultry 
 
 Glycine and Proline rich 
peptides include 
holotricin from beetles. 
LL37 from humans Plectasin derived from a 
fungi 
 
 
2.1 Cationic peptides enriched in specific amino acids 
The cationic peptides that are enriched in specific amino acid contain more than forty members. 
The amino acid in which they are enriched is greatly depending on the organism from which they 
are isolated. The largest subgroup of these peptides; the Proline- and glycine-rich, are mostly 
from insects and active against Gram-negative bacteria. Their mode of action is not fully 
elucidated but most like involves translocation without cell lysis. Another subgroup is the cystein 
enriched peptides which should not be mistaken for the defensin AMP family which represent 
the most diverse AMP family among arthropods. In mammals these AMP´s are usually enriched 
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in histidine and tend to be specific towards fungi e.g. Histatin found in Human saliva translocates 
the outer membrane of bacterial cells and is then targeted to the mitochondrion [22, 49, 50]. Also 
two tryptophan enriched peptides have been isolated from porcine. Both display a surprisingly 
broad specificity ranging from bacteria to fungi and even the enveloped HIV virus [51-53].  
 
 
Figure 2.1:    cartoon structure of indolicidin with the Tryptophans shown as blue sticks and the positively charged 
residues shown in red.  
2.1.1 Example: Indolicidin 
Indolicidin is cationic antimicrobial that was purified from the cytoplasmic granules of bovine 
neutrophils [53]. It consists of only 13 amino acids and out of these 5 are tryptophan’s making it 
a member of the AMP group that is enriched in is enriched specific amino acids. This makes it 
the naturally occurring protein with the highest known percentage of tryptophans ranking in at 39 
% but it is also the smallest known AMP. Indolicidin also contains three prolines, which are 
known to reduce the flexibility around the peptide backbone, giving it a distinct structure that is 
very different from the well known alpha helix and beta sheet structures in solution. Hancock et 
al showed that the circular dichroism spectra changed from unstructured to a poly – L – Proline 
II helical structure upon adsorption to POPC/POPG vesicles. This was complemented by the 
NMR structure of the peptide bound to zwitterionic dodecylphosphocholine (see figure 2.1) and 
the anionic detergent sodium dodecyle sulfate [54]. In both of these the structure is very well 
defined but represented a unique membrane-associated peptide structure. The complexes with 
DPC and SDS had a central hydrophobic core composed of Proline and tryptophan, which was 
bracketed by positively charged regions near the peptide termini. The tryptophan side chains, 
with one exception, folded flat against the peptide backbone, thus giving the molecule a wedge 
shape. It was established that the preferred location of Indolicidin in DPC micelles and lipid 
bilayers, using spin-label probes, was at the membrane interface. Indolicidin has a broad 
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spectrum of antimicrobial activity against Gram-positive and Gram-negative bacteria where it 
has been shown to have a Minimal Inhibitory Concentrations (MIC) between 0.5 and 64 µg/ml 
but it is also active against protozoa[55], fungi [56] and the enveloped virus HIV-1[57]. The 
mode of action seems to be bilayer disruption as it has been shown to cause cytoplasmic release 
of E-coli within minutes and also facilitate an increase in the transmembrane current of planar 
lipid bilayers[58]. 
 
 
2.2 Linear cationic helical peptides  
The largest and most diverse group of the antimicrobial peptides known so far is the linear 
cationic helical peptides where more than 300 different peptides have been found. These peptides 
are usually short meaning less than 40 amino acid residues, lack cystein residues and can 
sometimes have a kink or a hinge region in the middle [59]. They are active against a wide range 
of pathogens, including Gram-positive and Gram-negative bacteria, fungi and protozoa. In 
aqueous solution most of them are unstructured but upon adsorption to a lipid membrane or in 
the presence of alcohols or detergents they are converted into an α-helical structure [60].  
The mode of action by which this group of amps work, is to target the bacterial plasma 
membrane and permeabilized it in a concentration dependent manner. This is done in a variety of 
ways, including barrel-stave model [61], carpet model [62], and torroidal model [63]. In the 
barrel stave model the peptides reach the membrane either as monomer or oligomer and 
subsequently assemble on the surface, finally transversing the membrane by pore formation. This 
mode of action is mostly driven by the hydrophobic interactions with the acyl chains and is 
therefore less specific towards membranes of different lipid compositions. A minimum of 22 
amino acids is necessary to transverse the bacterial membrane for an α-helical peptide. In the 
carpet model the positively charged peptides cover the membrane in carpet like fashion until they 
reach a concentration where they permeate the cell by disrupting cell curvature. As opposed to 
the barrel stave model, the peptide does not need to assume a specific structure and the peptides 
are always in contact with the lipid headgroups at the interface with the acyl chains. This mode 
of action is more sensitive to the lipid headgroup charge, explaining why it is more specific 
towards the negatively charged surface of bacteria. The torroidal pore model is a mixture 
between the carpet model and the barrel stave model. Defined pores are formed as in the barrel 
stave model but the peptides lie in the lipid headgroup-acyl chain interface. This is possible 
because the peptides induce a sharp bending of the lipids so that the lipid headgroups can line the 
interior of the pore. 
There are several parameters that are important for how linear cationic AMP´s interact with 
membranes and what their mode action is. There is a substantial amount of evidence that not 
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only the net charge of the peptide that determines the specificity but also how this charge is 
distributed along the peptide chain [64, 65]. Anti microbial peptides with an evenly charge 
distribution along the peptide seem to have a higher affinity towards bacterial membranes rather 
than mammalian. On the other hand the peptides that have a low net charge or were the charge is 
unevenly distributed there is a lack of specificity and you can observe toxicity to bacterial, 
mammalian and fungal cells. Another factor is the propensity for helix formation as most of the 
linear cationic have a charge distribution that makes them amphipatic upon folding into a helical 
coil. This diversion of hydrophobicity and charge permits stronger interaction with the cell 
membrane as the peptide can bury itself in the interface between the lipid headgroup and the acyl 
chain. Another factor is the self association of AMP´s which is usually driven by either an N- or 
C terminus or by specific amino acids in the peptide sequence. This can allow for the formation 
of helical bundles that can initiate a strong hydrophobic interaction with zwitterionic membranes. 
An example of how peptide association can influence the selectivity of AMPs is the two AMPs 
Dermaseptin B and Dermaseptin S [11, 66] which differs in only a single amino acid and has the 
same amount of helix content in solution. But their degree of association is very different; 
Dermaseptin B oligomerises and permeates both zwitterionic and anionic membranes in contrast 
to the monomeric Dermaseptin S which only permeates anionic vesicles. A way to manipulate 
these self association properties is to attach a multimer forming moiety in the form of an acyl 
chain to the peptide. This way modulating the mode of action has been observed in vivo e.g. with 
the lipopeptide antibiotic polymyxin B [67]. 
Another measure for the peptide amhipacity is the hydrophobic moment [68] which is the 
dependence of the hydrophobic moment per residue on the mean residue hydrophobicity. There 
is a tendency for peptides with a high hydrophobic moment and moderate hydrophobicity to be 
the most membrane lytic [12, 69]. However, there are some drawbacks to this measure which 
makes it difficult to make absolute correlations between hydrophobic moment and activity. One 
is that often the AMPs have the charged residues unevenly distributed and the other is that it is 
assumed in the calculation of the hydrophobic moment that the helix is ideal with 100 % helicity. 
The calculation of hydrophobic moment allows intelligent mutations when it is desired to 
modulate the activity of AMP´s. 
Hydrophobic interactions play an important role in the partitioning of the amps into the 
membrane bilayer. There are two things that must be taken into account with regards to peptide 
hydrophobicity for amps to be useful in the host immune response system. One is that the 
peptide has to be soluble so that it can be stored for some period of time and not to self aggregate 
to a great extent but also to allow transport to the target cell. On the other hand the 
hydrophobicity has to be high enough to make it energetically favorable to interact with the 
hydrophobic region of the membrane and increase the permeability. 
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Figure 2.2:  Cartoon figure AMP Melittin showing the kinked α-helical structure with negatively charged residues 
shown in red.  
2.2.1 Example: Melitinin 
Melitinin was one of the first AMP´s that was described in 1972 [70] and it is also one of the 
most well studied AMP there is. Melitinin is the principal component of the venom of the 
European Honey bee Apis mellifera as it constitutes more than fifty percent of the dry weight of 
the bee venom. Mellitin induces membrane permeabilization and lysis of both eukaryotic cells 
prokaryotic cells in a non selective manner [71]. It is produced as a pro-protein (pro-Mellitin) 
that later gets formylated during its biosynthesis. The entire peptide consists of 26 amino acid 
residues that are cationic predominantly at the C- terminus where there is a stretch of positively 
charged amino acids See figure 2.2 while the N- terminus of the protein is mainly hydrophobic. 
The net charge of the protein is + 6 at physiological pH which will keep it in solution is able to 
keep it in solution but when exposed to naturally occurring membranes it will spontaneously 
insert [72, 73]. There is an asymmetric distribution of hydrophilic and hydrophobic amino acids 
that will make the peptide amphipatic upon folding into alpha-helix conformation. At low 
concentration Mellittin is monomeric and random coiled. At high concentration the alpha helical 
Mellitin will aggregate as a tetramers with very little structure difference [74], they are all helical 
with a kink around the prolin at position 14 giving them a bent rod shape. Melittin will partition 
into model membranes composed of PC with a partitioning coefficient of ~ 103-105 M-1 [75] 
while forming an α-helix structure. This association takes place in the matter of milliseconds. In 
spite of this the affinity of melittin towards negatively charged membranes have been shown to 
be a 100 times greater than towards those composed solely of zwitterionic vesicles[76]. 
Fluorescence studies looking at the local environment of the tryptophan at position 19 indicate 
that it is situated at the headgroup interface. The location of the tryptophan is modulated with 
increasing concentration of charged lipids in the membrane indicating functional difference in 
the lytic activity in the different bilayers[77]. Several studies have also shown that the lytic 
activity of melittin is reduced when there is cholesterol present in the model membrane possibly 
due a decrease in binding efficiency.[78, 79] Using peptide orientation sensitive techniques like 
oriented circular dichroism the mode of membrane lysis by melittin has been shown to be 
consistent with the torroidal pore model [80]. At higher concentrations melittin seems to disrupt 
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model membranes in a fashion similar to that of detergent with the formation of micelles and 
membrane fusion [81]. 
 
Figure 2.3: A schematic presentation of the helical wheel of Melittin with the helical moment displayed in the 
center. Hydrophilic residues as circles, hydrophobic residues as diamonds, potentially negatively charged as 
triangles, and potentially positively charged as pentagons. The most hydrophobic residue is green, and the amount of 
green is decreasing proportionally to the hydrophobicity, with zero hydrophobicity coded as yellow. Hydrophilic 
residues are coded red with pure red being the most hydrophilic (uncharged) residue, and the amount of red 
decreasing proportionally to the hydrophobicity. 
 
2.3 Anionic and cationic peptides that contain cystein bridges  
This group of peptides is mainly dominated by the AMP family known as Defensins. They were 
originally isolated from rabbit and human neutrophils but have but found in plants, insects, 
vertebrates and recently also fungi. All of the defensins are cationic and contain 6 to 8 much 
conserved cysteins that pair in three or four disulfide bonds. This high amount of disulfide bonds 
for a group of fairly small proteins 40 – 60 amino acids means that their secondary structure is 
much defined, often a mix between alpha helix and beta sheet. They are classified not only on 
the basis of their origin but also the pattern of disulfide bridging. For a classification of the 
defensins see table 1. Defensins are synthesized and as prepropeptides and are processed post 
translational into mature forms and in vertebrates they are then stored in granules. Several 
studies have shown that Defensins display a direct effect when used in concentrations above 2 
µM killing bacteria, protozoa, fungi and also viruses. The modes by which they work seem to be 
that they cause disruption of the cell membrane by interacting with specific components both in 
the membrane and in the interior of the cell. Furthermore, it has been shown that defensins can 
activate a host immune response against the invading organism. This is done by phagocytoysis, 
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degranulation of mast cells, initiating gene transcription and also stimulation of the innate 
immune system.  
 
Figure 2.4: The structure of Human betadefensin – 2 with alpha helix indicated in red, beta sheet in blue and the 
cystein bridges are shown in yellow.  
2.3.1 Example: Human betadefensin­ 2  
One example of this group is the Human beta-defensin-2; it is a cysteine rich, cationic 41 
residues long Antimicrobial peptide. There tertiary structure is much locked with 3 cysteine 
bridges that connect cysteins 1-5, 2-4 and 3-6 (see figure 2.4) and it is this cysteine bridge 
pattern that define it as a beta defensin. At the C-terminus it has an alpha helix and it has a pair 
of hydrogen bonded beta sheets that that are connected by a short turn to form a beta hairpin. It 
was originally isolated from psoriatic skin in 1997 [82]. The production is as a unique feature 
from other defensins inducible by various pro inflammatory agents and gram positive and 
negative bacteria [82, 83]. Although the messenger rna coding for human betadefensin 2 can be 
found in most tissues it appears to be mainly localized to the tract epithelia and the skin. The 
main function of this peptide is the killing of bacteria or fungi and LD50 values as low as 100 
ng/ml has been found. The mode of action is as yet not clear but Morgera and coworkers[84] 
have found that it might interact with membranes in a dimer form, as a cationic beta sheet 
platform presenting amphipatic helices for insertion into the bilayer. The interaction with of the 
peptides with the membrane then leads to the permeabilization which in turn could be part of the 
antimicrobial effect. The helix seems to modulate the antimicrobial activity with regards to 
membrane selectivity and killing kinetics.  
2.4 Anionic Anti Microbial Peptides 
The anionic peptides have not been described in much detail but include for example anionic 
peptides isolated from airway epithelial cells of humans, sheep and cattle. They are active against 
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both gram negative and gram positive bacteria are constituently produced and need zinc as a 
cofactor. Their mode of action has not been thoroughly investigated but it is suggested to be 
different from that of the linear cationic peptides where you have a charge interaction driving the 
association to bacterial membrane. 
 
Figure 2.5: The protein sequence of Dermacidin with the proteolyticly cleaved Fragment DCD-1. Negatively 
charged amino acids are marked in blue while the positively charged are shown in red.  
2.4.1 Example: Dermicidin 
 An example of the anionic anti microbial peptides is the 110 amino acid protein Dermicidin that 
was originally identified as the protein responsible for the 46 aa peptide proteolyticly processed 
product DCD-1 see figure 1 secreted from human sweat glands [85]. The full length protein has a 
pI of 6 and DCD-1 fragment has a pI of 5 based on calculation of the sequence seen in figure 2.5 
making them both anionic at physiological pH. There is no homology to any AMPs known to 
date. Dermicidin is constitutively expressed in the human dermis and it is transported through the 
sweat, where it can be found in concentrations 1-10 µg/ml, to the surface of the skin. In contrast 
to the other known human AMPS such as beta defensin it is not induced in the keratonocytes of 
skin diseases such as psoriasis. The DCD-1 fragment consists of 41 amino acids but smaller 
fragments of Dermicidins have also been found. These fragments have shown in vitro 
antimicrobial effect against Staphylococcus aureus, Escherichia coli, Enterococcus aecalis and 
Candida albicans. The importance of this antimicrobial effect in vivo have been substantiated by 
the fact that low expressions levels in humans leads to a chronic infection of the skin.[86] The 
structure of Dermicidin has not been solved and no biophysical experiments have been 
conducted so it is unknown how it interacts with bacterial membrane especially since it would be 
expected that there would be charge repulsion between the negatively charge Dermicidin and 
negatively charged bacterial membranes. The complexity and diversity of how these peptides 
work is underlined by the fact that Dermicidin has been shown to both activate normal human 
keratonocytes [44] and increased the turnover of fat in adipose tissue in mouse models [87]. 
2.5 Anionic and cationic peptide fragments of larger proteins 
This group of anti microbial peptides consists of a group of peptides that originate from larger 
proteins such as the peptide Casocidin derived from casein [13]. These fragments are created by 
either proteolytic auto cleaving or enzymes and then gain the antimicrobial activity although 
none was present in the paternal protein. The composition and structure of these AMP´s is 
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similar to those which we have already described and they do have any unique characteristics. 
 
Figure 2.6 : the structure of Lactoferrin shown in a cartoon form and shown with the surface potential on the rigth 
where the red colour indicates positively charged residues. 
2.5.1 Example: Lactoferricin 
In 1992 Bellamy and coworkers isolated lactoferricin is a 25 amino acid residue antimicrobial 
peptide from Bovine Lactoferrin. Lactoferrin is a 80 KDA iron binding glycoprotein that is 
present in milk[88] and also in polymorphonuclear leukocytes where it is released during 
inflammatory responses[89]. Lactoferrin has been shown to provide a natural defense against a 
wide range of bacteria[90] and fungi.[91] Originally, it was thought that the antimicrobial 
activity of the intact protein was due solely to its iron-binding properties. Scavenging of iron by 
Lactoferrin would make it unavailable for bacteria, which need it for growth. Later however it 
was shown that a peptide fragment near the N-terminus was much more potent as an antibiotic 
than the full length protein. It is noteworthy that the proper cleavage of Lactoferrin to form 
lactoferricin is catalyzed by pepsin at low pH suggesting that this could be occurring naturally in 
the stomach after ingestion. This feature of deriving Lactoferricin from Lactoferrin has also been 
shown for the Human analogue as well but this does not have the same anti microbial potency. 
The structure of lactoferricin changes dramatically when it is cleaved off from the intact protein. 
It loses its alpha helical structure and adopts a twisted beta-sheet structure as can be seen in 
figure 2.6. This new structure also has the effect that the peptide becomes more or less 
amphipatic with all the hydrophobic residues on one side and the basic residues on the other side. 
This amphipacity is something which is well known from the AMP group linear cationic helical 
peptides and is believed to be essential in the interaction with negatively charged membranes. 
But the two Trp are also essential for the activity but they are also well known for working as 
membrane anchors in membrane proteins and the NMR in DPC reveals that they indeed buried 
in micelle[92]. The mode by which lactoferricin exhibits its antimicrobial effect is not exactly 
clear but there have been some experiments with model membranes that can give us some 
indications. Differential scanning calorimetry show that lactoferricin has a preferential 
interaction with negatively charged membranes which is also seen for many of the native 
antimicrobial peptides [93]. These experiments also showed that lactoferricin perturbs bilayers 
by inducing a positive membrane curvature. Fluorescence studies looking at quenching of the 
Trp fluorescence signal with binding to membranes have shown that lactoferricin bind more 
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tightly and seem to penetrate deeper when the PG is present in the model membranes [94]. Based 
on this they estimate that the Trp aromatic ring is laying close to the glycerol portion of the 
phospholipids. Vogel et al [93] have suggested that the membrane perturbation facilitates the 
internalization of the peptide where it might bind RNA and DNA and work as a transcription 
factor as this has been shown for the full length Lactoferrin [95].  
 
 
 
 
Figure 2.7: A schematic of the three most established ways of membrane disruption. They all go through an initial 
peptide binding step (top picture) and then either make a pore by the barrel stave mechanism the hydrophobic part of 
the amphipatic peptide is facing the interior of the membrane and the hydrophilic side is facing the water filled 
lumen inside the pore (A). The second mechanism torroidal pore mechanism (B) which forms pores by lying in the 
headgroup region of the lipids, thinning and increasing the curvature stress of the membrane until we see the 
formation semi stable pores the or finally by interacting with the lipids in a detergent like fashion which destroys the 
membrane integrity by pulling fragments of the membrane into solution also known as the carpet mechanism (C) 
2.6 Mechanisms of bacterial resistance 
The way by which bacteria gain resistance is basically selected evolution where the bacteria are 
reacting towards an environmental pressure; those bacteria that have the genetic makeup that 
allows them cope, will survive and pass on their genes. With conventional antibiotics this is 
usually accomplished by drug inactivation or modification by enzymes for example by 
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penicillin-resistant bacteria through the production of β-lactamases or Alteration of target site as 
in the case of PBP—the binding target site of penicillin’s—in MRSA and other penicillin-
resistant bacteria. With Anti microbial peptides the case is slightly different as they primarily 
interact with the bacterial membrane which is more difficult to obtain resistance against. The 
strategies applied by the bacteria to circumvent these events all have to do with the peptide mode 
of attachment, peptide insertion and membrane permeability. For Staphylococcus aureus it has 
been shown it can modify its anionic membrane by production of basic phospholipid 
Lysylphosphatidylglycerol. This is done by up regulating the lysyl phosphatidyl-glycerol-
phosphate synthase that can transfer an L-Lysine from Lysyl-Trna to phosphatidylglycerol [96, 
97]. The idea is then that these positively charged phospholipids will then repel the cationic 
charged AMP´s. The Gram negative bacteria have also found ways of reducing the affinity of the 
cationic AMP´s to their membranes by changing the net charge of the lipid A moiety of the LPS. 
This change in the net charge comes about by substituting the phosphate group of lipid A by a 
phosphorylethanolamine residue with a free amino group and also adding a amino aribidose 
group to the ester linked phosphate group of the glucosamine group[10]. Another way is to 
increase the number of acyl chains in LPS by addition of palmitate. This will increase the 
hydrophobic interactions and retard the insertion of the peptides into the membrane [98]. There 
have also been some reports from in vitro experiments that indicate AMP resistance could be 
obtained by secretion of proteases. An example of this is the linear cationic AMP LL37 have 
been shown to be degraded into non active fragments by the Metalloproteinase Aerolysin 
produced by S Aureus [99].  
 
2.7 Experimental methods for characterizing AMP and lipid membrane 
interactions. 
 
This chapter will go through some of the different biophysical measurements and structural 
techniques. This list does by no means cover all the techniques which can be used to look at 
peptide membrane interactions, but covers most of the aspects which can be investigated. 
2.7.1 Nuclear Magnetic resonance (NMR) 
NMR is a method that involves the observation of specific quantum mechanical magnetic 
properties of an atomic nucleus in the presence of an applied, external magnetic field. Without 
going into details with the technique it enough to say that it allows the building of an atomistic 
model of a given molecule be it a small drug compound or a medium sized protein.  These three 
dimensional structures if obtained can give intimate details about the peptide - membrane 
interactions. Three-dimensional structures of antimicrobial peptides have been determined by 
solution NMR using short-chain phosphatidylglycerol micelles as a novel bacterial membrane-
mimetic mode solution [100, 101].  In these cases the NMR signal of the peptide backbone and 
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sidechain residues has been measured to give the constraints that allows the three dimensional 
modeling. It is problematic to get information about small peptides in lipid bilayers due to their 
high mobility (see figure 2.8), but it has been done for example for the AMP Tachyplesin which 
revealed a β-sheet conformation in the bilayer [102, 103]. Another approach is to look at how the 
lipid membrane is affected by the presence of AMP´s, especially with regards to the order 
parameters of the lipids. This has been done with success for both Pardaxin and Aurein [104, 
105] and showed how the binding of these affected the different parts of the lipids such the 
headgroup and the carbon atoms of the acyl chains. 
 
 
Figure 2.8 : Backbone alignment of the 10 best solution NMR structures  of both the N- and C- termini of  
Novispirin in SDS (red), LTAB (blue), and TFE (green). It is obvious from these images that there is a high degree 
of mobility of the AMP Novispirin, seen by the lack of alignment, especially in detergents. Adapted from wimmer et 
al. [106] 
2.7.2 X­ray diffraction 
The use of x-ray for solving protein structures has been known since the structure of myoglobin 
was solved in 1958 by Phillips and coworkers [107]. The technique involves forming crystals of 
the desired protein. The crystal is then irradiated with an X-ray beam which will be scattered 
upon hitting the crystal. The method now depends on the analysis of these diffraction patterns 
from which an atomistic model of the protein can be rebuilt. When trying to apply the 
Crystallography method to AMP´s it is a problem that many of them are intrinsically very 
dynamic making them unsuitable for crystallization.  One  AMP which has been crystallized is  
Alamethisin which actually crystallized in a pore like structure in methanol and the with the 
absence of lipids  [108]. This is the mayor drawback of crystallizing proteins, while the addition 
of various salts and organic solvents is needed, raising the question whether the observed 
structures represent natural phenomena. But instead of looking at the protein it is also possible to 
look at how AMP´s affect the lipid membrane by doing X-ray studies of the membrane. This has 
37 
2 The Role of Antimicrobial Peptides 
37 
 
revealed phenomena such as membrane thinning induced by the AMP LL37 and for Gramacidin 
S, cubic phase formation in the membrane [109-111]   
 
Figure 2.8:  The general workflow for solving a protein structure by X-ray crystallography. Initially a protein 
crystal is obtained and radiated with X-rays giving a diffraction pattern. The phases for the diffraction pattern are 
solved allowing the building of a electron density map. The atomic model is build on the basis of the electron 
density map allowing for further refinement of the analysis of the diffraction pattern. 
 
2.7.3 Fluorescence spectroscopy 
Fluorescence is a phenomenon where the molecular absorption of a photon triggers the emission 
of a photon with a longer wavelength.  The fluorescence of proteins is a mix of the fluorescence 
coming from the aromatic residues however mostly tryptophan residues, with some emissions 
due to tyrosine and phenylalanine. The normal maximum absorbance of Tryptophan is at 280 nm 
and the emission maximum from 300 to 350 nm. Tryptophan is a solvatochromic fluorophor 
which means that the maximum emission is sensitive to the solvent polarity of the local 
environment.  This fact that can be used for the study of AMP and lipid membrane interactions 
for as the peptide inserts into the membrane the polarity of the environment surrounding the 
tryptophan to peptide. The shift in fluorescence can then be measured as a function of increasing 
lipid or AMP concentrations in order to describe the AMP binding to the membrane [112]. It also 
possible to look at how the AMPs affects vesicle integrity by  including a fluorescent probe in 
the vesicles, that upon disruption of the vesicles will give rise to a change in the emission 
maxima or intensity [106]. It is also known that some AMP´s give rise to aggregation/fusion of 
vesicles and mixing of their contents. This can be shown with fluorescence by having a mix of 
two populations of vesicles containing separate fluorophors. If one of these fluorophors then 
quenches the other, this will give rise to a drop in fluorescence upon the aggregation/fusion of 
the vesicles which can be easily measured, as in the case of the AMP cryptdin4 [113]   
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Figure 2.9: A stick figure representation of the aromatic residues Tryptophan (left) , tyrosine ( middle) and 
phenylalanine (right) with the maximum absorption (blue arrow)  and fluorescence emission (red arrow) at pH 7. 
2.7.4 Circular Dichroism (CD) 
CD is a technique that measures the differential absorption of left- and right-handed circularly 
polarized light as a function of either the wavelength or the temperature. When measuring on 
proteins in general the measurements are usually done in the Far UV which can reveal important 
characteristics of their secondary structure.  CD spectra can be readily used to estimate the 
fraction of a molecule that is in the alpha-helix conformation, the beta-sheet conformation, the 
beta-turn conformation or random coil conformation (see figure 2.10).  The CD cannot give 
details on which part of the protein the alpha helices etc are or even completely predict how 
many there are. Despite this, CD is a valuable tool, especially for showing changes in 
conformation as a function of for example additives or denaturants [114-116].  For some AMP´s 
the mode of action when absorbed to lipid membranes is linked to a change in the secondary 
structure. For this reason CD has been measured for AMP, initially just in solution  [117] but 
also as a function of membrane mimicking detergents [118] and defined lipid vesicles [106]. The 
only prerequisite for CD samples is that there is a limitation with regards to the optical density of 
the sample and it has to be solubilized to give a signal. 
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Figure 2.10: A representation of three different proteins composed solely of α-helical (blue), β-sheet (orange) and 
random coil (red) structural components. The area shaded in blue is usually not accessible by a commercial CD 
apparatus but only Synctron radiation CD´s due to limitations in the light intensity. 
2.7.5 Molecular Dynamics (MD) 
With the increase in processing power there have also been advances in the computer simulations 
of dynamic biological systems. This also includes the interaction of AMP´s and membranes on 
the single molecule level simulated with coarse grain modeling.  The coarse grain modeling 
works by replacing an atomistic description of a biological molecule with a lower-resolution 
coarse-grained model that averages or smoothes away fine details. Coarse-grained models have 
been developed for investigating the longer time- and length-scale dynamics that are critical to 
many biological processes, such as lipid membranes and proteins (see figure 2.11). The main 
disputes regarding this technique are whether these simulations can reproduce the actual events 
that occur when peptides and membranes interact. Speaking in favor of this is the fact that it has 
been possible to see events which has been confirmed by biophysical measurements like the 
formation of pores by protegrin 1 [119] and a carpet like mechanism by maculatin [120]. The 
greatest limitations of this technique is the lack of processing power which is then reflected in 
the limited time lines which can be simulated and off course the reduction of atomistic details. 
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Figure 2.11: Timeline of the  insertion of Pardaxin into the bilayer modeled by coarse grain dynamics. Adapted from 
Thøgersen et al  [121] 
 
2.7.6 Atomic Force spectroscopy (AFM) 
The Atomic force microscopy is a technique that allows imaging and topography measurements 
of immobilized samples on the nanometer scale. The resolution is not yet at a stage where one 
can follow the organization of single AMP ´s into supra molecular structures like pores etc but 
rather gross morphological changes of the samples ( see figure 2.12) . These experiments have 
included looking at events in the AMP - membrane  interaction like  membrane thinning [122] or 
phase separation [123]  of model membranes. Furthermore there have also been studies looking 
at the formation of defects in live cells upon the addition of AMP´s [124, 125]. The limitations 
off this technique are the requirement for immobilization of the sample before measuring and 
differentiating between artifacts from immobilization and actual events. 
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3 Discussion of papers I, II and III 
This chapter will try to elaborate on and compare the different systems we have looked in paper I 
(Divorcing folding from function: How acylation affects the membrane-perturbing properties of 
an anti-microbial peptide), paper II (The anti microbial peptide Pardaxin displays a charge 
dependent orientation in lipid bilayers) paper III (Kinetic partitioning between aggregation and 
vesicle permeabilization by modified ADan). The common feature of these papers is that they 
encompass what has been the main focus of this thesis namely the interaction between proteins 
and lipid membranes.  
The three proteins we have been looking at have very individual features if we look at the net 
protein charge at a neutral pH we have the extreme of Novicidin that has a net charge of + 6 
Pardaxin with a net charge of + 1 and SerAdan with a charge of -1. This difference in the charge 
is bound to influence how this peptide interacts with membranes as numerous studies have 
shown that there is a strong correlation between peptide charge and membrane binding activity 
[126-129]. Furthermore it has been shown that, charge interactions between the bilayer and the 
peptide, does not only influence the initial binding but also the latter orientation in the bilayer 
[130, 131]. Their structures are also somewhat different with SerAdan´s b-strand regions 
connected by loops [132] Pardaxin´s α-helix structure with a pronounced kink and the positive 
charges pointing in opposite directions[133] and Novicidin that forms an α-helix with a distinct 
amphipatic nature with charged residues located on one side of the helix (Personal 
communications Magnus Franzmann). There is however no specific rules with regards to what 
structural elements AMP´s should contain except some degree of amphipathicity. The 
amphipatic structure has been shown to be essential both for alpha helical and beta sheet peptides 
for the interaction with membranes [134]. 
 
 
   
Figure 3.1:  The structure of the three proteins on which the work in this thesis is based. On the left SerAdan, in the 
middle Pardaxin, and on the right Novicidin. For SerAdan the two β-strands are shown in yellow and the β-hairpin 
connecting them in dark blue.  For Both Novicidin and Pardaxin the α-helices are shown in blue with positively 
charged residues shown in  
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3.1 Paper I: Kinetic partitioning between aggregation and vesicle 
permeabilization by modified ADan 
We will start out by looking at the least characterized of the peptides with regards to anti 
microbial effect namely SerAdan. SerAdan is derived from the ADan peptide but is designed not 
to be oxidized by replacing the Cys5 and Cys22 with Ser [1]. SerAdan is produced in humans 
due to a decamer duplication of the Bri gene which produces a prepro protein that after Furin 
cleavage results in the 36 AA peptide SerAdan. There have been studies showing that SerAdan is 
cytotoxic to neurocytes [1] but is likely to assume that SerAdan and the parent peptide ADan is 
not in its evolution origin an antimicrobial peptide. This assumption is based on the fact that 
ADan is produced due to a very infrequent mutation but still we see a strong membrane 
perturbing effect with as low as 1/500 molar ratio. Despite its negative charge we clearly see a 
preference towards anionic vesicles. This preference is visible in the secondary structure where 
we see that in the presence of DOPG vesicles SerAdan retains a structure that is very similar to 
the freshly dissolved peptide which is the membrane active species. This is contrary to the usual 
mode of action for non disulfide bond AMP´s where a large structural change is either the 
prerequisite or consequence of membrane perturbation [135]. We also observe the anionic lipid 
preference in the maximum release which is 80 %, 25 % and 15 % for vesicles composed of 
DOPG, 1/1 of DOPC/ DOPG and DOPC vesicles respectively. This is contrary to Novicidin and 
Pardaxin where we need ~ 5 times more protein to disrupt anionic vesicles. Furthermore this is 
the only one of the three peptides were we are not able to induce complete vesicle disruption just 
by adding copious amounts of peptide to the lipids. The reason for this is most likely due to the 
other unique feature of this peptide, namely the time dependency of its membrane permeablising 
abilities. The kinetics and mode of adsorption is apparently driven by electrostatic interactions 
with vesicles but if this is slow, due to a lack of anionic lipids, the protein that is not adsorbed to 
the lipids are transformed in to the non membrane permeabilising species. There has been two 
suggested structures of ADan one is two strands connected by a beta turn [132] the other a triple 
beta sheet [136]. Both of the structures, separates the charged residues into the turn regions, but 
with a lack of obvious anionic patches to facilitate electrostatic interactions specifically with 
anionic lipid. If we try to classify SerAdan according to the different types of AMP´s, which was 
listed in the introduction there is no obvious category where SerAdan fits the given criteria. This 
lack of structure homology with known antimicrobial peptides is again maybe due to the fact that 
it is not the native role of this peptide. We were not able to investigate the mode of the 
membrane disruption by looking at how they disrupt GUV`s in the same fashion as we have with 
Pardaxin and Novicidin due to incompatibility with the experimental procedure. There would 
have been a large motivation for doing this as the membrane permeabilization by beta-sheet 
peptides is the least well understood and might have offered some new insights. 
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3.2 Paper II, The anti microbial peptide Pardaxin displays a charge 
dependent orientation in lipid bilayers 
Pardaxin is peptide that been isolated from the fluid secreted from red sea mose´s sole 
pardachirus marmoratusa upon attack from predators like sharks. The pharyngeal cavity and the 
gills are the target organ for the repellent action of Pardaxin in shark [137] and the native role of 
the protein is not to work as an AMP but such activity has however been shown [138]. 
 Pardaxin has a α-helical structure in solution and there are no observable changes upon binding 
to zwitterionic vesicles while we see a shift towards a more beta sheet like structure when it 
adsorbs to anionic vesicles. Contrary to SerAdan this structural difference is not due to a lack of 
binding of Pardaxin to zwitterionic lipids. We base this conclusion on the fact that Pardaxin was 
the peptide with the lowest concentrations needed for zwitter ionic vesicle disruption with an 
observable effect at Peptide to lipid molar rations of 1/6000. Hence we can assume that this 
indicates that the structural difference of lipid bound peptide reflects differences in the mode of 
interaction with the membrane. Our calcein release experiments further underline the differences 
in membrane interaction as a function of charge as we need ~5 times more peptide to disrupt 
Anionic vesicles. When we performed the GUV measurements we saw a very clear pattern in the 
mode of disruption, zwitterionic vesicles leaked out their contents but the membrane remained 
intact while anionic vesicles lost their membrane integrity coinciding with full contents release. 
It has been previously been shown that Pardaxin orientation in the membrane was dependent on 
the acyl chain but this was the first time that it was shown that the mode of action was dependent 
on the charge of the headgroup. There are two general accepted modes of pore-formation one is 
the torroidal pore the other is the barrel stave, where the main difference between the two is that 
in the torroidal pore the peptide only interacts with the headgroup region. We could distinguish 
which of the two Pardaxin forms pores with our Carbon abundance NMR which indicates where 
in the membrane that the peptides interact. We see that in the zwitterionic vesicles the order at 
the C-terminal is increased which we interpret this as a transmembrane barrel stave pore.  
This is makes intuitively sense and is also in perfect agreement with others that have shown that 
a transmembrane protein will increase the acyl chain order [139, 140] while the formation of an 
-helix at the membrane's surface is supposed to induce positive curvature strain, which 
decreases the headgroup hydration and acyl-chain order of lipids [141]. When we performed 
LSCM measurements of a mixed solution of Zwitterionic and anionic vesicles with Pardaxin we 
observed a repetition with regards to the mode of and they occurred simultaneous. This indicates 
that in vivo Pardaxin will interact with both mammalian and bacterial cell walls 
nondiscriminatory, which has previously been suggested by in vitro experiments [138]. 
 
3.3 Paper III, Divorcing folding from function: How acylation affects the 
membrane­perturbing properties of an anti­microbial peptide: 
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Novicidin was the only one the three peptides which in its origin was a confirmed AMP as it 
primary structure was mainly based N-terminal region of the cathelicidin peptide SMAP-29 from 
sheep. When Novicidin was in the presence of anionic vesicles the secondary structure changed 
quite significantly from random coiled to α-helical but as with Pardaxin this did not reflect a lack 
of binding to the zwitterionic vesicle. Surprisingly Novicidin showed a preference towards 
zwitterionic vesicles in the calcein release studies, this time with a factor of ~12 even though 
Novicidin is much more negatively charged than Pardaxin. The ratio shifts as we make the 
peptide more hydrophobic by acylation with a ratio of around ~ 3 suggesting that if the 
electrostatic interactions are the governing forces this in some way increases the concentrations 
needed for disruption of vesicles. The question was whether the differences in vesicle disruption 
also reflected differences in the mode of binding such as with Pardaxin. We investigated this by 
attaching an environmental sensitive probe to Novicidin and here the picture was clear. With 
anionic vesicles we saw a large increase in the probe fluorescence prior to disruption of the 
vesicles but not indicating that prior to the vesicle disruption Novicidin buried itself in the 
membrane. This did however not tell us whether Novicidin was forming a trans membrane pore 
or just lying in the interface region. There were some indications in the fact that we needed many 
factors more protein, than for what we had so convincingly shown was pore formation, by 
Pardaxin in zwitterionic vesicles. We then performed the GUV measurements similar to what we 
had done for Pardaxin and now we saw something completely different. There was not the same 
fine distinction between the vesicle types with regards to mode of action. For both Anionic and 
zwitterionic GUV´s we a mix of different modes of interaction vesicle collapse, pore formation 
and vesicle aggregation with different frequencies depending on the vesicle charge and degree of 
acylation. All of this suggesting, that Novicidin worked by a mix of the torroidal pore 
mechanism and the carpet mechanism but with different degrees of membrane insertion 
depending on the charge of the lipid headgroup. Dynamic simulations of Magainin have shown 
something similar where it existed in two different forms a random coiled loosely associated to 
the surface and another where it folds into an alpha-helix that is deeper immersed into the bilayer 
[142]. Another interesting feature which the LSCM measurements of a mixed solution of 
Zwitterionic and anionic vesicles showed was that the anionic vesicles bound most of or all of 
the free Novicidin leaving zwitterionic vesicles untouched. This was interesting for two reasons, 
one is that this is to our knowledge, the first case where we show a discrepancy between vesicle 
disruption in a homogeneous and heterogeneous vesicle suspension. The other is that even 
though we show that Novicidin disrupts zwitterionic vesicles, which could indicate hemolytic 
activity, in the co presence of anionic membranes like bacterial cell walls Novicidin will disrupt 
the later.  
 
The methods in this thesis each have their own advantages and disadvantages and the study of 
peptide interactions with lipid membranes in this thesis clearly show that none of them on their 
own will give the full picture with regards to mode of interaction. We have shown by circular 
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dichroism that secondary structural changes of AMP´s are not a prerequisite for membrane 
perturbation but might rather decrease it. In our calcein release experiments we can observe clear 
differences in the amounts needed for vesicle disruption and kinetics suggesting distinctly 
different modes of interaction. An example is the differences in Pardaxin needed to permeate 
anionic and zwitter ionic which we show is due to total vesicle disruption and pore formation 
respectively. We suggest that molar ratios needed for vesicle disruption can also be compared to 
other proteins, to imply on their mode of action. An example hereof is the large difference in 
protein concentration needed for vesicle disruption by Pardaxin in zwitterionic and SerAdan in 
anionic vesicles clearly suggesting that SerAdan is not forming pores by the same mechanism as 
Pardaxin, if at all. But these results are however circumstantial and do unfortunately not give any 
definite answers with regards to the mode of interaction. The method of visualizing GUV´s after 
the addition of AMP´s by LSCM gives valuable information with regards to AMP mode of 
action. We can observe real-time the release of content and we determine pore sizes by 
encapsulating different size fluorophors. The work in this thesis also expands the use of the 
technique by looking at different types of vesicles simultaneously. We observed vesicles of two 
different types but given that the experimental set up will allow it one could easily imagine 
including more vesicle types. The drawback is that we lose the time resolution and it is not 
possible to stringently control the protein concentration which the vesicles are subjected to. 
 
Table 3.1: A listing of SerAdan, Pardaxin and Novicidin interaction with lipids and possible modes of action. 
 
Protein SerAdan Pardaxin Novicidin 
Concentration needed 
for membrane 
perturbation 
Active at 1/500 protein to 
lipid ratio 
Active at 1/6000 protein to 
lipid ratio 
Active at 1/2000 
protein to lipid ratio 
Structural changes upon 
lipid association 
Similar to monomer 
structure with anionic 
vesicles contrary to control 
Shifting towards Beta 
sheet with anionic vesicles 
From random coil to α-
helical with anionic 
vesicles 
Membrane orientation 
Zwitterionic lipids 
Unknown Perpendicular to the 
bilayer 
In the plane of the bilayer 
Membrane orientation 
Anionic lipids 
Unknown In the plane of the bilayer In the plane of the bilayer 
Mode of action 
Zwitterionic lipids 
Unknown Barrel stave Carpet /torroidal pore 
Mode of action Anionic 
lipids  
Unknown Carpet Carpet /torroidal pore 
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3.4 PERSPECTIVES AND OUTLOOK 
Since the first report of methicillin-resistant Staphylococcus aureus in the 1960s [143] there has 
been an increase in the frequency of bacterial strains that are resistant. Besides the methicillin-
resistant Staphylococcus aureus   there is now a prevalence of vancomycin-resistant enterococci, 
and extended spectrum β-lactamase-producing Enterobacteriaceae  [144]. The strains that gain 
resistance are often highly virulent and quickly gain resistance against new antibiotics reducing 
the lifetime of a new antibiotic dramatically. This is also reflected in the fact that less ten new 
antibiotics have been licensed from 1999 to 2008 [145]. The few numbers are partially due to 
difficulties in coming up with new products but also because of the reduced profit turn over from 
antibiotics.  The decreasing investment by major pharmaceutical companies in antimicrobial 
research has resulted in a rising concern from governmental health institutes around the world 
[146-148].  However one group of compounds that holds great potential is the AMP´s which so 
far seem to be more difficult to attain resistance against. The first AMP to undergo commercial 
development was the AMP Pexiganan a synthetic analogue of Magainin 2 derived the African 
clawed frog Xenopus laevis.  Pexiganan demonstrated excellent in vitro broad-spectrum activity 
against 3109 bacterial clinical isolates. Resistant mutants could not be generated following 
repeated passage with sub inhibitory concentrations[149] . Unfortunately in 1999, FDA approval 
was denied because Pexiganan was deemed to be no more effective that other antibiotics used to 
treat foot ulcers and further development of Pexiganan was stopped [150]. After this there have 
been other AMP´s such as Neuprex, Iseganan, Omiganan and Histatin variants which have gone 
in to clinical trials. Some of these projects have been stopped due to a lack of successful results 
in phase II clinical trials and others despite positive results have yet to be approved for clinical 
use [151].  One antimicrobial peptide which has reached the market is the lipopeptide 
daptomycin which have been approved in many countries for the management of Gram-positive 
infections [152]. Despite the poor success rate of AMP´s for commercialization this is still a 
large commercial interest because of the lack of alternatives. In December of 2008 The 
International medicinal companies Novozymes and Sanofi-Aventis declared that they were 
launching a project with the AMP Plectasin NZ2114 that targets the treatment of severe 
infections, such as pneumonia and septicemia, caused by bacteria like Staphylococcus and 
Streptococcus [153]. The likelihood of getting from a promising AMP to a commercial product 
is a greater if we can understand the forces governing AMP membrane interactions. The way to 
obtain this is by systematic biophysical studies and atomic structures of membrane bound AMPs. 
 
This thesis has mainly focused on the charge interactions between Membrane active peptides and 
lipids. To rule out other factors the lipid model membranes where primarily composed of only 
two different lipid types DOPC and DOPG. For future work it was be interesting to expand the 
scope of how SerAdan, Pardaxin and Novicidin interacts with membranes by looking at other 
factors as the presence of cholesterol. The effect of cholesterol in the membrane, is ordering of 
the acyl chains, increasing bilayer thickness and domain formation. This has been shown by in 
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vitro experiments to greatly influence peptide insertion. The cholesterol can both hinder the 
peptide insertion but also facilitate it followed by sequestering of the cholesterol into cholesterol 
rich domains [154-156]. These results have also been substantiated by experiments with mutant 
strains of live yeast cells producing different types of sterols, again showing a huge influence on 
peptide binding [157]. Another factor to investigate is the role of the lipid acyl chain lengths: as 
previously mentioned it can determine whether the peptide lays on the surface of the membrane 
or it transverses it. An NMR study has also shown that the interaction between lipids and 
peptides is very dynamic, the lipid can stretch the acyl chains or the peptide can tilt, depending 
what is most energetically favorable [158]. It would especially be interesting to compare 
Novicidin and Pardaxin as only the latter is long enough to transverse the 3-4 Å that usually 
comprises the membrane bilayer. Does the acyl chain length play an equally large role if the 
peptide only inserts in the headgroup region. Finally it would also be interesting to modulate the 
lateral membrane pressure by including lipids with the non bilayer forming headgroup PE or 
lipids with varying degrees of unsaturation, something that has not been studied systematically. 
 
Another issue to address is the acquisition of NMR spectra that can be used for determining the 
atomistic modeling of AMPs in the presence of membrane mimicking detergents or lipids. In this 
study we looked at how the AMP´s affected the NMR signal of the lipid bilayer but it would be 
very interesting to combine these with atomic structures of the AMP´s. As mentioned previously 
there are some inherent problems with studying AMP´s by NMR as they comprise a very 
dynamic system. One possibility could be the addition of the paramagnetic relaxant Gadolinium 
while measuring.  The Gadolinium will quench the NMR signal in a linear fashion away from 
the aqueous medium which for membrane AMP interactions can be used for determining how far 
away a give amino residue is from the aqueous solvent. It has already been shown that the 
technique can be used for determining the topology of alpha-helical membrane-proteins without 
the need for a complete NOE-based structure determination. [159, 160].  
 
The fact that monomeric and prefibrillar aggregates of SerAdan displays membrane effects that 
are similar to those of actual AMP´s, is very interesting considering that this is not the obvious 
role of this protein in vivo. A study of prefibrillar HypF-N aggregates showed that the early 
toxicity of these where very much dependent on the cholesterol contents of the cell type which 
they were subjected to [161]. This is a feature which is also known from AMP´s where the lack 
of affinity towards cholesterol enriched membranes is used to ensure the selectivity towards 
bacterial cells. So the question is whether all proteins have some inherent membrane perturbing 
effect and if this is the evolutionary basis for AMP´s. Are the AMP´s deriving from proteins with 
other functions but then being selected for due to their evolutionary advantage. Supporting this 
more generic membrane perturbing effect of proteins, are studies that show that aggregates of 
disease-unrelated proteins display the same cytotoxicity as those formed by proteins and peptides 
associated with disease suggest that toxicity is a consequence of the common structure of 
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aggregates [162, 163].  It would be interesting to test the ability of an ensemble of proteins with 
known functions and testing their ability to permeate vesicles as a function of their path towards 
a correct structural fold.  If this could be linked to atomic structures of the interactions between 
these otherwise non membrane active proteins, when they are situated in the membrane this 
would be a great leap in understanding not only the AMP membrane interactions. Furthermore it 
might also shed some light on the fundamentals of why, some otherwise good proteins suddenly 
turn bad. 
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SUMMARY 
This chapter involves the study of the mechanical stability of a membrane protein measured by 
dynamic Atomic force microscopy. This project was originally planned as the main goal of this 
thesis but due to problems with the data analysis of the force retraction curves; work was 
extended through the entire PhD. These studies will form the basis for additional studies to 
complete this work. All programming for the automatic determination of force peak size and 
length was done by Alberto Imparato.  
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5.1 INTRODUCTION 
Dynamic force spectroscopy has been used to explore the energy landscape of specific 
interactions between biological relevant molecules and for studying the unfolding pathway of 
single proteins [1-15]. The basis for these experiments is very simple: a cantilever is brought into 
contact with the molecule to allow it to bind. The binding can for example be a nonspecific 
binding or a covalent binding like a gold-thiol bond [16]. The cantilever is then moved away 
from the sample at a constant speed and when the protein can extend no more, the bond is then 
broken. By measuring the displacement Δx of the cantilever, Hooke’s law allows us to calculate 
the force F exerted on the cantilever: 
k
Fx =Δ
      (1)
 
It has been shown by Daniel Müller and coworkers [10-12, 17] that for membrane proteins the 
unfolding of membrane proteins in their natural membranes gives rise not just to a single force 
peak but to a saw tooth pattern of force peaks. Each of these peaks is proposed to coincide with 
the unfolding of certain structural elements such as a α-helix. In the work by Daniel Muller et al 
on Bacteriorhodopsin they found that its transmembrane helices predominantly unfold in pairs, 
each of the helices may also unfold individually and in some cases even only partially [18]. If we 
assume that helices unfold individually the scenario is sketched out in figure 5.1 for a membrane 
protein with 4 alpha helices.  
 
 60 
5 Investigating the mechanical stability of an inner membrane protein 
by atomic force spectroscopy  
Figure 5.1: Schematic overview of the unfolding of a protein with four structural elements shown in light blue each 
of which gives rise to an unfolding peak shown in read. 
The cantilever will bend until the structural elements unfold in a cooperative process reducing 
the force exerted on the cantilever to 0 again. The height of the peaks reflects the strength of 
interactions that are with the structural elements. To find the length of these structural elements 
the individual peaks can be fitted to the worm like chain model that gives a reasonable 
description of the behavior of the stretched protein [2, 19, 20]. The worm like chain model is 
model known from polymer physics and is used to describe the behavior of semi flexible 
polymers. The model assumes that the polymer is an isotropic rod that is continuously flexible. 
The model is especially suitable for describing stiffer polymers, with successive segments 
displaying a sort of cooperativity [21-23].  If this is done for all the peaks and compared to the 
primary structure of the protein this will give a map of the interactions that stabilize the protein 
[24] . The membrane proteins that have been unfolded so far all display multiple unfolding 
pathways each populated with different probabilities [5, 11, 13, 25-27]. These proteins have 
ranged from 6 to 12 transmembrane helices that have all been unfolded individually, pair wise or 
in triplets with unfolding forces ranging from 30-200 pN with some variations for the individual 
peaks. This will result in an ensemble of force curve patterns and to add on to the complexity the 
cantilever can in the case of a non specific binding attach at any given point of the protein. 
Therefore one of the obstacles for this technique is that quite a lot of data handling and sorting is 
involved. The Some methods have been developed for analyzing dynamic AFM data [28-30] but 
none of them have spawned a rise in the reported use of the dynamic AFM technique. To 
increase the likely hood of an attachment event people have used either 2 dimensional crystals of 
membrane proteins [31] or membranes that are naturally enriched in a specific protein like the 
purple membrane of bacteriorhodopsin [32] . However not all membrane proteins occur in high 
quantities in their natural membranes nor will they easily form 2D crystals. Therefore, for the 
technique to be of general use, it will have to be expanded to systems with a lower protein 
density. This is the task which we have undertaken in this work. We have chosen two different 
ways of immobilizing a membrane protein to a solid support. One is the use of a recombinantly 
produced membrane protein incorporated into phospholipid vesicles to form proteoliposomes. 
When transferred to a mica surface, the lipids will merge and form a bilayer containing the 
protein of interest. This has been applied with success to photosynthetic reaction centers which 
have been shown to retain both their structure and activity [33]. However there has also been 
reports of the opposite for example for the proton translocating nicotinamide nucleotide 
transhydrogenase protein were a loss of activity was observed subsequent to surface 
immobilization[34] possibly due to denaturation. If the protein denatures upon adsorption to the 
surface the dynamic force spectra will of course not contain peaks deriving from secondary 
structural elements. The other method is the tethering of a detergent solubilized membrane 
protein to a mica surface that has been functionalized with an amine reactive linker. This 
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technique was originally used for the soluble protein pea lectin [35] but has not previously been 
applied to a membrane protein. For the binding of the cantilever to the sample, both the 
unspecific binding and the use of a gold thiol bond were performed. The use of the gold thiol 
should increase the reproducibility of the experiments as the cantilever attachment point 
presumably would be the same every time.  
The model protein we have chosen for this study is the Disulfide bond forming protein B 
(DsbB). DsbB is an inner membrane protein and is an integral part of the network of catalysts 
that are required for the oxidative protein folding in proteo bacteria [36]. The protein is roughly 
20 KDa and consist of four transmembrane helices, a common feature of the whole DsbB family 
[36] and two large periplasmic loops [37] (see figure 5.2). Both periplasmic loops contain a 
conserved cysteine bridge at positions 41, 44 and 104,130 which have been shown to be crucial 
for the activity since removal results in loss of catalytic activity [38] DsbB has been co 
crystallized with Disulfide bond forming protein A and the crystal structure solved by Inaba and 
coworkers in 2005 [39-41] . The purpose was to see if we could get structural data from our 
dynamic AFM measurement that would coincide with the structural and stability data already 
obtained from the crystal structure[40] and other biophysical measurements [37, 42-50].  For the 
dynamic AFM experiments we used a mutant that lacked the cysteins at positions 41, 44, 49 104 
and 130 but retained a single cysteine at the position 8 which allows the formation of a specific 
gold thiol bond with a gold coated cantilever in the N-terminal part of the protein. In the reaction 
with the functionalized mica there are 7 possible points of attachment to DsbB, 6 lysines at 
positions 39, 66, 118, 167, 169 and 170 and the N terminus. For an overview of the DsbB 
structure and the key residues see figure 5.2 A. 
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Figure 5.2:  (A): Schematic drawing of a cystein deficient DsbB mutant showing the transmembrane helices in light 
blue the N-terminal in dark blue, the single cystein at position 8 is shown in yellow and lysines at positions 38, 65, 
117, 166, 168 and 169 are shown in green. (B) The liquid state NMR structure of DsbB [51] in complex with 
Ubiquinone shown in purple. Transmembrane helices are shown in blue, helices area shown in green and beta sheet 
is shown in orange.  
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5.2 MATERIALS AND METHODS 
Production and purification of DsbB: The purification protocol was adapted from Bardwell et al 
[52, 53]. C43(DE3) E. coli cells harboring the plasmid expressing the DsbB single cysteine 
mutant was transferred from a glycerol stock to two LB-agar agar plates containing 100µg/ml 
ampicillin grown overnight at 37oC. In the single cystein mutant cysteins at position 41,44,104 
and 130 have been mutated into leusine Agar plates were washed with 20ml LB-medium and 
inoculated into 2 L shaking flask with 1 Liter of LB medium containing 100µg/ml ampicillin and 
grown for 2 hours. The medium was the centrifuged for 10 min at 3000 g. The cell pellet was 
resuspended in 50 ml LB medium and used to inoculate 10 l of medium in a fermentor at 37oC. 
At an OD600 of ~ 1 the culture was induced with 450 µl 0.1M IPTG stock pr L. The culture was 
grown for another 4 hours and harvested by centrifugation at 4000g for 10min. The pellets were 
resuspended in 60ml 50mM tris HCl buffer pH 8, containing 300mM NaCl and 1mM EDTA. 
Subsequently PMSF dissolved in isopropanol was added to a final concentration of 2mM. Cells 
were lysed by rod sonication 5 times 1min... Cell debris was centrifuged for 10min. at 10000G 
and supernatant was subsequently centrifuged at 100.000G for 90min. The pellet was 
resuspended with a glass homogenizer in 50mM NaP pH 8, containing 300mM NaCl and 1% 
w/v DDM and loaded onto a Ni NTA column. A Ni NTA column was equilibrated with 5mM 
sodium phosphate (NaP) buffer pH 8, containing 300mM NaCl and 0.02% w/v DDM 0.02% 
DDM corresponds to. 0.4 mM, which is ~twice the detergent’s CMC value of 0.17 mM. The 
sample was loaded onto the column at a flow rate of 0.5ml/min, recycling the flow-through over 
the column overnight. The column was washed with 50mM NaP buffer pH 8 containing 300mM 
NaCl and 0.02% w/v DDM until baseline followed by an additional wash with 50ml containing 
30mM imidazole. A gradient was run from 30-500mM imidazole at a flow rate of 1 ml per and 
collected in 4 ml samples and analyzed on a 12% SDS gel. The purest samples were collected, 
concentrated and used for experiments. The final yield was ~ 3 mg/L of cell culture. 
Fluorescence labeling of DsbB: DsbB dissolved in 50 mM Phosphate buffer and 300 mM NaCl 
with 0.02 % DDM was bound on a Ni-NTA-agarose beads and incubated with a 3 molar excess 
of the thiol reactive Fluorescent probe 5 – iodacetamide fluorescein for 2 hours at 5oC with 
agitation. The beads were applied to an empty Pharmacia PD-10 column and washed with 
copious amounts of 50 mM PBS with 0.02 % DDM. The DsbB was then eluted by addition of 50 
mM EDTA and subsequently dialyzed against 50 mM PBS with 0.02 % DDM. 
Preparation of Small unilamellar vesicles: Lipid samples were prepared from chloroform stocks 
which were mixed and solvent was removed in a dessicator. Lipids were rehydrated to a 
concentration of 10 mg/ml in 50 mM PBS buffer pH 7.5 by vortexing. SUV´s were formed by 
inserting a rod sonicator in the liquid and pulse sonicating for 1 hour. The sample container was 
submerged in ice water to avoid lipid degradation due to elevated temperatures. Subsequently the 
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sample was centrifuged for 15 min in a table top centrifuge at 12000 rpm to remove titanium 
debris shed from the tip of the rod sonicator during operation.  
Determination of hydrodynamic radius: The hydrodynamic radius of samples was measured on a 
PDDLS/coolbatch 90T Dynamic light scattering apparatus from postnova analytics. The sample 
time etc was set to and the spectra were normalized according to molecular weight. Samples 
were diluted to ~ 100 ng/ml DsbB in 50 mM PBS buffer that had been filtrated through a 0.2 µm 
disposable filter syringe. 
Secondary structural changes measured by CD spectroscopy: Circular dichroism studies were 
performed on a Jasco J-810 spectropolarimeter (Jasco Spectroscopic Co., Hachioji City, Japan) 
with a Jasco PTC-348W1 temperature control unit. Scan speed was set to 100 nm min, slit width 
2 nm. All experiments were carried out in 50 mM PBS buffer pH 7.5, at 25oC using a 1 mm 
quartz cuvette. Samples were diluted to a protein concentration of 40µM. 
Reconstitution of DsbB into lipid vesicles: DsbB was mixed with sonicated lipid vesicles at a 
1:300 DsbB: lipid molar ratio with a DDM concentration of approximately 0.4 mM in 50 mM 
phosphate buffer with 300 mM NaCl. The samples were allowed to equilibrate with gentle 
agitation for an hour at 5oC. DDM was removed by addition of a surplus of Bio-Beads SM-2 
Macro porous Beads (Bio-Rad) and left to incubate for 30 min with gentle agitation, this was 
repeated two times and samples were subsequently used for analysis. There was no observable 
protein aggregation when subjected to a visual inspection.  
Functionalisation of mica: The functionalisation of mica with a primary amine reactive species 
was done according to the method described by Klein et al (ref): A water free solution of 
ethanolamine in dry DMSO (6.6 g in 12 mL) was heated up to 70oC . To keep the solution 
anhydrous, molecular sieve beads (0.3 nm) were added. Freshly cleaved muscovite mica sheets 
were incubated overnight in this solution. The mica sheets were washed four times in DMSO and 
twice in ethanol. The mica sheets were then dried under a nitrogen flow. At this stage the mica 
should be derivatized to expose primary amine groups which can then be bound to a bis-NHS 
ester. This is done by incubating the mica for 3 h in a solution of chloroform with 1mg/ml 
ethylene glycol bis(succinimidyl succinate) and triethylamine (0.5% v/v). The mica sheets were 
washed in chloroform and dried in a nitrogen flow. The mica sheets were immediately used for 
protein coupling. 
 
Activity measurements of DsbB  
The activity measurements of DsbB exploit the fact that DsbA loses its fluorescence as it is 
oxidized by DsbB. The assay was performed at 30°C in a reaction mixture containing 50 mM 
sodium phosphate (pH 6.0), 300 mM NaCl, 0.5 mM EDTA, 0.1% DM, ubiquinone-1 (coenzyme 
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Q1; Sigma), DsbB, and the reduced form of DsbA that was prepared as described [52, 53]. The 
rates were derived from the initial linear fluorescence decrease.  
 
Fluorescence imaging 
Fluorescence images of collapsed liposomes and immobilized fluorescently labeled DsbB were 
recorded on a Nikon TE2000 inverted microscope and using a 20× long working distance 
objective. Fluorescence excitation was done with a halogen lamb and using a G-2A filter cube 
(Nikon). Images were recorded with a high sensitivity CCD camera (Sensicam em, 1004×1002 
pixels, PCO-imaging, Kelheim, Germany) and operated with Camware software (PCO) 
 
AFM imaging and dynamic AFM of DsbB on solid supports: AFM images were done in a fluid 
chamber on a PicoSPM atomic force microscope (Molecular Imaging, Phoenix, AZ) in contact 
mode. For imaging of membranes the vesicles were deposited on a piece of freshly cleaved mica 
in 50 mM Phosphate buffer pH 7.5 with 300 mM NaCl and left for 1 hour to allow vesicle 
collapse and bilayer formation. Afterwards the sample was washed by exchanging the sample 
volume 10 times to remove excess layers of lipid. For binding of DsbB in DDM to amine 
reactive mica, the sample was placed on the mica for 1 hour to allow covalent binding, after 
which the sample fluid was replaced 10 times to remove any unbound protein. The dynamic 
AFM spectra were recorded on a JPK Nanowizard AFM system (JPK Instruments AG). The 
cantilevers had either triangular silicon nitride or silicon gold coated tip from budget sensors 
(Sofia, Bulgaria) with a nominal spring constant of 0.01 N/m and 0.06 N/m respectively. The 
pulling speed was set to 100 nm/sec and the cantilever was set to pause for 1 sec upon touching 
the sample surface. For every sample, ~1800 force curves were collected, and for every 25 
spectra the tip was moved to a new spot on the sample surface. The data collection for each 
dataset took roughly 5 hours. 
 
Dynamic AFM data analysis: The original was recalculated into force using Hooke’s law: 
k
Fx =Δ
     (1)
 
 and the data was sorted manually into spectra contained force peaks and those that did not. The 
spectra were analyzed automatically by a program written in C++ by Alberto Imparato. The 
program determined the baseline by a linear fit to the final part of the force spectra and the point 
where this intersected with the initial pressure slope was set as the starting point of protein 
extension.  Data were smoothed by averaging all values per nm extension which in average was 
~ 15 points pr nm. The length and unfolding force of each force peak was then determined by 
fitting to the wormlike chain model [2, 19, 20] and was compiled in an output file together with 
the value of the offset. 
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5.3 RESULTS 
 
5.3.1 Expression, purification, reconstitution and functional characterization of DsbB 
The expression and purification of functional detergent solubilized DsbB has been established as 
a routine procedure both in our lab and by other group’s [54-57]. However, it was necessary to 
establish a protocol for lipid reconstitution of DsbB and assay how this influenced the secondary 
structure and enzymatic stability. Both the wild type and cysteine deficient DsbB were 
successfully over expressed and Purified in DDM. The wt DsbB was then reconstituted into 
lipids containing both zwitterionic and anionic lipids. The samples turned slightly opaque upon 
removal of the detergents indicating a change in the vesicle morphology. This was tested by 
measuring the mean diameter of the vesicle suspension prior to and after DsbB reconstitution. 
Upon reconstitution an increase in the mean vesicle diameter of approximately 100 nm was 
observed (Table 5.1). There were no significant differences in the vesicle diameters as a function 
of the lipid composition.  
Table 5.1: Mean hydrodynamic radius (Rh) of different DsbB-amphiphile complexesa 
  
Protein Amphiphile Rh (nm) 
DsbB DM 6 
- DOPC 32 
- 8DOPC:2DOPG 27 
DsbB DOPC 68 
DsbB 8DOPC:2DOPG 72 
 
 
 
 
Notes: 
a All experiments at 25 degrees C in 50 mM Phosphate buffer with 300 mM NaCl. 
The sample was centrifuged in order to sediment the lipid fraction. According to SDS-PAGE, 
more than 75 % of the proteliposomes could be centrifuged down by a normal table top 
centrifuge (Fig. 5.3), indicating that they have a size much larger than that which was given as 
the mean average in the DLS. The pellet had a clear purple hue indicating that the DsbB still 
bound a quinone. This is a strong indication that it has retained the native fold during the 
reconstitution into lipids. 
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a     b             c  
Figure 5.3:  (A): 12% SDS gel with a molecular marker in lane (a), pellet (b) and supernatant (c) after 
centrifugation for 30 min at 12000 rpm in lane b. (B): pellet of DsbB solubilized in DOPC vesicles. After 
centrifugation a clear pink hue is seen. 
The secondary structure was measured for DsbB both reconstituted in DDM, 100% DOPC and 
20% DOPG: 80 % DOPC (Fig. 5.4 A). The structure of DsbB dissolved in DDM is clearly α-
helical with two local minima at 208 and 222 nm. The lipid reconstituted DsbB displays two 
essentially identical CD spectra which retain the double-minimum shape characteristic of α-
helices but with a slight shift in the wavelength of the initial minimum from 222 to 228 nm and 
the second minimum at 208 reduced to a shoulder compared to the detergent solubilized DsbB. 
Although the DDM- and lipid spectra are not completely identical, this is likely to reflect slight 
structural changes in the reconstitution process rather than actual protein unfolding. Furthermore, 
some artifacts may be introduced by light scattering from the liposomes.  
Activity was measured by an assay which monitors the decrease in the fluorescence signal of the 
periplasmic protein DsbA at 355 nm upon interaction with DsbB (Fig. 5.4 B). This decrease in 
fluorescence is caused by the oxidation of DsbA by DsbB, which in turns changes the 
environment around DsbA´s tryptophan. Assuming random insertion of DsbB into lipid vesicles, 
activity will be halved compared to that of detergent solubilized DsbB. This is because only 50 
percent of the DsbB molecules will present the long flexible loops that are responsible for the 
reoxidation of DsbA to the exterior of the vesicles. What we observe in the activity 
measurements is that there is activity but it is reduced by half for the DsbB reconstituted in 20% 
DOPG & 80 % DOPC and even more for the DsbB reconstituted in pure DOPC. Hence we 
conclude that DsbB is correctly inserted into vesicles, retaining its bound quinine, its secondary 
structure and to a large extent also the enzymatic activity. 
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Figure 5.4: (A) Circular dichroism spectra of DsbB in 50 mM PBS buffer pH 7.5 DDM ( ), DOPC ( ) and 20% 
DOPG & 80 % DOPC ( ). (B) Activity of DsbB in 50 mM PBS buffer pH 7.5 5 DDM ( ), DOPC ( ) and 
triangles 20% DOPG & 80 % DOPC ( ).  
 
5.3.2 The immobilization of DsbB on solid substrates 
Our force spectroscopy measurements require us to immobilize DsbB to a solid support by (a) 
covalent binding of detergent solubilized DsbB or (b) collapse of proteoliposomes containing 
DsbB onto freshly cleaved mica. Once DsbB is immobilized, we are unable to check if it retains 
its secondary structure or activity. As an alternative, we examined the distribution and 
morphology of the deposits. To check whether we had a homogeneous distribution of DsbB in 
the supported bilayer, we fluorescently labeled DsbB with fluorescein and checked for 
localization of fluorescein fluorescence at the mica surface by fluorescence microscopy. Most of 
the mica surface showed a homogeneous fluorescence indicating an even distribution of DsbB 
(Fig. 5.5 A). There were however also areas where there was either a lack of DsbB in the lipid 
bilayer or defects in the bilayer itself indicated by dark patches indicated by arrow 1 (Fig. 5.5 A). 
There were also spots where increased fluorescence suggested aggregation of DsbB. Most often 
these two phenomena’s could be observed in conjunction suggesting that the defects in the 
bilayer were caused by protein aggregation or vice versa. The same procedure was used to test 
whether the functionalized mica bound DsbB solubilized in DDM. Again the fluorescence could 
be localized just above the mica surface but the distribution was very different from what was 
observed in the lipid system. There are large contiguous regions of DsbB-fluorescence 
interrupted by spherical areas with low fluorescence, but there were no signs of protein 
aggregates on the surface of the type seen with lipids (Fig. 5.5 B). This would indicate that DsbB 
is bound to the surface but is very unevenly distributed. This might influence the data acquisition 
in dynamic AFM. 
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2 
1 
Figure 5.5: (A): Fluorescence image of fluorescein-labeled DsbB in DOPC vesicles collapsed on to a mica 
substrate. Arrow one indicating low fluorescence points possibly due to defects in the membrane. Arrow two 
indicating an area with increased fluorescence most likely due to the presence of protein aggregates. (B): 
Fluorescence image of amine reactive mica incubated with fluorescein-labeled DsbB in DDM. The fluorescence is 
shown in light color corresponding to the presence of fluorescein-labeled DsbB, which is very unevenly distributed.  
 To compare surface morphology of both DsbB in supported bilayers and on the functionalized 
mica surface, we imaged the surface by AFM. The lipid bilayer image (Fig. 5.6 A) shows a 
homogeneous flat bilayer with small perturbations with a height on the order of 1-2 nm and a 
width of 10-50 nm. These perturbations are too large to be individual DsbB molecules and most 
likely represent small protein aggregates. No defects could be observed in the bilayer but when 
applying excessive force on the membrane lipids, a layer could be peeled off that corresponds to 
the thickness of a bilayer. The surface of the functionalized mica with DsbB (Fig. 5.6 B) showed 
a much more rugged surface morphology with pronounced height variation but again in the 1-3 
nm scale. Some defects in the surface coverage could be observed indicated in figure 5.6 B by 
arrow no 3. Thus, the AFM imaging confirmed our fluorescence microscopy observations; the 
sample surface is unevenly covered by DsbB, but without obvious indications of protein 
aggregation.          
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20 Å 
3
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Figure 5.6: (A) Atomic Force Microscopy images of amine reactive mica incubated with fluorescein labeled DsbB 
in DDM in 50 mM Tris buffer pH 7.5 µm image arrow indicating small holes in the surface. The scale bare is 
250nm. (B) Atomic force image of fluorescein labeled DsbB in 20% DOPG & 80% DOPC vesicles collapsed on to 
a mica substrate. A color height scale bar going from 0 to 20 Å is shown n the right. 
5.3.3 Measuring Dynamic AFM on DsbB in DDM and Anionic lipid membranes  
The dynamic AFM of measurements of DsbB in lipids and detergent was undertaken to establish 
a method of mapping the structural elements of DsbB. Approximately 1800 force spectra were 
recorded for each of the different conditions, leading to 2.5-12% data sets with force peaks 
(Table 5.4). The dataset set that contained the most unfolding events was the sample with 
detergent solubilized DsbB covalently bound to mica (unfolded with the gold cantilever) while 
the one with the fewest events was DsbB in lipids (also unfolded with the gold cantilever). When 
unfolded with the SiNi cantilever, both samples contained 6-7% unfolding events. None of the 
spectra contained more than 3 unfolding events, with the great majority (73-100%) containing 
only one unfolding event. 
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Table 5.4: The frequency of force peak events in the dynamic AFM data sets and also the number of force events.a 
   Percentage 
of all curves 
Percentage of curves with force peaks 
Amphiphile Surface Cantilever Curves with 
force peaks 
Single peak Two peaks Three peaks 
8DOPC:2DOPG Mica SiNi 7.8 73 24 3 
8DOPC:2DOPG Mica Gold 2.56 100 0 0 
DDM F.-micab SiNi 6.27 90 8 2 
DDM F.-micab Gold 12 84 13 3 
Notes: 
aAll measurements in 50 mM PBS pH 7.5. 
b Functionalized mica allowing DsbB to bind covalently to the surface via Lys residues. 
When the rupture force and the rupture length of the unfolding peaks were plotted against their 
frequency, they displayed the signature of a normal distribution for all four experimental 
conditions except for the lipid reconstituted DsbB unfolded with SiNi cantilever where two 
overlapping sigmoidial distributions were observed. The sigmoidial curves were fitted to 
Gaussian functions and the peak values and widths are shown in Table 5.5.  
Table 5.5: Rupture forces and lengths for unfolding of different preparations of DsbBa  
Notes: 
Amphiphile Surface Cantilever Peak position 
Rupture 
force 
[pN]
Peak width 
rupture 
force[pN] 
Peak position 
Rupture 
length 
[nm] 
Peak width 
Rupture 
length 
[nm]
8DOPC:2DOPG Mica SiNi 449 355 16.7&34.5 10.6 & 28.3 
8DOPC:2DOPG Mica Gold 172 110 11.4 10.25 
DDM F.-micab SiNi 487 386 41.2 57.4 
DDM F.-micab Gold 78 52 11.8 21.1 
a All experiments performed in 50 mM PBS buffer at 15oC. Data obtained from Gaussian distribution fits to the 
histograms of the distribution of rupture force and the rupture length shown in Fig. 6. 
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The peak rupture forces observed for the unfolding of lipid reconstituted and detergent 
solubilized unfolded with SiNi cantilevers displayed similar rupture forces ~ 500 pN. The 
rupture forces using a gold cantilever were significantly lower, with peak rupture forces of 172 
and 78 pN for lipid reconstituted and detergent solubilized DsbB, respectively. The peak 
positions for the rupture length for the lipid reconstituted and detergent solubilized DsbB using a 
gold cantilever were very similar (~11 nm). This corresponds to roughly a sixth of the entire 
protein length indicating that the majority of the unfolding events represent the unfolding of a 
single helix. The rupture length of DsbB in DDM on functionalized mica with a SiNi cantilever 
was approximately 41 nm which could correspond to three out the four helices. Under the 
assumption that DsbB is bound to either of either the N terminal or the three leusines at the C 
terminal this would suggest that the cantilever preferably binds somewhere in which ever of the 
large periplasmic loops that is farthest away from the point of attachment. For the lipid 
reconstituted DsbB measured with a SiNi cantilever we see two rupture length populations one 
with a distribution around 17 nm and one around 34 nm. This would suggest that the cantilever 
attaches with an even frequency in either of the two periplasmic loops. The 5 most similar 
spectra of the force spectra, preferably with peaks around the most frequent rupture length where 
overlaid to elucidate on force peak characteristics, see figure 5.7.  
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Figure 5.7: left: Overlay of 5 force curves with a rupture length at +/- 7 nm from the maximum values of the 
Gaussian fit to rupture length frequency for:  DsbB in lipids and using a SiNi cantilever ~ 17 (top left) & 34 nm (top 
right), DsbB in DDM ~ 41 nm (bottom left) using a SiNi. The bottom right is DsbB in DDM using a Gold cantilever 
but here spectra could not be aligned at the maximum values of the Gaussian fit to rupture length frequency but 
where instead aligned for spectra with rupture lengths at ~34 nm. 
None of the datasets that were collected contained sufficient spectra with unfolding curves that 
were similar to that of the full length protein ~ 63 nm for comparison and overlay. As seen in 
table 3 DsbB incorporated into lipids and unfolded with a SiNi cantilever predominantly two 
unfolding peaks with a contour length of 17 nm and another of 34 nm was observed. For both of 
these values 5 spectra could be overlaid displaying only a single unfolding peak but with some 
noise in the initial 5-10 nm. This indicates that the protein favors unfolding in a cooperative 
manner regardless of where the cantilever attaches to the protein.  We observe the same for the 
unfolding of DsbB in DDM with a SiNi cantilever, 5 spectra could be overlaid with one 
prominent peak in this case at ~ 44 nm. These spectra overlaid better than the two previous but 
again some degree of noise can be observed within the initial 5-10 nm. For the unfolding of 
DsbB in DDM with a gold cantilever we could not overlay 5 spectra with peaks at the most 
frequent unfolding length ~11 nm. This was due to the very low signal to noise ratio but 5 
spectra with peaks around 34 nm could be aligned with an acceptable result. For DsbB in lipids 
unfolded with a gold cantilever the lack of spectra meant that it was not possible to align 5 
spectra with a satisfying result.  
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5.4 DISCUSSION 
 
5.4.1 The reconstitution of DsbB in lipids 
The meaning of measuring dynamic AFM on non Crystalline DsbB was to make the dynamic 
AFM method more generally applicable for measuring the mechanic unfolding of membrane 
proteins. The initial step was therefore to ensure that we started out with DsbB that was correctly 
folded which would be evaluated by CD measurements and activity measurements. From our 
centrifugation study we established that the main fraction of liposome-DsbB could be spun down 
with the lipid fraction of the sample. The liposome-DsbB retained the cofactor Q8 indicated by 
the purple color contrary to the Cys deficient mutant, which was yellow, and aggregated DsbB 
which is white (data not shown). The pink color is due to the charge-transfer interaction between 
Cys44 and ubiquinone Q8 [41, 58, 59] which strongly indicates that DsbB is properly folded 
upon insertion into lipids. The secondary structure of liposome - DsbB was more or less the same 
indicated by the CD measurements with a slight decrease of the signal intensity at 208 nm. 
However Otzen 2003 [60] showed that unfolding of DsbB by increasing fractions of SDS only 
changed the CD spectra intensity at 208 nm with a slight increase, the opposite of what we 
observe in lipids. All the experiments indicated that the lipid reconstitution of DsbB was 
successful. The activity was reduced by ~50% in lipids but this can be explained both by lack of 
substrate accessibility due to random insertion and scattering effects from the lipids at high 
protein concentrations. The protein insertion direction has been shown to be very dependent on 
the detergent addition and further work could be done to elucidate this [61]. 
5.4.2 Evaluating the morphology of DsbB on a solid substrate 
We had no direct means of measuring how the structure of DsbB is affected by immobilization 
either in a supported bilayer or on functionalized mica. There are some reports that the structure 
of soluble proteins change upon immobilization on a solid substrate [62-64] but this does not 
seem to be transferable to membrane proteins [31, 32, 65]. Based on this we assume that DsbB 
retains its structure on the surface. We were able to evaluate the protein distribution and the 
gross morphology by Fluorescence microscopy and AFM respectively. We observed that DsbB 
seemed to be more evenly distributed in the lipid bilayers compared to the functionalized mica 
judging from the fluorescence images. When we zoomed in by the aid of AFM we observed 
what seemed to be more or less homogeneously covered surfaces. This would suggest that the 
inhomogeneous coverage of the functionalized mica does not pose a problem as long as a 
suitable surface area is chosen for dynamic AFM.  
5.4.3 Dynamic AFM of DsbB reveal patterns in the unfolding events 
 The dynamic AFM measurements showed a force peak frequency in the order DsbB in DDM 
with gold cantilever > DsbB in lipids SiNi cantilever > DsbB in DDM with SiNi cantilever > 
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DsbB in lipids with gold cantilever. The low occurrence of force peaks in the DsbB in lipids with 
gold cantilever can easily be explained by lack of accessibility of the free Cysteine. If the free 
cysteine is facing the mica surface the cantilever has to penetrate the lipid bilayer in order to 
establish the covalent gold-thiol bond. The accessibility in combination with the formation of 
covalent bond could then explain why we observe the highest frequency of binding in the DsbB 
in DDM with gold cantilever. The main bulk of spectra obtained in DDM with gold cantilever 
was however not of lengths compatible with that of the full length protein or of a significantly 
better quality than those obtained with the SiNi cantilever. This work is the first to our 
knowledge that describes the unfolding of a detergent solubilized membrane protein by dynamic 
AFM. The force spectra obtained were of a quality similar to or better than those that were 
obtained for the lipid solubilized protein. The maximum number of force peaks observed in a 
single spectrum was three, indicating either that the single helices do not pose an unfolding 
barrier or that we have obtained an insufficient number of force trajectories. Dynamic AFM 
measurements have shown that not all transmembrane give rise to unfolding barriers for example 
Bacteriorhodopsin only shows 3 force peaks for 5 TM-helices [10] and AdiC only 7 force peaks 
for 12 TM-helices [65] The length of the force peaks suggest that this is due to pair wise 
unfolding of TM-helices. If the TM-helices of DsbB also unfold pair wise we should only 
observe 2 force peaks, which are supported by the lack of force spectra with 4 peaks. For three of 
the systems 5 spectra with a contour length comparable to that of the most frequent unfolding 
length were overlaid. They all displayed a single unfolding peak suggesting that primarily DsbB 
unfolds in a cooperative manner. These results does not exclude that more force peaks 
corresponding to helice pairs can be seen but the data available in this study does not support 
this. Less than 1 % of the total number of spectra contained spectra with a total length 
corresponding to that of DsbB. This meant that there were not enough contours to give a 
meaningful comparison by overlaying force spectra that had a contour of what would be 
expected for the full length protein. In a similar study on proteoliposomes by Fotiadis et al they 
recorded more than 400000 force spectra to get ~ 600 spectra they could overlay for pattern 
recognition. If we compare this to the total of ~8000 spectra that we recorded our work will have 
to be characterized as an initial study.  
 
5.4.3 Perspectives and future work  
This work described the immobilization of an inner Membrane protein to a solid support either 
solubilized in lipids or the detergent DDM. The sample preparation was standardized and could 
be routinely performed to a satisfactory degree confirmed by the techniques we had available 
such as fluorescence, CD and microscopy. The data analysis was also made partly automatic by 
the development of a program that determined both the protein rupture length and unfolding 
force. The bottleneck was the accumulation of sufficient amount of data which were suitable for 
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analysis and secondly the initial sorting of data into force spectra that contained force peaks and 
those that did not. The latter could be overcome by refining the data analysis program to be able 
do the initial data screening. The data acquisition could be optimized by creating a macro that 
would automate the procedure of moving and recalibrating the cantilever to a new point on the 
surface after a given number of measurements. This would make data acquisition a standalone 
process greatly increasing the number of force spectra that is feasible to obtain after protein 
immobilization. It would of great interest to pursue the path of mechanical unfolding of a 
membrane protein solubilized in detergent for several reasons. One is that one of the limitations 
of this technique has been the accessibility of pure protein sample material in high concentrations 
in a lipid suspension. The solubilization of membrane proteins in detergent is a standard 
procedure that is used in most membrane protein purifications [66-68]. Furthermore this would 
allow for example the inclusion of the detergent SDS which is known to destabilize proteins [69-
72]. A series of experiments could be performed with an increasing concentration of SDS to 
methodically study the effect the destabilizing effect of SDS on the mechanical stability of 
DsbB. These results could then be compared to the results previously obtained by circular 
dichroism and stopped flow fluorescence [60, 73]. 
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Vesicle permeabilizationss Familial Danish Dementia (FDD) is linked to formation and aggregation of the
34-residue ADan peptide, whose cytotoxicity may be mediated by membrane interactions. Here we
characterize the derived peptide SerADan, in which the two cysteines found in ADan have been changed to
serines to emulate the reduced peptide. SerADan aggregates rapidly at pH 5.0 and 7.5 in a series of
conformational transitions to form β-sheet rich fibril-like structures, which nevertheless do not bind
amyloid-specific dyes, probably due to the absence of organized β-sheet contacts. Aggregation is prevented
at neutral/acidic pH and low ionic strength by anionic lipid vesicles. These vesicles are permeabilized by
monomeric SerADan assembling on the membrane to form stable β-sheet structures which are different
from the solution aggregates. In contrast, solution ageing of SerADan first reduces and then abolishes
permeabilization properties. The competition between lipid binding and aggregation may reflect bifurcating
pathways for the ADan peptide in vivo between accumulation of inert aggregates and formation of cytotoxic
permeabilizing species. Our work demonstrates that non-fibrillar aggregates can assemble in a series of steps
to form a hierarchy of higher-order assemblies, where rapid formation of stable local β-sheet structure may
prevent rearrangement to amyloid proper.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Familial Danish Dementia, first described in 1970 [1] as heredo-
pathia ophthalmo-oto-encephalica, is an example of a degenerating
neurofibrillar disease of the same type as the more common and
better characterized Alzheimer's disease (AD) [2]. The illness involves
progressive dementia and is fatal with death occurring at the age of
50–60. The earliest clinical manifestation is cataract formation before
the age of thirty followed by progressive hearing loss and cerebellar
ataxia. A 34-amino acid peptide, ADan, has been identified in
circulation and in plaques in post-mortem tissue samples [2]. In
contrast to the Aβ aggregates formed in AD, these plaques appear to
be predominantly pre-amyloid in nature with amorphous morpho-
logy containing sparse and disperse fibrils, and are negative for
staining with the amyloid-specific dyes Congo red and thioflavin S [3].
The ADan peptide is formed due to a decamer duplication in the 3′-
end of the Bri gene causing a frameshift and generating a larger-than-ic light scattering; DOPC, 1,2-
yl-sn-glycero-3-[phospho-rac-
Amyloid Polypeptide
ence Centre, Department of
s Vej 10C, DK-8000 Aarhus C,
l rights reserved.normal precursor protein [2]. C-terminal degradation of the precursor
by furin yields the 34-amino acid ADan peptide rather than the native
23-amino acid Bri peptide [4] (Fig. 1). Both wild-type Bri and mutant
ADan peptide circulate in plasma, but only ADan has been found to
accumulate in tissue [5]. The oxidation state of the two cysteines in
serum-circulating and plaque-deposited ADan is controversial, with
some groups claiming it to be reduced [6] and others oxidized
between Cys5 and Cys22 [7]. The deposited form of the peptide is
highly heterogeneous [7], with the N-terminal glutamate modified to
pyroglutamate in a large percentage of the peptide chains, which are
also N- and C-terminally processed at position 3, 28 and 33.
Previous studies of the aggregational tendencies of ADan in both
the reduced and oxidized forms [8,9] did not observe classical fibril-
formation of the type routinely observed for Aβ and similar fibrillation
protein peptides under physiological conditions. Formation of amy-
loid-like material was only possible for the oxidized form of ADan
under mildly acidic conditions (pH 4.8) and after extensive ageing
(10–15 days). At other experimental condition, including a wide range
of pH values and peptide concentrations, oxidized and reduced ADan
were found to readily aggregate into various amorphous structures.
However, studies using SH-SY5Yor neuro2a cell lines showed that the
reduced form of ADan had higher cytotoxicity than the oxidized form
and led to marked caspase activation [8]. The distinct prevalence of
pre-amyloid over amyloid deposits makes ADan an interesting case
Fig. 1. Primary structure of wildtype Bri (wtBri), ADan and SerADan peptides. #:
Location of pyroglutamate found in physiological aggregates of ADan peptide. ⁎:
Mutation of cysteine to serine. ¤: Mutation of phenylalanine to tryptophane. -:
Elongation found in physiological aggregates of ADan peptide.
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cytotoxicity. Here we examine the aggregational properties of a
modified ADan-like peptide, termed SerADan, designed to prevent any
oxidation by replacing Cys5 and Cys22 with Ser. Besides mimicking
the reduced state which has been shown to be more neurotoxic than
the oxidized state in cell cultures [8], it also avoids the formation of
covalent crosslinks that complicate in vitro studies of ADan. Addition-
ally, the phenylalanine in position 14 was replaced with the
fluorescent probe tryptophan, which may also be considered a
conservative mutation. To address charge effects, the peptide was
investigated at both the approximately neutral pH-value 7.5 and the
slightly acidic pH 5.0, which is similar to the pH-value at which the
oxidized variant form amyloid-like structures. These two pH values
are on either side of the estimated isoelectric point of pH 6.05.
In order to elucidate the possible mechanism of cytotoxicity, we
investigated the direct interaction of SerADan with lipid membranes.
Several fibrillation-prone peptides are known to interact with anionic
lipid membranes but with different outcomes. Anionic membranes
stimulate fibrillation of Islet Amyloid Polypeptide (IAPP) [10,11], while
Aβ40 is protected from fibrillation when fully inserted in anionic
membranes but experiences accelerated fibrillation when surface
bound [12]. Interestingly, zwitterionic lipids may also reverse
fibrillation of amyloid and lead to cytotoxic species [13]. The anionic
lipid phosphatidylserine has been shown to trigger fibril formation for
a number of peptides and proteins including lysozyme, insulin and
transthyretin [14]. In contrast, annular structures that exhibit
heterogeneous single-channel conductance have been observed for
ADan bound to zwitterionic phosphatidylcholine membranes in a
manner highly similar to those of other fibrillation-prone peptides e.g.
α-synuclein and Aβ [15]. We consequently examined peptide-
membrane interactions using fluorescence spectroscopy and calcein
release assays for vesicles of anionic and zwitterionic phospholipids.
2. Materials and methods
2.1. Materials
SerBri (EASNSFAIRH FENKWAVETL ISS) and SerADan (EASNSFAIRH
FENKWAVETL ISFNLFLNSQ EKHY, in which Cys5 and Cys22 found in
ADan are replaced by Ser) peptides were obtained N90% pure
(EZBiolab Inc., Westfield, IN, USA). 1,2-Dioleoyl-sn-glycero-3-phos-
phocoline (DOPC) and 1,2-Dioleoyl-sn-glycero-3-[phospho-rac-(1-
glycerol)] (DOPG) were from Avanti Polar Lipids (Alabaster, AL).
Thioflavin T and other chemicals were from Sigma (Sigma-Aldrich, St.
Louis, MO).
2.2. Preparation of SerADan samples
Freeze-dried SerADan peptide was dissolved in 10 M urea and
allowed to disaggregate overnight at room temperature to obtain a
monodisperse monomeric population in the random coil conforma-
tion according to circular dichroism. Concentration was monitored by
absorbance at 280 nm (extinction coefficient estimate obtained using
the ProtParam tool at http://www.expasy.org) and found to be within
5% of the weighed amount. Stock concentration was adjusted to
2.5 mM. Stock aliquots were flash frozen and stored at −80 °C. They
were thawed and centrifuged immediately before use. Samples foraggregation were prepared by freshly thawed peptide stock to the
appropriate concentration (10–75 μM) in either 50 mM sodium
acetate (pH 5.0) or 50 mM Tris (pH 7.5) with or without 100 mMNaCl.
2.3. Preparation of liposomes and calcein release assay
Vesicles were prepared from stock solutions of lipids dissolved in
chloroform and dried overnight in vacuum. Lipids were then
resuspended by vortexing in milliQ water to a final concentration
of 10 g/L (∼14 mM), exposed to at least seven cycles of freezing in
liquid nitrogen, followed by thawing in a 50 °C water bath, before
extrusion through a 100 nm pore filter 12 times using a 10 mL
thermo barrel extruder (Northern Lipids, Vancouver, Canada).
Vesicle size was verified by DLS and vesicles were used the same
day they were made.
Calcein-containing vesicles, which were made immediately before
each experiment, were prepared similarly, except that lipid was
dispersed in 1.5 mL calcein-containing buffer (70 mM calcein, 50 mM
Tris, pH 7.5) prior to freeze–thawing and extrusion. Vesicles were
isolated from the calcein buffer by filtration through a pre-equili-
brated Pharmacia PD-10 column and small aliquots of the collected
fractions were monitored by fluorescence (excitation 490 nm, emis-
sion 500–600 nm) using Triton X-100 to obtain release of calcein and
thereby increased fluorescence of vesicle-containing fraction(s). Those
with the highest signal-to-background ratio were selected for further
use. The fluorescence measurements were conducted on a Cary
Eclipse Fluorescence Spectrophotometer (Varian, Palo Alto, CA) using
a 10 mm quartz cuvette with magnetic stirring. The vesicles were
diluted in 50 mM Tris buffer pH 7.5 to a concentration of ∼0.017 mg/
mL (21 μM), yielding a maximum signal of around 90 U under these
settings. For ageing experiments, SerADan was diluted from a 2.5 mM
stock in 10 M urea to 10 μM peptide and 0.04 M urea in 50 mM Tris
buffer pH 7.5. At different time points, 10 μL of this solution was
diluted 10-fold to 1 μMSerADan in the presence of 21 μMcalcein-filled
vesicles and calcein release was monitored bymeasuring fluorescence
emission intensity at 515 nm (excitation at 490 nm, 5 nm slits for both
monochromators) every 11 s until it reached a plateau. Spectra were
normalized with regards to maximum fluorescence, i.e. the fluores-
cence level achieved when 1% of Triton X-100 is added. For
permeabilization experiments with different concentrations of Ser-
ADan, the peptidewas first diluted from 2.5mM stock in urea to 50 μM
peptide and immediately diluted to the appropriate concentration in
the presence of 21 μM calcein vesicles.
2.4. Circular dichroism
Circular dichroism (CD) spectra were recorded on a Jasco J-810
spectropolarimeter (Jasco, Hachioji, Tokyo, Japan; 110QS cuvette,
Hellma, Müllheim, Germany) using averaging over 10 scans, resolu-
tion 0.1 nm and 10–50 μM peptide.
2.5. Fourier transform infrared spectroscopy
Spectra were recorded on a Bruker Tensor 27 infrared spectro-
meter (Bruker Optik GmbH, Ettlingen, Germany) with a Specac Golden
Gate single-reflection ATR unit (Specac Ltd., Orpington, UK). Aged
aggregates were washed twice in milliQ water and isolated by
centrifugation. Three independent samples were investigated (64
scans, 2 cm−1 resolution). The secondary structure was estimated
using OPUS 5.5. If needed, the presence of water vapor was corrected
for by subtraction of a fresh vapor spectrum or the inbuilt atmospheric
compensation function. Peaks were assigned from the 2nd derivative
and deconvolution of spectra [16]. The non-deconvoluted spectra
were fitted using the Levenberg–Maquardt method, the areas of
individual peaks calculated and the secondary structure content
estimated.
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Time-resolved fluorescence spectroscopy was performed on a
Cary Eclipse fluorometer (Varian, Palo Alto, CA), excitation at
290 nm and emission measured at 350 nm. Freshly thawed peptide
stock was diluted to 10–50 μM in buffer with or without lipid (LP
0.1–10). Aggregation was monitored for 30 min in 10 s increments
and for the following 600–1200 min in 1 min increments. Initial
reaction rates were calculated by linear regression as the slope of
the timecurve over the initial 10 min. Emission spectra were
obtained at start and at end points before and after vigorous
agitation of the sample to resuspend sediments. Time resolved
emission spectra were recorded similarly on a LS55 fluorometer
(Perkin-Elmer, Wellesley, MA), excitation at 290 nm, emission
310 nm–390 nm.
2.7. Dynamic light scattering
Time-resolved estimates of the hydrodynamic radius were
obtained by dynamic light scattering on a PDDLS/CoolBatch+90T
system (Precision Detectors, Bellingham, MA). Buffers were filtrated to
remove dust particles. Samples were prepared by dilution of freshly
thawed and centrifuged peptide stock into buffer (50 μM peptide,
50 mM Tris, pH 7.5) with or without freshly prepared and centrifuged
lipid vesicles (LP 0.1–10). Temperature was held at 22.5 °C and Rhyd
estimates were obtained every 2–3 min.
2.8. Electron microscopy
Electron microscopy was performed as described [17] by placing
5 μL aliquots on 400-mesh carbon-coated, glow-discharged grids for
30 s followed by washing with distilled water and staining with
phosphotungstic acid (pH 6.8). Samples were visualized using a Jeol
1010 transmission electron microscope. For time-based electron
microscopy on the hour timescale, aliquots were removed directlyFig. 2. Time-resolved electron micrographs of 50 μM SerADan at pH 5.0. Black bar correspon
Same sample as A. but showing a more electron-dense morphology. (C) Sample obtained aft
structures shown in B. (D) Sample obtained after 2 h and frozen for later imaging. Morpholog
shown morphology coexists with thin filaments.from the aging sample. For longer experimental periods, the aliquots
were flash-frozen in liquid nitrogen and stored at −80 °C.
3. Results
3.1. SerADan is sparsely soluble and quickly forms β-rich but
non-amyloid aggregates
The serine-variant of the short non-toxic wildtype Bri peptide
(SerBri) readily dissolves in dilute buffer to adopt a predominantly
random coil-like structure when examined with circular dichroism
(data not shown). In contrast, the longer SerADan peptide forms large,
insoluble aggregates when diluted from 10 M urea to 0.2 M urea at pH
5.0 (Fig. 2) and 7.5 (Fig. 3) as shown by time-resolved electron
microscopy. The aggregates can be observed within minutes of
dilution (Figs. 2A–B, 3A) and have μm-scale dimensions, consisting
of thin filaments that persist over the entire visualized time-span of
5 days (Figs. 2D, 3C, E). At pH 5.0, a more electron-dense and less
organized morphology can be observed for samples obtained 19 min
after dilution, but not for later time points. Smaller, transient
amorphous structures were also present during the first hour of
aggregation (Fig. 3B, shown for pH 7.5 only) but slowly disappeared.
When studied by attenuated total reflection infrared spectroscopy
(ATR-FTIR, Fig. 4A) the secondary structure of aged (12 h) and washed
samples, which are structurally stable over a period of several days,
appear rich in β-sheet with similar sheet content for pH 5.0 and 7.5
(34–36%). Circular dichroism spectra (Fig. 4B) show that β-structure
with a characteristic minimum around 215 nm appears within a few
minutes of dilution from the stock solution (within the dead-time of
themeasurement), suggesting that the peptide rapidly collapses into a
β-rich structure in solution. Over time, the spectra diminish in
intensity, particularly within the first 100 min of incubation (insert to
Fig. 4B), but retain the overall β-sheet appearance. At pH 7.5 there is a
lag phase of around 30 min before the ellipticity starts to decline,
while the lag phase is absent at pH 5.0.ds to 400 μm. (A) Thin filaments observed within the method deadtime (2–3 min). (B)
er 19 min showing dense, less organized morphology, which coexisted with the type of
y consists of long, thin filaments. (E) Sample obtained and frozen after 5 days aging. The
Fig. 3. Time-resolved electron micrographs of 50 μM SerADan at pH 7.5. Black bar corresponds to 400 μm. (A) Morphology after 6 min. (B) Amorphous structures observed after
24 min. Structures coexistent with structure of the type shown in A. (C) Sample obtained after 62 min contains filaments and amorphous elements. (D) Long, thin filaments of clear
morphology obtained after 2 h and frozen for later imaging. (E) Sample obtained and frozen after 5 days aging. Thin filaments persist as dominating structure.
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marks. However, no binding of Congo Red or Thioflavin T can be
observed (data not shown), just as reported for wildtype ADan
deposits [2,3]. This indicates a different arrangement of the β-
structure within the observed filaments. Our previous X-ray fiber
diffraction data show a strong signal at 4.76 Å arising from the
distance between adjacent β-strands [18]. However, signals at 10–11 Å
(which are strong in regular amyloid fibrils and reflect inter-sheet
distances) are essentially absent for pH 7.5 aggregates and very diffuseFig. 4. Secondary structure of aggregated SerADan. (A) Fourier transform infrared spectroscop
aggregates were washed in water and found to be stable over several days. The secondary
structure content by curve fitting. (B) CD spectra of 50 μM SerADan in 10 M urea (no buffer)
there is a clear minimum around 215–220 nm, indicative of β-sheet structure. The spectra r
change in molar ellipticity at 215 nm over time when 50 μM SerADan is diluted into 0.2 M
100 min. Ellipticity levels for the two runs have been offset for clarity. Note the lag phase afor the pH 5.0 aggregates [18], indicating a lack of organized higher-
order structure.
3.2. Time-resolved fluorescence data shows two distinct phases
The images obtained by EM show that the aggregates formwithin a
very short time span of a few minutes. The Phe11Trp substitution
provides a fluorescent probe to follow the time course of the aggregate
formation (Fig. 5A).y of 10 and 50 μM SerADan at pH 5.0 and 7.5, aged for 12 h at 10 and 50 μMpeptide. The
structure appears independent of pH and concentration. Table: Estimate of secondary
and at pH 5.0 and 7.5 after 50-fold dilution into 0.2 M urea. Immediately after dilution,
educe in intensity over the next 12 h but retain minimum around 215–220 nm. Insert:
urea from 10 M urea, indicating that most of the ellipticity change occurs over the first
t pH 7.5 which is absent at pH 5.0.
Fig. 5. Aggregation behavior of SerADan at pH 7.5 and 22.5 °C. (A) Time-resolved intrinsic fluorescence (excitation 290 nm, emission 350 nm) at 10 μM,15 μM and 50 μM, respectively.
An exponential decline of ∼5–7% is followed by a linear decline of ∼5%, a steep drop of ∼30% and a slower decline of ∼20%. Insert shows a blow-up of the first 25 min of the reaction.
(B) Dynamic light scattering data for 50 μM SerADan at pH 5.0 and 7.5 followed over time. Note the immediate increase in particle size in contrast to the lag observed by CD and
fluorescence.
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the fluorescence emission was monitored over time, we observe a
rapid and only slightly concentration-dependent ∼5–7% decline in the
signal over the first 5–10 min, followed by a ∼5% linear decline (∼5%).
After an additional 10–100 min (depending on concentration), there is
a very steep decline over 10–100min in emission down to ∼60% of the
initial fluorescence intensity, which slowly declines further by ∼20%
over the next 6–9 h. Incubation at pH 5.0 also leads to a similar 20%
decline in signal although the change is somewhat slower (Fig. 5A,
insert). In conjunction with the differences in the time-profile for the
CD signal between pH 5.0 and 7.5 (Fig. 4B), this suggests subtle
differences in the initial conformational changes at these two pH
values. The rapid fluorescence phase completed within 5–10 min at
pH 7.5 coincides with the formation of β-sheet structure within the
dead-time of the recording of the first CD spectrum (Fig. 4B). The
subsequent 5% signal change occurs over the next ∼100 min at 10 μM
peptide, and the rate of the linear decline (raw fluorescence emission
intensity per time unit) scales with protein concentrationwith a slope
of 1 in a log–log plot, indicating that this step does not involve a
change in the molecularity of the SerADan aggregate formed at this
stage (data not shown). However, the length of this phase (ending at
the onset of the steep fluorescence decline) is shortened dramatically
at 50 μM to around 15 min, indicating that the next step involves
aggregation. In fact we have two observations that indicate that the
large decline in emission to around 60% is simply caused by bulk
sedimentation of aggregated material. Firstly, there is no decline if the
experiment is performed with agitation, which prevents sedimenta-
tion (data not shown). Secondly, resuspension of the aggregates
returns fluorescence to the plateau value reached after the first 20%
decline in signal (data not shown).
Emission spectra recorded at different times at both pH-values
reveals that change in fluorescence signal within the initial exponen-
tial phase and slow linear decline (prior to the sedimentation step) is
due to changes in fluorescence intensity rather than a major shift in
maximum emission wavelength, since we only observe a slight blue-
shift from ∼353 nm to ∼350 nm (data not shown).
The rapid fluorescence decline to a 60% level (completed after
20 min at a concentration of 50 μM SerADan) is complemented by DLS
data for 50 μMSerADan at both pH 5.0 and 7.5 which showan increase
in particle size to a plateau level within 20–30 min (Fig. 5B). During
this period there is no change in the CD signal at 50 μm SerADan (Fig.
4B insert). Rather, the slow decline in CD signal seen for 50 μMSerADan (Fig. 4B insert) coincides with the slower decay over several
hundreds of seconds from ∼60 to ∼40% intensity after the rapid
fluorescence decline. Thus there appears to be several phases in the
sedimentation process, of which only the last one is detected by CD. As
a reporter of tertiary and quaternary structure, Trp fluorescence is a
more sensitive reporter of protein changes than CD signal and it is
therefore not unexpected that more phases are revealed by the former
method.
Early onset of formation of large aggregates and thereby
sedimentation can also be triggered by addition of seeds of preformed
aggregates, which is a well-known characteristic of batch fibrillation
in vitro. Thus, addition of 1.5% seeds reduces the sedimentation half-
time from around 200 to around 120 min, while 15% seeds have little
further effect (data not shown).
3.3. SerADan interacts with the anionic lipid DOPG
Wildtype ADan is cytotoxic to the commonly used SH-SY5Y
neuronal cell line [8,9] in both oligomeric and more extensively
aggregated forms. The known interaction between cytotoxic peptides
and cell membranes prompted us to study the membrane interactions
of the SerADan peptide. Fibrillation of numerous proteins has
previously been shown to be stimulated by the presence of anionic
lipids [10–12,14] so we investigated the effect on aggregation by both
the zwitterionic DOPC and anionic DOPG. While little interaction was
observed with DOPC at both pH values (data not shown), DOPG
interacted strongly with freshly diluted peptide. The presence of
anionic lipid prevented the sedimentation of large aggregates (Fig.
6A). This effect was pronounced at even 1:10 lipid:protein ratios at pH
7.5 while 10:1 lipid:protein ratios were required at pH 5.0 (data not
shown). For pH 7.5, the anti-sedimentation effect was abolished for all
but the highest lipid concentration (LP 10) by the presence of 100 mM
NaCl, indicating electrostatic forces as an important factor in the
interaction. However, the lone tryptophan also appears involved in the
interaction as the peptide fluorescence spectrum shows a clear
blueshift from ∼353 nm to ∼340 nm when incubated with lipid
(Fig. 6B insert). In contrast, the far-UV CD spectrum has a minimum
around 210 nm (Fig. 6B) which is different from andmore intense than
that in the absence of lipid (Fig. 4B). Furthermore, it does not undergo
any significant band shifts or intensity changes over time. Interest-
ingly, the small pre-sedimentation exponential decay in emission
(within the first 20 min, Fig. 5A) is not affected by lipids, suggesting
Fig. 6. Spectroscopic and microscopic investigations of SerADan lipid interactions at pH 7.5 and 22.5 °C. (A) The effect of anionic lipid (DOPG) at high and low ionic strength on the
change in fluorescence signal (excitation 290 nm, emission 350 nm) of 10 μM SerADan over time. The presence of lipids prevents sedimentation but the effect is abolished by the
presence of 100 mM NaCl at lipid-to-protein ratios (LP) of 1 and below. (B) CD spectra for fresh (immediately after dilution from stock in 10 M urea) and aged (12 h after dilution)
SerADan (10 μM) in the presence of DOPG, LP 10 at pH 7.5 (no NaCl). Fresh spectrum in absence of DOPG (from Fig. 4B) included for comparison. Insert: Emission spectra showing
significant blue-shifting. (C) Time-resolved DLS of 10 μM SerADan showing inhibition of aggregation at LP 1 and 10. (D) Electron micrograph of 50 μM SerADan with DOPG (LP 10) at
pH 7.5 after 5 days aging. Black bar corresponds to 400 μm. The previously observed thin filaments are absent in favour of amorphous material.
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can occur on the lipid surface.
When examined at pH 7.5 by DLS, the formation of large species is
highly dependent on the presence of lipids (Fig. 6C). As described
previously the formation of large species is fast in the absence of
lipids, while the presence of small amounts (LP 0.1) slows the
formation of large species considerably. At higher lipid concentrations,
the formation of large species is negligible within the observed time
window. Electron microscopy of samples aged for 16 h or 6 days did
not show straight fibril-like structures but rather small amounts of
wool-like morphologies (Fig. 6D), suggesting mixed, amorphous lipid/
peptide material. This suggests that the presence of anionic lipid
prevents the formation of fibril-like aggregates instead of just
preventing their sedimentation.
3.4. SerADan affects release of calcein from vesicles in competition
with ageing
To investigate more closely the interactions of SerADan with
lipids, we studied the ability of the peptide to release calcein fromdifferent vesicles. In this assay, calcein is initially trapped in vesicles
at self-quenching concentrations and subsequent release of calcein
leads to a large rise in fluorescence which for SerADan follows an
approximately exponential time course (Fig. 7A). This permeabiliza-
tion ability towards DOPG vesicles is maintained at peptide:lipid
molar concentrations down to 1:500 (Fig. 7B). SerADan's ability to
release calcein is highly dependent on its age. While SerADan
freshly diluted from a stock in 10 M urea is able to affect release of
almost 60% of all trapped calcein from 21 μM DOPG vesicles, this
figure drops precipitously to around 30% within 15 min of ageing
(Fig. 7C), and subsequently remains at a plateau until it drops
further after around 3 h of ageing (corresponding to the onset of
precipitation seen in Fig. 5A). Over the same 15 min ageing time
range, the rate constant at which calcein release occurs (approxi-
mated by a first order fitting to the release data) drops by around a
factor of 10, after which it remains at a very low value. The ability to
release calcein is also sensitive to vesicle type. SerADan diluted from
a stock in 10 M urea and aged for about 10 min is able to effect only
release of around 31% of the trapped calcein from pure DOPG
vesicles (Fig. 7A) over a period of about an hour, and the figure
Fig. 7. Ability of SerADan to permeabilize vesicles at pH 7.5 and 22.5 °C. (A) Time profile of the release of calcein from 21 μMof vesicles of different compositions by 1 μMSerADan (50-
fold diluted from a 50 μM solution in 0.2 M urea that had been aged for an hour after 50-fold dilution from a 2.5 mM stock in 10 M urea). Lines indicate best fits to single exponential
decays. The fit is not particularly good for DOPG, but the associated rate constant and amplitude provide useful (if approximate) measures of the efficacy of permeabilization. (B)
Ability of different concentrations of freshly diluted SerADan to permeabilize 21 μMcalcein-filled DOPG vesicles. SerADanwas first diluted from 2.5mMpeptide in 10M urea to 50 μM
peptide in 0.2 M urea, and then immediately diluted to the indicated concentrations in the presence of vesicles. SerADan permeabilizes a significant proportion of the vesicles at
molar protein:lipid ratios down to 1:500. (C) Effect of ageing on ability of SerADan to permeabilize DOPG vesicles, measured in terms of the rate constant and amplitude of calcein
release (derived from exponential decays as in panel A). SerADan was aged at a concentration of 10 μM in 0.04 M urea (diluted 250-fold from a 2.5 mM stock in 10 M urea) and
subsequently diluted to 1 μM in the presence of 21 μM DOPG. The time profile thus reports on the ageing at 10 μM concentration. (D) Effect of ionic strength on ability of 1.0 μM
SerADan to permeabilize 21 μM DOPG vesicles, measured as in panel A.
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DOPC vesicles, respectively. Just as high NaCl concentrations abolish
the interaction between lipids and SerADan (Fig. 6A), they also
prevent SerADan from permeabilizing vesicles (Fig. 7D).
4. Discussion
4.1. The multifaceted nature of SerADan aggregation
SerADan is an interesting model aggregation system for several
reasons. Firstly, the close similarity to the original ADan peptide
provides a direct link to aggregation processes occurring in vivo.
Secondly, despite the preponderance of β-sheet structure and the
overall amyloid-like appearance of the aggregates at longer time
points, it presents no bona fide amyloid structure (according to
both tinctorial assays and X-ray fiber diffraction studies). Diffraction
data [18] indicate that the peptide is able to form organized β-
stranded structure at the local level, but cannot assemble the
ensuing β-sheets into supramolecular structures that are suffi-
ciently organized to provide binding sites for amyloid-specific dyessuch as Thioflavin T and Congo Red. In this sense SerADan occupies
an intermediate position between classical amyloid and more
diffuse protein aggregates, which may occur naturally as reversible
associations in secretory granules [19]. These less well organized
structures can be stabilized by local interactions in competition
with proper amyloid structures [20] or may be held together by e.g.
complementary charges mediated by detergent molecules [21].
The conformational and functional transitions identified for
SerADan based on the use of 6 different techniques (circular
dichroism, FTIR, Trp fluorescence, dynamic light scattering, electron
microscopy and the release of calcein entrapped in vesicles) indicate
that non-fibrillar aggregates can also assemble in numerous steps. We
can thus build up a rather detailed picture of the different steps
involved in SerADan aggregation after it has been diluted out from
10 M urea into buffer (summarized in Fig. 8). The following data
pertain to behavior at pH 7.5 but are essentially the same at pH 5.0
unless indicated otherwise. SerADan is calculated to have a negative
charge of −1 to −2 at pH 7.5 and ∼+1 at pH 5, but the minor difference
in behavior at these two pH values reveals that the overall charge does
not play a significant role.
Fig. 8. Model of the different aggregation steps for SerADan and its interaction with lipids. Times indicate the approximate lengths required to complete the step in question (at
concentration ranges spanning 10–50 μM SerADan). The first phase (first 10 min) involves formation of β-sheet structure, a ∼5% loss in Trp fluorescence, initial aggregation and ∼50%
loss of permeabilization ability. Over the next 10–100 min aggregation levels increase, leading eventually to a multi-step sedimentation of large aggregates with loss of
permeabilization ability, CD and Trp signals. Calcein-containing vesicles are denoted by circles. The different shades of grey indicate different levels of ability of SerADan aggregates to
permeabilize the vesicles.
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independent decline in Trp fluorescence; concomitantly a large
amount of β-sheet structure forms rapidly according to circular
dichroism, after which it stabilizes temporarily. In this period,
SerADan's ability to permeabilize calcein-loaded membranes declines
50% in terms of the amount of calcein that can be released and
around 10-fold in terms of the rate constant of permeabilization. This
initial Trp decline is not so evident at pH 5.0, and at this pH the CD
signal starts to decline straight away, suggesting that the rearrange-
ment step occurs more rapidly at pH 5.0 or is bypassed to some
extent. Over the next 5–100 min (depending on peptide concentra-
tion), there is a minor (∼5%) linear and concentration-independent
decline in fluorescence which may indicate a modest conformational
rearrangement, but no change in permeabilization efficiency or CD
signal at pH 7.5. Compared to the initial non-aggregated species
which can permeabilize up to 60% of the vesicles, the aggregates
present at this stage have a two-fold reduced membrane permeabi-
lization activity, perhaps based on a limited ability to dissociate and
re-aggregate productively in the membrane environment. Alterna-
tively, these aggregates do not rearrange in the membrane, but
simply possess a more modest permeabilization activity than the
aggregated species formed by assembly of monomers in the
membrane environment; the assembly process in the membrane is
likely to be different from that in solution and also leads to β-sheet
assemblies with stronger CD signals and more blue-shifted Trp
fluorescence than in solution. In this time range, we also observe a
marked growth in aggregate size by dynamic light scattering and the
transient appearance and disappearance of amorphous aggregates
according to electron microscopy. Although we do not include this as
a separate step, it is likely that there is a gradual build-up of soluble
species of increasing size in this period. From 2 h onwards, fibril-like
aggregates (which already appear after a few minutes but not as the
major species) dominate the EM images and there is a marked
increase in aggregate size (probably due to the formation of
intermeshed structures), leading to precipitation from solution andthe complete loss of membrane permeabilization activity. This
aggregation process is complex and proceeds in several stages; the
steep drop in fluorescence to around 60% of the initial value (which is
not paralleled by CD changes) is followed by a more measured
fluorescence decline towards 40% over the next 2–10 h as well as a
decline in CD signal. Although EM provides no categorical distinction
between the different levels of aggregation on these time scales, the
final decline is nevertheless accompanied by the consolidation of
large filament-like structures by EM (Fig. 3). No major rearrange-
ments occur over longer time intervals at the level of secondary
structure (FTIR) or ultrastructure (EM). The modest decline in
fluorescence prior to precipitation can be viewed as an apparent
lag phase, as it represents the time required for accumulation of
aggregates of a certain size. Similar to other nucleation-limited
process, precipitation can be accelerated by the addition of
preformed aggregates around which the smaller aggregates can
coalesce as well as by an increase in the protein concentration.
In the presence of sufficient amounts of lipids, and provided
there is not significant amount of electrostatic screening, there is
only a small decline in Trp fluorescence (i.e. no precipitation) but a
marked increase in β-sheet structure compared to the absence of
lipids. Nevertheless EM does not indicate formation of straight
fibril-like structure in lipids but rather wool-like threads. The
decline in Trp fluorescence is accompanied by a ∼13 nm blueshift,
suggesting direct hydrophobic interaction between the aromatic
residue and lipid. In contrast, the lipid-free process associated with
the 15% Trp fluorescence decline gives rise to a negligible shift.
Thus there is a kinetic partitioning between lipid binding and
aggregation. In fact the inability of fresh SerADan to permeabilize
vesicles 100% could be due to dead-time formation of aggregated
species. Aggregation will dominate under physiological conditions
(cfr. the screening effect of 100 mM NaCl), but permeabilization is
not completely abolished and will be facilitated by higher lipid:
peptide ratios, so that its effects may accumulate over longer time
spans.
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The previous studies of the reduced form of ADan showed no
formation of amyloid-like structures but did demonstrate the presence
of a dimer in fresh samples, which aggregated over several days [8,9]
into an electron-densematrix. Thatmatrix shares somemorphological
similarities with the electron micrographs we present here although a
stronger similarity can be seenwith so-called immature fibers formed
by oxidized ADan [9]. However, the kinetics of SerADan aggregation at
pH 5.0 and 7.5 alike are an order of magnitude more rapid than those
previously measured for the cysteine-containing ADan variants. This
acceleration of aggregation is unexpected given the nature of the
substitutions (Cys→Ser and Phe→Trp). These donot significantlyalter
the β-sheet propensity [22,23] or, in the case of F15W, the propensity
for β-aggregation [24]. For C5S and C22S, the substitution theoretically
lowers the β-aggregation propensity rather than increasing it.
However, due to the proximity to the theoretical pKa for cysteine
(∼8.0),∼17% of the Cys residues in reduced ADanwill be charged at pH
7.5. In principle, the elimination of charge by themutations in SerADan
could play a role at pH 7.5, but not at pH 5.0 where only 0.1% of the Cys
residues will be charged. However, since the kinetics are rapid at both
pH 5.0 and 7.5, we conclude that charge elimination by the Cys-Ser
mutations will not contribute significantly. An alternative explanation
for the effect of the mutations is that the elimination of cysteine
prevents shuffling and formation of intermolecular disulphide bonds
that could trap the peptide in ‘aggregation-protected’ conformations.
Thus the mutations in SerADan allow us to filter out the covalent
interactions and focus entirely on hownon-covalent interactions affect
the aggregation process.
4.3. SerADan interacts strongly with anionic phospholipids
SerADan shows the preference for anionic lipids that is seen for
most other lipid-interacting aggregating proteins. These interactions
are mediated by electrostatics, as they are reduced at medium ionic
strength. At pH 7.5, the charge is predicted to be −1 to −2, leading
to overall repulsion from anionic lipid membranes. Inspection of the
primary structure does not reveal an obvious basic region that could
account for the interaction with the negatively charged lipid.
However, several authors have attempted molecular modeling of
the ADan peptide based on (a) the 101–123 segment of transthyr-
etin [9] or (b) a previous model for the related ABri peptide [8,25].
The former (a) resulted in a double-stranded β-sheet stabilized by
disulphide and hydrogen bonding and terminating in a long loop
with the C-terminal tyrosine residue hydrogen bonded to the β-
sheet. The latter (b) showed a triple β-sheet in which strands one
and two are similar to the double-stranded model while the third
strand consist of the C-terminal region. Both of these models are
interesting in that they largely isolate the charged residues at one or
both ends of the β-sheet albeit not in a manner that creates a clear
cationic region. In addition, the peptide contains two histidine
residues and local environmental effects could very well shift the
effective pKa of this group. The residue corresponding to the single
tryptophan in SerADan is also located at one end of both models.
Together with the observed strong blueshifting of the emission
spectrum in SerADan, it is tempting to speculate that Trp is buried
within the core or border region of the membrane while a local
basic region of the peptide interacts with the lipid head group; this
whole interacting region is located at one end of a double- or triple-
stranded β-sheet.
4.4. SerADan share characteristics with antimicrobial peptides
The rapid release of calcein from vesicles demonstrates that
SerADan (and by implication ADan) has a potent perturbing effect
on lipid membranes at molar peptide:lipid ratios down to 1:500,which is comparable to bona fide antimicrobial peptides [26]. Unlike
small antimicrobial peptides such as Novispirin [27], lipid-bound
SerADan does not contain notable amounts of α-helical structure.
However, amphiphilic antimicrobial peptides forming β-hairpins in
the active form have been identified such as the cationic β-
defensins and bactenecin [28,29], and self-assembling β-sheet
peptides are able to form transient pores in membranes [30].
Furthermore, formation of α-helix structure is not a prerequisite for
the ability of Novicidin to permeabilize e.g. zwitterionic lipids (B.S.
Vad and D.E. Otzen, unpublished observations).
SerADan's predilection for β-sheet structure in lipids is in
marked contrast to IAPP, which in the presence of anionic lipids is
able to form α-helical assemblies that lead to membrane leakage
and subsequent fibril assembly through α-to-β conversion within
the α-helical assembly [31]. Similarly, the fibrillating polypeptides
α-synuclein [32] and Aβ [33] both form α-helical structures in lipid
bilayers which may be intermediates in fibril formation [34].
Although programmes such as TANGO [35] predict Aβ to have a
significantly higher β-sheet propensity in buffer than SerADan
(whose propensity in turn is much higher than that of IAPP), this
may be overruled by the pronounced tendency of SerADan to
associate rapidly by a more general collapse. SerADan's inability to
form highly organized fibrillar structures may thus reflect that it is
quickly trapped in locally well-organized aggregates that are unable
to reorganize at the molecular level to make regular β-sheet
contacts. It is tempting to speculate that the swiftness with which
these oligomeric structures are formed in solution and in lipid
bilayers is a key factor that will facilitate an aggressive behavior
towards cellular membranes at the monomeric and early oligomeric
level.
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ABSTRACT 
Pardaxin is a 33 amino acid neurotoxin from the Red Sea Moses sole Pardachirus marmoratus 
that has been studied intensively as a model peptide membrane interaction. There are different 
proposals for its mode of action in terms of peptide aggregation and the effect of pH and lipid 
composition. Many of the techniques that have been used to characterize the interaction between 
amps and lipids all have limitations with regards to describing the specific interactions and mode 
of action for the amp. For example looking at the general release of dye entrapped in lipid 
vesicles will give you an indication of how the interaction is but it will be ensemble 
measurements. Here we combine optical spectroscopy and standard dye release experiments with 
natural abundance 13C NMR and Laser Scanning Confocal Microscopy to provide a more 
complete picture of how Pardaxin interacts with lipids. We demonstrate that there is a pH/charge 
dependent release of entrapped fluorophor from both LUV´s and GUV´s with respect to the time 
release profile and the mode of action. In DOPC GUV´s there is either formation of stable or 
transient pores that allow release of contents without loss of vesicle integrity while the presence 
of DOPG facilitates a total vesicle collapse. NMR results show that in the presence of 14-O-PC: 
6-O-PC bicelles Pardaxin is transmembrane where as Pardaxin interacts only with the headgroup 
of the lipids when 14-O-PG is mixed in. 
Introduction  
There is an increasing occurrence of bacterial strains that are resistant to conventional antibiotics 
which demands a steady output of new antimicrobial agents. The mode by which the bacteria 
gain resistance against a single antibiotic has a tendency to improve their tolerance to that entire 
group of antibiotics like the quinolones, sulfonamides, penicillins and cephalosporins. This 
means that even though the cost for developing antibiotic compounds becomes even more 
difficult and costly, their longevity for treating bacterial strains decreases.  For exactly these 
reasons the Antimicrobial peptides have become an attractive alternative as new antibiotic 
compounds. The rate with which bacteria can become resistant towards anti microbial peptides is 
much lower if at all and the resistance against one type does not seem to induce a general 
increase in anti microbial peptide resistance. 
The mechanism by which cationic linear anti microbial peptides interacts and permeates 
membranes has been thoroughly studied and a consensus has been reached with regards to three 
different models, the barrel-stave - [1], carpet -[2], and toroidal pore model [3]. The barrel stave 
model is the only one that requires that the protein interacts with the hydrophobic core of the 
protein while in the two other systems they are lying on the surface or in the headgroup region of 
the lipid bilayer.  
Pardaxin is a 33 amino acid neurotoxin that was originally isolated from the Red Sea Moses sole 
Pardachirus marmoratus in 1986 [4]. Over the years, many studies have been done on Pardaxin 
looking into the mode of action [5, 6] its connection to peptide aggregation [7, 8] and how it is 
influenced by factors such as pH and lipid composition [8-12].  Several techniques have been 
used to elucidate how Pardaxin interacts with phospholipid membranes. Hallock et al showed by 
differential scanning calorimetry that very low concentrations of Pardaxin reduced the fluid 
lamellar-to-inverted hexagonal phase transition temperature of POPC vesicles. The presence of 
anionic lipids or cholesterol was found to reduce the peptide's ability to disrupt bilayers [13] 
They speculated that this indicated that Pardaxin worked by the barrels stave mechanism in 
POPC vesicles but could not make definite conclusions about the effect of POPG. Solid state 2H 
NMR was employed by Ramamoorthy and co-workers to demonstrate that Pardaxin induces 
considerable disorder in both the head-groups and the hydrophobic core of the POPG bilayers 
[14]. Remarkably, solid state 15N NMR spectroscopy on mechanically aligned bilayers showed 
that Pardaxin aligned in the plane of POPC bilayers but perpendicular to DMPC bilayers [13]. 
Thus, Pardaxin mode of action is sensitive to the acyl chain of the bilayer, using a barrel stave 
mechanism in DMPC and the carpet mechanism in POPC. A combination of a vesicle 
permeation assay and fluorescently labeled Pardaxin has been used to conclude that Pardaxin 
forms pores with ~ 6 molecules per pore [7]. Interpretation is complicated by the fact that the 
lipids used were a mix of naturally derived lipids which consist of a mix of carbon lengths from 
16 to 20 with varying degree of saturation. Given that pore formation appears to be very lipid 
specific, a combination of different peptide-membrane interactions might be taking place under 
these conditions. In this study we use lipids with a defined acyl chainlegths in order to keep the 
focus on the relevance of charge interactions. In addition to this the NMR studies of Pardaxin 
where done at a relative low pH somewhat from the pH in vivo in cells and in seawater which 
lies between 7.5 and 8.4 meaning charge dependent differences in the binding . Given that 
Pardaxin interactions are sensitive to lipid composition such as lipid headgroup charge, we 
decided to make a thorough investigation of the role of electrostatics in Pardaxin-membrane 
interactions. This was done in three ways. Firstly, the effect of headgroup charge (lipid 
composition) and Pardaxin protenation (at different pH values) on the kinetics of vesicle 
disruption. Secondly, Real-time analysis of Pardaxin’s disruption of individual vesicles using 
Confocal Laser Scanning Microscopy. Thirdly, structural analysis of the interaction between 
Pardaxin and lipids using solid state natural abundance 13C NMR on anionic and zwitterionic 
bicelles. We find that the kinetics of vesicle permeation by Pardaxin is affected by the pH and 
vesicle charge but in a discrete way that cannot be linked to favorable electrostatic interactions. 
Confocal Laser Scanning Microscopy measurements clearly show that Pardaxin forms pores in 
GUV´s composed of zwitterionic vesicles while it causes complete loss of membrane integrity 
when the GUV´s contain anionic lipids. The solid state natural abundance 13C NMR show that 
Pardaxin interacts with the zwitterionic lipids all along the lipid molecule indicating a Trans 
membrane conformation. A different mode of interaction is measured when anionic lipid are 
mixed in. In this case Pardaxin interacts only with the upper layer of the lipid membrane. 
 
 
 
 
MATERIALS AND METHODS 
Chemicals: All lipids were from Avanti Polar Lipids (Alabaster, AL). Protected amino acids, 
1,2-ethane dithiole (EDT), triisopropylsylane (TIPS), Di-chloromethane (DCM), 
Dimethylformamide (DMF), N,N-Diisopropylethylamine (DIPEA), 1H-Benzotriazolyl)-1,1,3,3-
tetramethyl-uronium hexafluorophosphate (HBTU), acetonitrile chromasolv gradient grade, 
trifluoroacetic acid (TFA), Sucrose 99.5 % purity and D(+) Glucose 99.5 % purity were from 
Sigma (St. Louise, MO). DiIC18(3) and Alexa488 and Alexa633 hydrazide were from Invitrogen 
(Carlsbad, California). Calcein disodium salt was from Fluka (Buchs, Switzerland).  
Peptide synthesis: Pardaxin (sequence GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE) was 
synthesized on an automatic CEM liberty microwave assisted peptide synthesizer by solid phase 
synthesis using standard Fmoc chemistry on Wang resin. Wang resin was used with the C-
terminal Glu residue coupled to the linker group at a concentration of 0.66 mmol Glu/gresin. The 
resin was initially swelled with DCM for 30 min, followed by 5 repeating washes with DMF. 
The Fmoc protective group was removed with 20% piperidine solvated in DMF. Fmoc-amino 
acids were coupled to the resin bound peptide in 4 times molar excess together with 4 times 
molar excess of HBTU and 8 times molar excess of DIPEA solvated in DMF. The resin was 
washed with DMF and the procedure was repeated for each residue. The Lysine side chains had 
BOC as a protective group. The crude peptide mix was run on a on a Dionex Ultimate 3000 
HPLC system with a Reverse Phase semi-preparative C16 column and an AJO-7371 guard 
column in an AJO-7220 guard column system. Prior to each purification, the column was 
equilibrated with 15% acetonitrile. After loading the peptide to the column, an initial step with 
15% acetonitrile was run for 2 min followed by a gradient from 15% acetonitrile from 15% to 
99.9% acetonitrile over a period of 30 min. The column was allowed to run another 30 min at 
99.9 % acetonitrile followed by a gradient from 99,9% acetonitrile to 15% acetonitrile over a 
period of 30 min. The eluent solutions all contained 0.1 % TFA. The fractions containing 
peptides were freeze dried and the peptide dissolved in the appropriate buffer. 
 
Calcein release assay measured by fluorescence: LUV´s (Large unilamellar vesicles) containing 
calcein were prepared from stock solutions of lipids dissolved in chloroform and dried overnight 
in a Heto VR-1 centrifuge vacuum drier. Lipids were then resuspended by vortexing in the 
respective buffers plus an additional 40 mM calcein sodium salt, to a final concentration of 10 
g/L (~14 mM). The vesicles were exposed to at least seven cycles of freezing in liquid nitrogen, 
followed by thawing in a 50oC water bath, before extrusion through a 200 nm pore filter 12 times 
using a 10 ml thermo barrel extruder (Northern Lipids, Vancouver, Canada). The lipid solutions 
were run on a PD10 column pre-equilibrated with 50 mM NaCl solution. Eluent fractions were 
gathered and tested by fluorescence measurements with and without the addition of Triton X-100 
to test for calcein release. Those with the highest signal-to-background ratio were selected for 
further use. All extruded vesicles were used within two days from when they were made. 
All fluorescence measurements were conducted on a Cary Eclipse Fluorescence 
spectrophotometer (Varian, Palo Alto, CA). Release of free calcein from the vesicles and the 
subsequent increase in fluorescence, was monitored by excitation at 490 nm, recording emission 
at 515 nm every second using a slit width of 2.5 nm for both monochromators. The time delay 
between each measurement was set to 0.2 seconds. The vesicles were diluted in buffers with the 
desired pH values to a concentration of ~ 0.017 g/L, leading to a maximum emission signal of 
around 200 units under these settings. A 10 mm quartz cuvette with magnetic stirring was used 
and the vesicle solution was allowed to equilibrate thermally for a minute before starting to 
record fluorescence. For each recording, Pardaxin was injected and emission was followed until 
it reached a plateau (typically after several minutes). Since calcein fluorescence is pH sensitive 
and varies by approximately a factor of 5 within the concentration range used here, we 
normalized the spectra at each pH with regards to maximum fluorescence. This is operationally 
defined as the fluorescence level obtained when 1% of Triton X-100 is added. Data are 
normalized using the equation:  
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where Ft is the time-dependent fluorescence intensity induced by Pardaxin and Fo and Fmax are 
fluorescence intensities prior to Pardaxin addition and with Triton X-100, respectively. 
Laser confocal microscopy measurements: GUVs (giant unilamellar vesicles) were prepared by 
the electroformation method originally described by Angelova and Dimitrov [15]. The GUVs 
were electroporated using a home-built electroformation chamber partly built on the 
specifications published by Baggatoli and Gratton [16]. GUVs were prepared from chloroform 
stocks containing 10 g/L lipid as well as 0,01 g/L DiI. ~10 µl of chloroform lipid stocks were 
spread on each platinum electrode. The chamber was incubated at 50oC for 2 hours to evaporate 
any remaining solvents and then filled with a solution of 200 mM sucrose containing Alexa488 or 
Alexa633 hydrazide. The platinum wires were connected to a function generator (Digimess FG 
100, Grundig Instruments, Nurnberg, Germany), and a low-frequency alternating field sinusoidal 
wave function with a frequency of 10 Hz and amplitude of 1,5 V was applied for 90 min 
followed by 30 min at 1 Hz and amplitude of 3 V. The GUV´s were removed from the platinum 
electrodes by gently pipetting up and down. The excess free fluorophor was removed by running 
the GUV´s over a PD10 column pre-equilibrated with 200 mM glucose. The eluent from the 
column was collected in 0.5 ml fractions; samples were selected on the basis of absorption of 
free fluorophor and transferred to an eight-well microscopy chamber (Lab-Tek Brand Products, 
Naperville, IL). Tris pH 8 was added to a final concentration of 10 mM and the GUVs were left 
overnight at 4oC to allow them to sediment at the bottom of the viewing chamber prior to 
viewing.  
Vesicles were equilibrated to room temperature on the microscope slide for 15-20 minutes before 
measuring. GUVs were observed with a LSM 510 scanning confocal microscope (Zeiss GmbH, 
Jena, Germany). Excitation of Alexa488, Alexa633 and DiI was done at 488, 633 and 543 nm, 
respectively. Fluorescence emission was measured at 505-548, 650-700 and 558-612 nm for 
Alexa488, Alexa633 and DiI respectively. 10µl of Pardaxin of 30 µM dissolved in Mq was injected 
into the microcopy chamber outside the field of vision, and the measurements started 
immediately afterwards with images recorded every 15 s. Typically no changes were observed 
for the first 10-15 min after injection, probably due to slow diffusion of peptides into the field of 
vision in the viscous sucrose medium. Vesicle lysis was usually preceded by fluctuating vesicle 
movement associated with bulk solution changes, indicating the arrival of peptides diffusing in a 
lower-viscosity solution. Controls with addition of equivalent amounts of deionized water and 
buffer were performed but none of them showed signs of vesicle disruption. 
Secondary structural changes measured by CD spectroscopy: Circular dichroism studies were 
performed on a Jasco J-810 spectropolarimeter (Jasco Spectroscopic Co., Hachioji City, Japan) 
with a Jasco PTC-348W1 temperature control unit. Scan speed was set to 100 nm min, slit with 2 
nm. All experiments were carried out at 25oC using a 1 mm quartz cuvette. Each spectrum in 
titration experiments represents a unique sample which was mixed 2-5 min before measuring. 
Each spectrum was based on an average of three scans. Background spectra for the different 
buffer and additive solutions without peptide were measured and subtracted to yield the final 
spectra. Pardaxin concentrations kept at 20 µM and diluted into 20 mM Tris pH 8. 
Changes in lipid chain mobility measured by NMR: Bicelles were made from 14-O-PC(1,2-Di-
O-Tetradecyl-sn-Glycero-3-Phosphocholine), 6-O-PC(1,2-Di-O-Hexyl-sn-Glycero-3-
Phosphocholine) and 14-O-PG(1,2-Di-O-Tetradecyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)]). 
All lipids except 14-O-PG were solubilized in chloroform except for 14-O-PG which was 
purchased as a dry powder. Two different bicelle samples were prepared, one containing only 
14-O-PC and 6-O-PC at a molar ratio of 3.2:1 and the other containing 14-O-PC, 14-O-PG and 
6-O-PC at a molar ratio of 2.6:0.6:1. Each sample contained a total of 56mg of lipids. The lipids 
were dried separately over a stream of nitrogen and left on vacuum over night. 200µL of a 
10mM phosphate buffer (pH=6.8) was added to the dry 6-O-PC and briefly vortexed until 
solubilized. The clear solution of 6-O-PC was added to the dry 14-O-PC/14-O-PG and vortexed 
in an ice bath for 20 minutes. After a few heat and freeze cycles the sample was transferred to a 
3cm long 5mm tube and sealed. It was left at room temperature for 10 days. The final sample is 
clear and viscous at ambient temperatures and becomes fluid below 10 °C. The Pardaxin was 
added to the bicelles suspension as a lyophilized powder followed by agitation to allow 
solubilization. 
All experiments were performed on a Bruker Avance 400 spectrometer with a 9.4 T magnet 
employing a custom 5 mm Bruker triple-resonance probe for static experiments in double-
resonance configuration. The 1H RF field strength was 35 kHz for the 90 pulse while it was 
reduced to 20 kHz during the 3 ms CP period as well as the t1 period of the PISEMA experiment. 
The 15N RF field strength was 20 kHz during CP and t1 of the PISEMA experiment. SPINAL-64 
was employed for decoupling of the 1H during detection. The PISEMA experiment employed 45 
t1 increments, each acquired using 64 scans. Upon processing, the scaling factor of sqrt (2/3) in 
the indirect dimension was accounted for by increasing the spectral width accordingly. The 
temperature was 32oC for samples containing only PC lipids while it was 30oC for samples 
containing PG lipids. The temperatures chosen gave the best possible spectra. 
RESULTS 
Conformational changes in Pardaxin as function of solutes 
The motivation for these measurements was to determine whether the secondary structure of 
Pardaxin was sensitive to the presence of amphipatic molecules like phospholipids and in turn 
how this was affected by the pH. It was also tested how the strengthening of intramolecular 
bonds affected Pardaxin’s secondary structure by adding TFE and again as measuring it as a 
function of the pH. We measured the CD Spectra for Pardaxin in the presence of 50 % TFE, 
DPC, 100% DOPC and mixed vesicles containing 20% DOPG: and 80 % DOPC as a function of 
pH from 2 till 10 in increments of 1 pH unit but no differences in the spectra characteristics 
could be observed when we normalized for protein concentration (Fig. 1). At pH 6-8, ~ 20 % of 
the Pardaxin solution precipitated (according to Bradford assays on the supernatant left after 
centrifugation).  In both 50% TFE and DPC, we observe spectra that resemble that of classical 
alpha helical spectra with two local minima at 222 and 208 nm. It should be noted here that we 
have chosen the lipid/TFE/DPC concentrations were we observe the most intense CD spectra. 
For DOPC the local minimum at 208 nm is much less pronounced than in DOPC and TFE. This 
suggests a lower degree of helix formation and it becomes much clearer when we include 20 % 
of the anionic DOPG. The local minimum at 208 almost completely disappears indicating that 
we have a shift towards a random coiled structure. This is underlined by the clear decrease in 
signal intensity. 
The degree and kinetics of vesicles disruption depends on pH and lipid charge 
Having established that the ensemble structure of Pardaxin is not affected by changes in pH and 
thus peptide protenation, we next investigated how the protenation of Pardaxin affected its ability 
to permeate vesicles of both zwitterionic and anionic composition. We measured the release of 
the fluorescent probe calcein from vesicles consisting of DOPC and 20% DOPG & 80 DOPC at 
pH 5.5, 8 and 10 where Pardaxin has a net charge of + 2, 0 and -1 respectively according to 
simple side chain titration calculations. In the same pH range, DOPC has a net charge of 0 and 
DOPG a net charge of -1. 
The release of calcein from DOPC vesicles at all the pH values could be fitted to an equation 
involving two exponential decays, suggesting that the release of vesicle contents occurs in a two 
step (either consecutive or parallel) process (Fig. 2). The same is observed for vesicles consisting 
of 20% DOPG and 80% DOPC, except at pH 8 where we consistently observe two specific 
processes that do not overlap in their time course (Fig. 2). Such a step-type function can be 
rationalized as a three-phase process, in which the second (intermediate) phase has an amplitude 
that is opposite in sign to the first (fast) and last (slow) phase, leading to an apparent lag phase. 
Accordingly, the kinetics of the calcein release pattern of 20% DOPG and 80 DOPC vesicles at 
pH 8 could be fitted to an equation involving three exponential decays. However, the inherent 
singularity problems associated with the fitting of multiple exponential decays reduced 
reproducibility significantly compared to the two-exponential fits used for the other kinetic 
profiles. 
In contrast to the pH invariance displayed by the CD spectra, the kinetics of calcein release are 
highly sensitive to both pH and lipid type.  Comparison of the two lipid types (Figs. 3A and 3B) 
reveals that five-tenfold less Pardaxin is required for maximum disruption of DOPC vesicles 
(~20 nM) compared to DOPC:DOPG vesicles (~100 nM at pH 5.5, ~240 nM at pH 8 and ~180 
nM at pH 10). This indicates a remarkable difference in the mode of interaction. Furthermore, 
the maximum amount of calcein release from DOPC vesicles is independent of the pH; whereas 
the mixed vesicles are permeabilized 2-3 fold more efficiently at pH 5.5 compared to pH 8 and 
10. The reason for this is most likely preferential electrostatic interactions between Pardaxin 
(which has a net charge of +2 at pH 5.5) and the anionic lipids. 
Several interesting features are revealed when we plot the half lives of the different exponential 
phases versus Pardaxin concentration (Fig. 4). Although there is very little difference between 
the 3 pH-values in terms of the amount of Pardaxin needed for complete disruption of the 
vesicles, it is clear that release occurs much more rapidly at pH 10 than at pH 5.5 and 8 (Fig. 4A 
and 4C). Furthermore, the half life of release reaches a plateau at pH 10 at 2-3 fold lower 
Pardaxin concentrations than at pH 5.5 and 8. The kinetic plateau at pH 5.5 and 8 (~20 nM) 
coincides nicely with the amplitude plateau (Fig. 3A), whereas the kinetic plateau at pH 10 is ~7 
nM in contrast to ~30 nM for the amplitude plateau. This indicates a difference in the mechanism 
of interaction at the three pH values and highlights a remarkable attraction between negatively 
charged Pardaxin and zwitterionic lipids. The plateau presumably reflects a situation in which 
the rate limiting step changes from diffusion-controlled protein association on the vesicle to 
unimolecular rearrangements on the vesicle. 
In contrast, for the DOPC: DOPG vesicles the situation is completely reversed. For the fast 
phase, kinetics are fastest at pH 5.5 for all Pardaxin concentrations, followed by pH 10 and then 
pH 8 (Fig. 4B); furthermore, the plateau level is reached first at pH 5.5 followed by pH 10 and 
then pH 8, but in all cases the plateau level is reached at a ~2 fold higher concentration than the 
amplitude plateau (Fig. 3B). The same trend is seen for the slow phase although it is less distinct 
(data at pH 8 are complicated by the triple exponential decay).   
Thus pH and lipid composition combine to make the kinetics of Pardaxinlipid interactions very 
variable and subtle. 
Pardaxin displays a charge dependent disruption of Giant unilamellar vesicles 
The use of LSCM and giant unilamellar vesicles allows us to visualize how Pardaxin disrupts 
individual lipid vesicles. This is achieved by loading the GUVs with a water soluble fluorophor 
and incorporating a lipid specific dye in the vesicles. This setup allows monitoring how the 
release of entrapped fluorophor corresponds with disruption of the GUVS and distinguishing 
between for example disruption by pore formation or a more global vesicle disruption. For 
DOPC vesicles we observe the release of vesicle contents over a time course of roughly 15 min 
but insubstantial loss of vesicle integrity (Fig. 5). So there is an efflux of vesicle contents in a 
semi controlled manner indicating that we may have pore formation.  
When the GUV´s contain 20 % DOPG the effects are quite different. We observe the same lag 
time as with DOPC vesicles but upon binding there is release of fluorophor with simultaneous 
loss of membrane integrity. The time scale on which this occurs is also much faster than with 
DOPC vesicles, from initial interaction to disruption of more than 95 % of the vesicles it takes a 
maximum of 50 minutes. These two distinct modes of vesicle disruption are also apparent when 
we have a mixture of the two types of vesicles.  This means that we can exclude the possibility 
that what we observe is an effect of small differences in experimental conditions. Furthermore 
we observe that the two processes happen at equal time rates meaning in heterogeneous solution 
there no preference towards neither zwitterionic nor anionic vesicles. (Data not shown).  
Carbon NMR shows that Pardaxin interacts with the lipid acyl chain is charge dependent 
To complement our spectroscopic and microscopic studies, we finally turn to solid-state NMR 
spectroscopy to analyze the conformation/orientation of Pardaxin when incorporated into or 
binding to the two lipid types. As mimics of vesicles and phospholipid bilayers, we use bicelles 
[17] composed of a mixture of long-chain (14-O-PC with and without 14-O-PG) and short-chain 
(6-O-PC) phospholipids. In these phospholipids, the ester bonds linking the two acyl chains to 
the glycerol backbone are replaced with a non-hydrolysable ether bond. This increases the 
chemical stability of the lipids but does not affect the secondary structure of Pardaxin according 
to circular dichroism spectra (data not shown). Bicelles mixed using appropriate stoichiometry 
will align when placed in a strong magnetic field, making them especially useful for oriented-
sample solid-state NMR spectroscopy. Such studies aim at determining the orientation of 
anisotropic nuclear spin interactions (e.g., 13C-1H dipole-dipole couplings, being collinear with 
the internuclear axis) and through these establish information about the orientation of the 
molecules relative to the external magnetic field. With the bicelles oriented as disks with the 
normal of the disk perpendicular to the magnetic field, it is possible to obtain information about 
the orientation of peptides relative to the bicelles they are binding to or incorporated into. 
Furthermore, we can observe changes in the conformation of the lipid molecules upon interacting 
with the peptides. The latter approach has the advantage that it may be conducted with both 
lipids and peptides in natural abundance (i.e., without incorporating 15N or 13C isotope labels). 
We recorded 13C natural abundance PISEMA [18] NMR spectra of the two types of bicelles, and 
observe differences when Pardaxin is added. In the present context, the PISEMA spectrum 
correlates 13C chemical shifts with the 1H-13C heteronuclear dipole–dipole coupling reflecting the 
binding of the carbon to directly attached protons. The dipole-dipole coupling (and to a smaller 
extent the chemical shift) is very sensitive to reorientation of the lipids and thereby changes in 
lipid order. Therefore changes between PISEMA spectra with and without Pardaxin provide 
information on how Pardaxin interacts with the lipid bilayer at individual atomic sites as 
described previously by Ramamoorthy and coworkers [19, 20]. The change in the lipid 
conformation may conveniently be expressed in terms of an order parameter (28). Fig. 6 shows a 
2D PISEMA spectrum (A) and 1D slices obtained for a bicelle composed of 14-O-PC:DHPC 
(molar ratio 3.2:1.0) lipids [21] and 14-O-PC:14-O-PG:6-O-PC(molar ratio 2.6:0.6:1,0) lipids 
(E-G). In the slices (extracted from the 2D spectra), we focus on 1H-13C dipole-dipole couplings 
observed for three representative carbon sites along the 14-O-PC molecule, namely Cα (d,e), C3 
(c,f), and C14 (d,g) with the slice in red representing pure lipids while the slice in black represents 
the case where Pardaxin is incorporated. It is evident that Pardaxin interacts differently with lipid 
bilayers depending on their surface charge. Fig. 6B-6D show that the order parameter changes at 
carbon sites all along the lipid molecule, indicating that Pardaxin is incorporated in a 
transmembrane configuration when the lipid head groups have a net charge of zero. This agrees 
very well with the formation of pores according to GUV analyses (Fig. 5). A different pattern is 
observed for bicelles containing a mixture of 14-O-PC:14-O-PC:6-O-PC as illustrated in Figs. 
6E-6G. In these bicelles, only the order parameters for the head group region (C3 (E) and Cα 
(D)) change upon addition of Pardaxin, while that of C14 remains invariant (F). Accordingly, in 
this case the NMR data suggest that Pardaxin is positioned flat on the surface of the PC/PG 
bicelle and only interacts with the head group. This also correlates very well with our GUV data 
(Fig. 5). 
Figs. 6H and 6I provide a color code representation of the relative changes in order parameters 
when Pardaxin is added to PC bicelles (6H) and PC:PG mixed bicelles (6I). Red indicates an 
increase in the order parameter, while blue represents a decrease. The diameters of the spheres in 
Figs. 6H and 6I are proportional to the measured order parameter in bicelles without Pardaxin. It 
is not surprising that the headgroup order generally decreases as peptide is added to the bicelles. 
We interpret this as the peptide interacts with the lipids and the conformational average ordering 
of the bilayers is disturbed (i.e., decreased) upon accommodation of the peptide. Similarly it 
appears intuitively correct that the order of the very disordered C14 site increases when Pardaxin 
is suggested to be transmembrane. An explanation could be that the free rotation of the acyl 
methyl group is restricted when Pardaxin is transmembrane. This would make the methyl group 
less dynamic and more ordered. Similar arguments apply to g1 (The first carbon in the glycerol 
linker region of the lipid molecule) which also becomes slightly more ordered when Pardaxin is 
added to PC bicelles (Fig. 6I).  
For the PG-containing bicelles we observe no change in the conformation order of the acyl 
chains in the deeper parts of the bicelles. This is indicated by the generally white color of the C4-
C14 in Fig. 6I reflecting the data in Fig. 6E- 6G where only small changes in the dipolar splitting 
(and thereby the order parameter) are observed. 
DISCUSSION 
Calcein release patterns are dependent on lipid headgroup charge 
There has been numerous studies looking at the interaction of Pardaxin with lipid membranes [7-
14, 22-28] but none of them have methodically investigated how the rate of vesicle permeation 
was affected by the pH of the solution and the charge of the lipid headgroup. In this study the 
vesicle permeation was studied by measuring the fluorescence increase upon the contents release 
from Calcein loaded vesicles. The Calcein release patterns show that Pardaxin mediated lipid 
permeations are dependent on lipid headgroup charge and show subtle kinetic effects. From the 
maximum calcein release data in figure 3 A & B it was clear that we only observe a dependence 
of Pardaxin protenation with vesicles containing the anionic DOPG lipid. We needed less protein 
to permeate anionic vesicles when Pardaxin had a net charge of + 1. Despite of this 5 times less 
Pardaxin was needed to permeate purely zwitterionic vesicles. It is known that there is large 
difference in the concentrations needed to permeate vesicles by either pore formation or the 
carpet mechanism with the later being the most protein demanding [29]. These findings suggest 
that the differences in Pardaxin concentration needed for permeation reflects differences in the 
mode of action with zwitterionic and anionic vesicles.  This is further supported by a similar 
lipid dependence shown for the anti microbial peptide Mellitin which was found to form pores in 
zwitterionic vesicles and aggregation/fusion [30]. This study reported on a 10 fold increase in the 
Mellitin concentrations needed for permeating anionic vesicles compared to zwitterionic 
vesicles. 
The kinetics of the membrane disruption by Pardaxin reveals two distinct processes, an initial 
fast process and a subsequent slow process.  The measured release time profiles represent the 
final result(s) of permeabilization, i.e. they are not just intermediate rearrangements of Pardaxin 
(as one might interpret e.g. a Trp fluorescence time profile in a refolding experiment). Thus it 
seems as if there are several more or less distinct ways of perturbing the membrane.  The kinetics 
of membrane disruption by the AMP Cecropin also displays two distinct kinetic processes. The 
two processes consist of an initial fast step that relates to initial peptide binding and a second 
slower process that is linked to the more specific mode of action like the formation of pores or 
shedding of membrane fragments. Sawyer et al are able to show that the kinetics of vesicle 
disruption is markedly slower for a Cecropin mutant that works by the carpet mechanism 
contrary to the pore formation by wt Cecropin [31].  A similar scenario is observed with 
Pardaxin with regards to the kinetics of membrane disruption of zwitterionic and anionic 
vesicles. We observe that the T(1/2) for both the fast and the slow process vesicle disruption 
process has reached a minimum plateau with zwitterionic vesicles before there is any 
measureable disruption of anionic vesicles. This should be  viewed in the light that the Gouy-
Chapman theory describes how negative charge on the acidic membrane creates a membrane 
potential which causes cationic peptides to redistribute to the membrane [32, 33]. This passive 
accumulation of peptides near an anionic membrane surface will results in a high apparent 
binding constant. If the initial fast process relates to peptide binding it should be expected that 
these would either be of the same order of magnitude or even more pronounced for anionic 
vesicles. Hence the initial fast process must relate to an initial step in the mode of action for 
Pardaxin be it pore formation or carpet mechanism. 
 
 Another important point that this study reveals is the step process by which Pardaxin seems to 
permeate vesicle at low peptide concentrations at pH 8. Simulations conducted using the kinetics 
software program KinTek [34] revealed that the characteristic step-pattern observed for pardaxin 
at pH 8 could be satisfactorily reproduced by a three-step mechanism (A ↔ B ↔ C ↔ D) in 
which each step represents the formation of a species with a specific level of permeabilization 
activity (D.E. Otzen, data not shown). The reason why this feature has not been shown before is 
due to the fact that previous studies have looked at endpoint permeation and not the release as a 
function of time [8-10, 23, 25]. The LSCM experiments did not reveal any phenomena that could 
explain this behavior which means it might not be related to changes in the mode of action. 
 
GUV experiments reveal two distinct vesicle disruption patterns 
There have previously been suggested that the mode of action of Pardaxin is sensitive to the 
charge of the lipid groups with clear indications of pore formation in pure POPC vesicles which 
appeared to change upon the inclusion of anionic lipids [13]. With these GUV experiments we 
can without a doubt say that Pardaxin forms pores in pure DOPC vesicles and disrupts anionic 
vesicles in a none or all fashion indicative of the carpet mechanism.  There have previously been 
studies that combine the use of GUV´s and LSCM to elucidate on the mode of action of AMP´s. 
These studies included Maculatin, Citropin, Aurein and Magainin 2 and proved capable of 
resolving whether the peptides worked by either pore formation or the carpet mechanism in 
vesicles composed of a mixture of zwitterionic and anionic lipids[35, 36]. This study of Pardaxin 
is however the first that is able to show that the mode of action can be dependent on the lipid 
composition of the vesicles. These findings are cooperated both by the calcein vesicle disruption 
assay and the NMR data. Furthermore we were able to reproduce the specific modes of action in 
a heterogeneous mixture composed of anionic vesicles and zwitterionic vesicles. These two 
different modes of action were observed on the same timescale showing there was no preference 
for either lipid composition.  This demonstrates the robustness of the method as Pardaxin has 
been shown in vitro to be active against the anionic membranes of bacteria and the zwitterionic 
membranes of mammals [6]. 
The interaction of Pardaxin with membranes changes the lipid  
The use of 2D NMR experiments, of natural abundance 13C observed from bicelles containing 
DMPC and DHPC lipid molecules were developed by Ramamoorthy and coworkers. The 
technique allows probing the interactions of molecules with lipid membranes without the 
addition of exotic probes to the sample which might in turn effect the molecule-lipid interactions. 
It has been used in for studying the membrane interactions of the antidepressant Desipramine 
[37] but also the AMP Pexiganan[19, 38]. Pexiganan has been shown by various techniques as 
has been established via fluorescence assays, calorimetric techniques, microscopy, and solid-
state NMR spectroscopy and neutron diffraction to work by a toroidal pore mechanism. In the 
natural abundance 13C NMR experiments this resulted in an increase in the disorder of DMPC 
mainly at the headgroup group region and the upper part of the acyl chain.  Given that Pexiganan 
works by the toroidal pore mechanism, the NMR signal is a mixture of the signal from the 
bilayer forming lipids and the lipids that line the toroidal pore making specific interpretations of 
peptide induced changes in the lipid conformation.  The calcein release measurements and the 
LSCM results for Pardaxin revealed two distinct vesicle disruption patterns compatible with pore 
formation and the carpet mechanism for zwitterionic and anionic vesicles respectively. This is 
then reflected in the natural abundance 13C 2D NMR measurements. For bicelles composed only 
of zwitterionic vesicles there was a slight disordering of the lipid headgroup and an increase in 
the order of the acyl chain. This is the opposite of what was observed for Pexiganan indicating 
that Pardaxin does not form toroidal pores. The increase in acyl chain order is rather what would 
be expected if the Pardaxin was transmembrane and thereby restricting the movement of the acyl 
chains. This ordering effect on lipid acyl chains by transmembrane peptides has been reported 
previously [39, 40] corresponding to the formation of pores by the barrel stave mechanism [41]. 
For the bicelles containing anionic lipids a disordering of the headgroup region is observed when 
Pardaxin is added. From the LSCM measurements we have shown that Pardaxin works by a none 
or all mechanism as would be expected from a peptide that worked by the carpet mechanism. All 
though it has been shown that the toroidal pore formation is followed by membrane disruption at 
higher concentration  [42] no pore formation was observed by lowering the Pardaxin 
concentration. These results indicate that there is a significant difference in the impact on acyl 
chain order induced by the toroidal pore formation and the carpet mechanism. This is interesting 
from the standpoint that in both processes the peptide is lying in the lipid headgroup and acyl 
chain interface [43-46]. If this is a general characteristic of natural abundance 13C NMR for these 
two mechanism this would allow for an easy way of distinguishing between but this would 
require testing on more systems to exclude that these results are not peptide specific. 
This paper describes how the combination of a vesicle disruption assay, LSCM and natural 
abundance 13C NMR allowed the determination of mode of action of Pardaxin and the 
underlying kinetics of these. There is a clear difference in the peptide concentrations needed for 
the permeation of zwitterionic and anionic vesicles with more peptides needed for the latter 
regardless of the protenation state of Pardaxin. These findings alone are a strong indicator in 
differences in the mode of action but it is further confirmed by the LSCM measurement. Real-
time images taken Zwitterionic and anionic GUV´s after the addition Pardaxin revealed that the 
Pardaxin formed pores in zwitterionic GUV´s and disrupted anionic vesicles by an all or none 
mechanism. Natural abundance 13C NMR finally showed that Pardaxin forms pores by the barrel 
stave mechanism in zwitterionic lipids and disrupts anionic lipid membranes by the carpet 
mechanism. 
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FIGURE LEGENDS 
 
Figure 1. CD spectra of 20 µM Pardaxin in 20 mM PBS buffer pH 7.5 in the prescence of TFE 
( ), DPC( ), 100 % DOPC vesicles( ), 20%DOPG - 80% DOPC vesicles( ). 
Figure 2: Two representative time profiles from the calcein release experiments. The addition of 
Pardaxin to DOPC: PG vesicles at pH 8 shows a step-type time profile that can be fitted to a 
triple exponential decay, while Pardaxin at all other conditions (pH 5.5-10 and both vesicle 
types) follows a double-exponential decay. 
Figure 3 Maximum release of calcein by Pardaxin from (A) DOPC vesicles and (B) 20 % DOPG 
and 80 % DOPC vesicles at pH 5.5, 8 and 10. In all the experiments the lipid concentration was 
held constant at 20 µM 
Figure 4  the t(1/2) for both the initial (A & C) and the second phase ( B & D) of the calcein 
release plotted for DOPC (top) and 20% DOPG & 80 %DOPC vesicles as a function of the 
protein concentration. 
Figure 5: Time course of the fluorescence from a water soluble fluorophor (green) and a 
membrane specific (blue) after the addition of 5 µM Pardaxin to GUV composed of DOPC (top) 
and 20% DOPG & 80 % DOPC (bottom). 
Figure 6:Static solid state natural abundance NMR data of oriented PC or PC/PG bicelles with 
and with out pardaxin. (a) 2D PISEMA spectrum of a PC bicelle with Pardaxin.[21] 1D slices 
from 2D PISEMA spectra of PC bicelles with(black) and without(red) Pardaxin. From b to d the 
slices represent Ca, C3 and C14. (e-g) 1D slices from 2D PISEMA spectra of PC:PG bicelles 
with(black) and without(red) Pardaxin.(h) 14-O-PC molecule size of spheres represent are 
proportional to measured order parameter in pure PC:PG bicelles, larger means less ordered. The 
colors represent the relative change in order parameter as Pardaxin is added. More disordered 
sites are blue while more ordered sites are red white is no measured change. (i) 14-O-PC with 
order parameters and relative change in order parameters for Pardaxin added to PC:PG bicelles.  
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ABSTRACT
Many small cationic peptides, which are unstructured in aqueous solution, have antimicrobial 
properties. These properties are assumed to be linked to their ability to permeabilize bacterial 
membranes, accompanied by the transition to an -helical folding state. Here we focus on the 
link between folding of the antimicrobial peptide Novicidin (Nc) and its membrane 
permeabilization. N-terminal acylation with C8-C16 alkyl chains, as well as the inclusion of 
anionic lipids, both increase Nc’s ability to form -helical structure in the presence of vesicles. 
Nevertheless, both acylation and anionic lipids reduce the extent of permeabilization of these 
vesicles as well as intact E. coli cells, and lead to slower permeabilization kinetics. This suggests 
that significant induction of -helical structure in this class of antimicrobial peptides is not a 
prerequisite for membrane perturbation. Our data suggests that induction of -helical structure 
rather than facilitating membrane disruption may inhibit it, and that a more peripheral interaction 
may be a more efficient permeabilization mechanism. Furthermore, acylation leads to a deeper 
embedding in the membrane, which could lead to an anti-permeabilizing “plugging” effect. We 
observe multiple modes of interaction between antimicrobial peptides and simple model 
membranes, suggesting that antimicrobial peptide interactions with bacterial membranes may be 
even more varied in the complex environment of live bacterial membranes.
Abbreviations used: CD, circular dichroism; D-Nc, Novicidin consisting of D-amino acids; Nc, 
Novicidin; Nc-CX, N-terminally acylated Nc where X refers to the number of carbon atoms in 
the acyl chain; PRE, paramagnetic relaxation enhancement.
Keywords: Novicidin; membrane permeabilization; confocal laser scanning microscopy; circular 
dichrosim; liquid- and solid-state NMR; peptide acylation.
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INTRODUCTION
Over the past two decades, more than 800 antimicrobial peptides (AMPs) have been reported 
from sources as diverse as animals, plants, insects, and fungi 1; 2; 3; 4. As parts of the innate 
immune system in vertebrates, AMPs are often the first line of defence against an invading 
organism, and thus show activity against a broad range of targets. Microorganisms do not easily 
evolve resistance to them, making them of great interest as alternatives to small-molecule 
antibiotics. Over the recent few years significant resources have been directed towards their 
commercialization. So far, only a few products have succeeded, while several promising
candidates have been halted because of adverse effects or effects similar to existing antibiotics 5.
The lack of success most likely reflects limited understanding of their mechanism of action and 
microbial specificity. At present the common procedure is to search for naturally occurring 
AMP´s and then subsequently mutate them to change their specificity 6; 7; 8; 9; 10. More detailed 
insight into AMP activity may ultimately allow design in silico 11.
AMPs are generally understood to target the bacterial plasma membrane and can do so in a 
variety of ways, including a barrel-stave model, a carpet model, and a toroidal pore model 12. In 
the barrel-stave model, the peptides completely traverse the membrane by pore formation,
quickly ruining the electrochemical gradient and killing the cell. This mode of action is mostly 
driven by hydrophobic interactions between an amphipatic peptide and the lipid’s acyl chains 
and is therefore less specific towards membranes of different lipid compositions. A minimum of 
22 and 8 amino acids is necessary to straddle the bacterial membrane for an -helical- and a -
sheet peptide, respectively. In the carpet model, the positively charged peptides cover the 
membrane surface in a carpet-like fashion until they reach a concentration where they 
permeabilize the cell by disrupting the membrane curvature. As opposed to the barrel-stave 
model, the peptide does not need to assume a specific oligomeric structure and the peptides are 
always in contact with the lipid headgroups at the interface with the acyl chains. This mode of 
action is more sensitive to the lipid headgroup charge, explaining why it is more specific towards 
the negatively charged surface of bacteria 13; 14; 15. Finally, the toroidal-pore model is a mixture 
between the carpet model and the barrel-stave model. Defined pores are formed as in the barrel-
stave model but the peptides lie in the lipid headgroup-acyl chain interface. This is possible 
because the peptides induce a sharp bending of the lipids so that lipid headgroups can line the 
interior of the pore. 
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It may be possible to modulate the mode of antimicrobial action, and thus the spectrum of 
applications, by modifying the AMPs with acyl chains, since this modification will increase 
AMP hydrophobicity and potentially also its membrane affinity. This has been studied in two 
different approaches: Makovitzki et al. 16 synthesized tetrapeptides with acyl chains of length 8-
16 (number carbons in the acyl chain) and found that the tetrapeptides conferred bacterial species 
specificity while their aggressiveness correlated with acyl chain length. The same group also 
showed that conjugation of the AMP magainin with acyl chains of length 7, 11, and 16 had 
important effects on magainin activity, with the membrane permeabilizing ability increasing
uniformly with chain length. Furthermore, the attachment of the acyl chains also resulted in a 
change of the secondary structure of C11 magainin and C16 magainin in solution from that of the 
wildtype Magainin. While the C7-Magainin, like the wild type, was disordered and monomeric 
in solution, both C11 Magainin and C16 Magainin adopted -helical structure. The C11 
Magainin was only -helical above a threshold concentration indicating detergent-like properties 
in which the protein assumed an -helical structure in the micellar state. In contrast, C16 
Magainin remained -helical at all investigated concentrations, suggesting that the longer acyl 
chain was able to sequester the hydrophobic residues in the folded Magainin at the monomer 
level.
To explore in greater detail how acylation can modulate membrane binding properties, we 
report here a detailed study on the effect of acylation on the AMP Novicidin (Nc) 7; 17; 18; 19; 20. 
This AMP is a variant of the 18-residue Ovispirin, which in turn is derived from the N-terminal 
region of the cathelicidin peptide SMAP-29 from sheep. Ovispirin (sequence KNLRR IIRKI 
IHIIK KYG) showed unacceptably high haemolytic activity, but the mutation Ile10→Gly 
(Novispirin) reduced this to more appropriate levels. Subsequently, the C-terminal mutation 
Gly18→Phe (Novicidin, abbreviated Nc) led to improved efficacy towards microorganisms 
(personal communication, Hans-Henrik Kristensen). Novispirin and Nc are unstructured in 
solution but readily adopt -helical structures in the presence of anionic lipids and detergents, as 
well as to a smaller extent in the presence of cationic and zwitterionic detergents 21, in agreement 
with its amphipathic character (Fig. 1A). We focus on the structural and vesicle-disruptive 
properties of Nc, its D-amino acid diastereomer D-Nc, and its N-terminally acylated derivatives.
Surprisingly, we find that the induction of measurable amounts of -helical structure is not a 
prerequisite for membrane permeabilizing properties and that acylation actually reduces 
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permeabilization efficiency. We suggest that a more peripheral membrane contact may be the 
most productive mode of action for at least some AMPs. 
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RESULTS
Interaction of Nc and acyl derivatives with lipids 
We start by analyzing the degree to which zwitterionic (100% DOPC) and mixed, partially 
anionic (80% DOPC:20% DOPG) lipid vesicles induce structure in the different Nc variants. 
These vesicles were used as simple mimics of the mammalian plasma membrane (predominantly 
zwitterionic) and the outer leaflet of the bacterial cell membrane (at least 25% anionic lipid in E. 
coli). The secondary structure of Nc, D-Nc, and the acylated derivatives (termed Nc-CX, where 
X refers to the number of carbon atoms in the acyl chain) was monitored by far-UV CD. Figure 
1B shows the CD spectra of Nc, D-Nc, Nc-C8, Nc-C12, and Nc-C16. Note that the CD spectrum 
of D-Nc is the mirror image of Nc because of its D-amino acids. Nc, D-Nc, Nc-C8, and low 
concentrations (40 µM) of Nc-C12 display CD spectra characteristic of a random coil. At high 
concentrations (200 µM), the CD spectrum of Nc-C12 changes to a distinct -helical profile with 
minima at 209 and 222 nm. Nc, D-Nc, and Nc-C8 remain unstructured at 200 µM (data not 
shown). The CD spectrum of C16 is primarily -helical over the entire accessible concentration 
range (20-200 µM). In the presence of 0-2 mg/ml DOPC, Nc and D-Nc shows only a slight 
change in their CD spectra, retaining the features of a random coil structure (data not shown) 
though there is a small increase in ellipticity between 0 and 2 mg/ml lipid (Fig. 2A). This agrees 
with the observation that high (several hundred mM) concentrations of non-ionic and 
zwitterionic surfactant are required to induce helical structure in the closely related peptide 
Novispirin 21. In contrast, Nc-C8 and Nc-C12 both change from random coil to -helical 
structure with increasing concentrations of lipid over the range probed (data for Nc-C8 shown in 
Fig. 1B). In the presence of DOPC:PG vesicles, the spectra of Nc, Nc-C8, and Nc-C12 changed 
dramatically from random coil to -helix (representative spectra shown in Fig. 1B, summarized 
in Fig. 2B). The ellipticity at 208 nm, which is indicative of -helical structure, shows a 
reasonably linear increase with lipid concentration, apart from a more hyperbolic behavior for 
Nc-C12 in DOPC (Fig. 2A). As we have previously reported for Novispirin 21, this slope most 
likely represents the initial linear stage of a hyperbolic binding curve, whose slope (summarized 
in Table 1) is directly proportional to the lipid binding affinity. To avoid artifacts from light 
scattering, we did not record data at higher lipid concentrations. For both lipid compositions, wt 
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Nc shows the lowest lipid affinity of all the peptides (measured in terms of -helix induction), 
although it has a clear preference for DOPC:PG vesicles where the slope is ~7 times higher. Nc-
C12 has slightly greater affinity for DOPC than Nc-C8, but the switch to DOPC:PG vesicles only 
increases Nc-C12 affinity by around 30% while that of Nc-C8 increases 5-fold. D-Nc displays an 
affinity towards mixed lipids similar to those of Nc-C8. The CD spectra of Nc-C16 remained 
essentially unchanged by the addition of both lipid types.
Acylation leads to a marked decrease in the efficiency of lipid permeabilization
We now turn to a functional analysis of the Nc peptides, i.e. their ability to permeabilize 
vesicles, using a manual calcein release assay. We prepared LUV´s containing calcein at a 
concentration (50 mM) in which calcein fluorescence is self-quenched, and measured the release 
of calcein as function of peptide concentration, using the addition of Triton X-100 to obtain the 
fluorescence level associated with 100% release. The presence of calcein did not affect the 
ability of lipids to induce structural changes in the peptides (data not shown), nor did Triton X-
100 influence the fluorescence of calcein (data not shown).
Three distinct calcein release patterns were observed (Fig. 3A): (i) instantaneous (<10 s) 
calcein release, followed by a steady baseline, (ii) relatively rapid release of calcein which could 
be described by first order kinetics with a plateau being reached after a few minutes, or (iii) rapid 
overshoot of fluorescence to a value well above that of free calcein, followed by a decrease to a 
signal corresponding to roughly 100 % calcein release. The fraction of calcein released as a 
function of peptide concentration in the two different lipid compositions is illustrated in Fig. 3B-
C. The efficacy of release is quantified by the amount of peptide needed to effectuate 50% 
calcein release (R50). In all cases, very high concentrations of peptide lead to a drop in calcein 
release (data not shown), possibly due to vesicle aggregation (vide infra).
The ranking order of the lipolytic effect of the peptides is as follows (summarized in Fig. 3D): 
Nc > D-Nc > Nc-C8 > Nc-C16 > Nc-C12. For all of the peptides, it was apparent that R50
increased in DOPC:PG vesicles. The ratio R50
DOPC:PG/R50
DOPC (the higher this ratio, the greater 
the preference for DOPC) decreased in the order Nc>Nc-C8>D-Nc-Nc-C12-Nc-C16, reaching a 
plateau of around 3 for D-Nc, Nc-C12 and Nc-C16. This indicates that the more hydrophobic the 
peptide, the lower the preference for DOPC vesicles. Interestingly, it also highlights a change in 
the lipid affinity between D- and L-Nc. For Nc-C8 and Nc-C12 these permeabilization data 
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contrast with the structural data provided by CD, which reveal that acylation decreases the 
preference for DOPC:PG vesicles in terms of inducing -helicity.
Exposure of E. Coli to Nc variants show that acylation reduces the efficacy of Nc as an 
antimicrobial peptide
To compare the data on synthetic vesicles with Nc’s biological targets, i.e. bacteria, we 
measured the lysis of E. Coli at different concentrations of the Nc variants. Lysis was measured 
by the release of cytosolic β-galactosidase, monitored by the hydrolysis of the chromogenic 
substrate o-nitrophenyl galactose. All peptides lead to the same level of release at concentrations 
around 20-40 µM (Fig. 4), but differ at lower concentrations. When we quantify this as 
[NcX]50%, the concentration of Nc at which release is 50% of the maximal value, we obtain a 
value of ~1 µM for Nc wildtype and values of 5-7 µM for all 3 acylated peptides. Thus, both in 
calcein assays and biological assays, unacylated Nc permeabilizes more efficiently than acylated 
Nc.
Fluorescence anisotropy measurements show that Nc mobility is decreased upon mixing 
with DOPC and DOPC:PG vesicles 
The calcein release measurements indicate that Nc binds to and permeabilizes both neutral 
and partially anionic vesicles, although CD titration data show that α-helical structure is only 
induced in the partially anionic vesicles. This suggests that induction of α-helix structure in 
peptides that are unstructured in solution is not a prerequisite for AMP action. To monitor 
binding independent of folding, we used a Dansyl-labelled variant of unacylated Nc to measure 
how the fluorescence anisotropy of the dansyl group changes as lipid is added. Immobilization of 
the peptide on the vesicle surface is expected to lead to a significant increase in anisotropy. Upon 
increasing the concentrations of lipid, we observe a hyperbolic binding curve which for both 
DOPC and DOPC:PG vesicles reaches a plateau at a lipid:protein molar ratio of ~250 (Fig. 5).
Lipids were added stepwise to a single Nc solution. We were able to probe higher lipid:peptide 
ratios than in the CD experiments because of the low concentrations of Nc required for these 
experiments. To obtain reproducible results, we had to let the system equilibrate for a few 
minutes, particularly at the lower concentrations. This is most likely due to reorganization of the 
lipids into micellar-like structures as we can see from our calcein-release measurements that the 
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binding happens on a much faster timescale. We observe a slightly larger increase in 
fluorescence anisotropy for the DOPC vesicles. This could tentatively be interpreted as increased 
propensity to aggregate and thus permeabilize these vesicles compared to DOPC:PG vesicles (cf. 
Fig. 3D).
Dansyl-labelled Nc highlights differences in peptide insertion into different lipids
We combined the time-resolution of stopped-flow kinetics with the environmental sensitivity 
of a Dansyl fluorophor, attached to the N-terminus of unacylated Nc, to investigate the coupling 
between peptide binding and calcein release. When Dansyl-Nc is mixed with DOPC vesicles, we 
observe a slight increase in Dansyl fluorescence prior to vesicle disruption (indicated by the 
increase in calcein fluorescence), indicating a modest degree of peptide interaction with the 
membrane before disruption (Fig. 6A). However, when Dansyl-Nc is added to DOPC:PG 
vesicles, we observe a 10-fold higher increase in Dansyl fluorescence (compared to DOPC), 
which also precedes vesicle disruption (Fig. 6B). This increased Dansyl-fluorescence in 
DOPC:PG vesicles compared to DOPC vesicles indicates that Novicidin undergoes a greater 
change in environmental polarity when it inserts into DOPC:PG vesicles. This suggests that Nc 
inserts more deeply into the DOPC:PG membrane than into the pure DOPC membrane. We also 
observe an additional increase in Dansyl fluorescence during the process of calcein release from 
DOPC:PG vesicles, suggesting a further rearrangement of Dansyl-Nc in the DOPC:PG 
membrane upon vesicle disruption. 
Visualization of vesicle leakage, aggregation and lysis
Confocal laser scanning microscopy (CLSM) with giant unilamellar vesicles (GUVs)
provides an alternative way of elucidating the mechanism of action of the different peptides, 
since we can focus on individual vesicles rather than measuring ensemble changes. The GUVs 
contained a lipid fluorophor (DiIC18) and were loaded with membrane impermeable water-
soluble fluorophors (Alexa 488 for DOPC:PG vesicles and Alexa 633 for DOPC vesicles),
allowing us to monitor changes in both membrane integrity and permeability. The increased 
imaging facilities come at the expense of kinetic resolution, because diffusion limitation led to 
typical lag times between 10~15 min until the added peptide reached the field of vision, which 
makes it unrealistic to compare with the time-profile provided by stopped-flow experiments. As 
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illustrated in Fig. 7 and summarized in Table 2, the interactions between peptide and vesicle 
could be classified into three groups: (i) slow leakage that led to complete release of the vesicle 
content over 5-10 min, leaving an empty but intact vesicle behind; (ii) vesicle aggregation where 
the vesicles clump together, without necessarily facilitating the release of trapped fluorophor and 
(iii) vesicle lysis, causing immediate release of the vesicle content and complete loss of vesicle 
structure. Within the framework of current models for AMP action, (i) is most simply interpreted 
as pore formation and (iii) as the carpet model for membrane lysis, whereas (ii) represents an 
alternative class of interactions which do not occur in the absence of Nc and which to our 
knowledge has not been described before using CLSM. Images recorded at different stages of the 
process are provided in the supplementary material.
Nc added to DOPC vesicles caused both vesicle lysis and aggregation (Table 2). The fused 
vesicles seemed partially stabilized, as they were the last to rupture and little to no leakage was 
observed. For Nc, it was clear that there was a higher degree of vesicle aggregation when the 
vesicles contained 20% DOPG. The aggregation caused partial entrapment of the water-soluble 
probe and leads to larger particles with greater light-scattering properties, could very well 
explain the overshoot in steady-state measurements at high concentrations that was more 
prominent with DOPG vesicles. Both lysis of the vesicles and slow leakage was observed during 
and after the aggregation of the vesicles. The increase in vesicle aggregation observed with 
DOPC:PG vesicles might be explained by favorable electrostatic interactions between adsorbed 
(cationic) Nc and neighboring (anionic) vesicles. We have also observed aggregation of the 
related peptide Novispirin in the presence of different concentrations of SDS 21.
The addition of Nc-C8 to either DOPC vesicles or DOPC:PG vesicles did not cause vesicle 
aggregation to any observable degree, but we did observe vesicle lysis. Vesicle leakage was only 
evident for DOPC:PG vesicles. The leaky vesicles retained their structural integrity despite the 
fact that they did not aggregate, in contrast to observations with Nc. Nc-C12 did not cause slow 
leakage from neither DOPC nor DOPC:PG vesicles but resulted in vesicle lysis, and, in contrast
to Nc-C8, vesicle aggregation. Thus, vesicle aggregation seems to be independent of whether the 
peptide causes lysis or leakage. For Nc-C16 the vesicle leakage behavior was comparable to that 
of Nc for both DOPC and DOPC:DOPG vesicles but Nc-C16 caused an equally high degree of 
aggregation of vesicles irrespective of their lipid composition. 
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We also investigated the behavior of Nc when presented with a mixed population of different 
vesicles. In the presence of both DOPC and DOPC:PG vesicles, we see a clear preference for the 
vesicles containing DOPG. We distinguish between the two vesicle types by filling them 
separately with different water-soluble fluorophores (Alexa 488 for DOPC versus Alexa 633 for 
DOPC:PG). While the DOPC:PG vesicles behave more or less in the vesicle mixture as we have 
observed for neat DOPC:PG vesicles (both aggregation, lysis and leakage are observed), we only 
observe rupturing of a few of the DOPC vesicles in the mixture. This indicates that the 
DOPC:PG vesicles compete effectively with pure DOPC vesicles in attracting free Nc (Fig. 8). 
Nc-C16 is more deeply embedded in micelles than Nc wt
In order to analyze the effect of acylation on Nc’s anchoring in amphiphilic environments, we 
have used solution state NMR to determine the structure and extent of insertion of Nc-C16 in 
zwitterionic (DPC) micelles. The structure was determined with traditional homonuclear 2D-
spectra for the proton shift assignment and 1H-13C-HSQC natural abundance spectra for the Cα
and Cβ shifts assignment. Key values of the structure calculation are listed in Table 4. The 
structure of Nc-C16 consists of a single slightly bent amphiphatic α-helix with the acyl-chain 
attached to the N-terminal part of the peptide (Fig. 9A). Similar structures have been reported for 
the homolog peptides Ovispirin and Novispirin in SDS micelles36; 37; 38. The only NOE cross 
peaks between the peptide and the attached acyl group that could be assigned were the 
correlation between the HN of residue 1-3 and the protons located on the fatty acid -carbon 
atom. In the calculated structures the acyl-chain therefore appears highly flexible without this 
necessarily being correct.
To determine the relative insertion depths of Nc and Nc-C16 in DPC micelles, samples with 
the micelle bound peptides were titrated with the paramagnetic agent Gd(DTPA-BMA) that is 
known not to interact with peptides and micelles32; 33. T1 relaxation values for the H
 protons in 
the peptides were calculated from peak volumes of cross peaks with the H atom appearing in 
the indirect dimension of inversion-recovery weighted NOESY spectra. The R1 relaxation rates 
of the Hα atoms measured at different concentration of Gd(DTPA-BMA) were subsequently 
plotted against the concentration of the paramagnetic agents giving the PRE values of the atoms. 
In Fig. 9B the Hα PRE values of Nc and Nc-C16 can be seen as a function of the residue 
numbers. The PRE curves of both peptides give a wavelike pattern with a wavelength of either 3 
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or 4 residues between the maxima of the PRE curves which for both peptides are located at the 
residues Asn-2, Arg-5, Lys-9, His-12 and Lys-16 corresponding to the hydrophilic side of the 
amphipathic helix. 
As the PRE values depend on the inverse of the sixth power of the distance between the 
hydrogen and the paramagnetic atom33 the results shows that the hydrophilic side of the helix is 
facing the outside of the micelle as expected. The PRE values of the Nc atoms are significantly 
larger than the corresponding atoms in Nc-C16 which clearly indicates that the acylated variant 
of Novicidin is buried deeper into the micelles. This difference is most pronounced for Asn2 in 
the N-terminal part of the peptides where the acyl-chain of Nc-C16 is attached, which suggests 
that the hydrophobic acyl-chain of Nc-C16 is pulling the N-terminus of the peptide towards the 
hydrophobic core of the micelle.
Solid-state NMR experiments reveal stronger interactions of acylated Nc with lipids
We now turn from Nc-detergent to Nc-lipid interactions using solid-state NMR spectroscopy. 
Atomic-resolution details on the insertion of novicidin and acylated variants of novicidin into 
different phospholipids may be obtained by recording 1H-13C PISEMA spectra 34 of natural 
abundance samples with the peptides reconstituted into bicelles. Such experiments may be used 
correlate 13C chemical shifts with 1H-13C dipole-dipole couplings for the abundant lipid 
molecules as demonstrated previously for other systems by Ramamoorthy and coworkers 39; 40. 
By monitoring the positions and lineshapes of the resonances for various lipid carbons in 2D 
PISEMA spectra, it is possible to probe small differences in local dynamics and orientation of the 
lipid functional groups and thereby get information about the influence of the peptides on the 
various parts of the lipids. This is illustrated in Fig. 10 by excerpts from 2D PISEMA spectra 
recorded for pure lipid (red line), lipid and wt Nc (green line), lipid and Nc-C8 (blue line), and 
lipid and Nc-C16 (magenta line) with the lipids being either pure zwitterionic bicelles (DMPC 
together with DHPC, left column) or a mixtures of zwitterionic and anionic bicelles 
(DMPC:DMPG in ratio 4:1 together with DHPC; center column). The spectra report the 
perturbation of headgroup (Cα), a central carbon (C3), and a terminal acyl carbon (C14) according 
to the structural model given in Fig. 10g. In addition to contour plots from relevant parts of the 
2D PISEMA spectra for the four different samples, the individual panels also contain sum 
projections (left and top) onto the 13C chemical shift axis (vertical) and the 1H-13C dipolar axis 
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(horizontal). The individual panels also contain (right and bottom) the corresponding traces taken 
through the maximum point of the 2D spectra for the pure bicelles. While changes in the local 
environment (structure/orientation and time averaged dynamics) may be monitored from the 2D 
contours as well as the projections, it is evident that most sensitivity towards minor changes in 
peak positions will be probed through the traces. We note that all samples were prepared with 
approximately the same peptide concentration, and that we based on information from calcein 
release data (Fig. 3) might expect Nc to display stronger interactions with zwitterionic vesicles 
than with the mixed  zwitterionic and anionic vesicles; on the other hand, the CD data (Fig. 2) 
suggest that DOPC:PG vesicles bind Nc more strongly. 
From the upper panels in Fig. 10, it becomes evident that Nc as well as the acylated Nc 
variants interact with the headgroup of both types of lipids. This is seen from the position and 
shape of the contours, and very clearly from the traces taken at the position of the resonance in 
the pure lipid spectra. A closer inspection of the spectra provides a more diverse set of 
observations for a deeper penetration of the peptides into the various lipids. From the left-hand 
column of Fig. 10, it is seen that Nc-C16 interacts with all carbon sites of the zwitterionic lipids 
and thereby may adapt a transmembrane (or transiently transmembrane) configuration with 
significant effect on the carbons on the central region of the lipids. In contrast, it appears that 
largely only the headgroup region (Cα and C3 carbons) are affected by the peptides with shorter 
or no acylation. Turning to the PC:PG lipid bicelles (center column), it appears that the 
perturbing effect from the various peptides on the local environment of the lipids are somewhat 
less pronounced (weaker interactions) and to a large extend only influence the headgroup region. 
For the wt Nc sample only a slight shift in the resonance position is observed for the α and  (not 
shown) carbons, indicating a relatively weak perturbation as compared to the interaction with the 
pure bicelles. 
The observed changes (summarized in Table 3) overall indicate that novicidin and its acylated 
variants mainly interact with the surface of bicelles composed of zwitterionic and anionic lipids, 
while more pronounced interactions are observed for the pure zwitterionic lipids. In the latter 
case is seems that addition of acyl chains accelerates the interaction with perturbation of the 
inner parts of the membrane for the Nc-C16 acylation. We note that the 1H-13C PISEMA 
experiments do not provide information on whether this transmembrane perturbation is caused 
by the formation of ion channels (barrel stave) or static/transient incorporation of 
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monomer/oligomers of acylated peptides. We note that, in full consistency with the NMR 
observations, the biophysical measurements report the strongest membrane perturbation for the 
DOPC vesicles, with the requirement of less peptide to penetrate/perturb the vesicles relative to 
the DOPC:PG vesicles – although this appears to occur with very little induction of secondary 
structure. 
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DISCUSSION
In this study, we have increased the hydrophobicity of the antimicrobial peptide Nc by adding 
acyl chains of various lengths to the N-terminus. These modifications do not directly alter the 
intrinsic secondary structure of the peptide but modify the extent to which it interacts with 
amphiphilic environments by virtue of their own hydrophobicity. Closer association with the 
membrane will also induce folding of Novicidin, since the membrane environment requires the 
formation of organized secondary structure such as α-helices to satisfy the peptide’s hydrogen 
bonding requirements. In this way we can test how increased association with the lipid 
membrane and increased structure changes its functional profile. We have studied how vesicle 
disruption changes with peptide concentration and how the peptides’ preferences for two 
different lipid compositions change with increased hydrophobicity.
Acylation promotes higher order assemblies and -helical structure
The CD spectra of Nc and the acylated derivatives in buffered solution clearly shows that the 
C12 and C16 chain changed the peptide structure through their change of the local environment 
of the peptide chains towards a more lipid-like environment. Nc-C12 is random coil at 40 µM 
but -helical at 200 µM, whereas Nc-C16 was -helical at all measured concentrations (10-100 
µM). For Nc-C12, this can be explained by the peptides arranging in a surfactant like fashion 
with a critical micelle concentration (CMC) between 40 and 200 µM. Micelle formation results
in an -helical structure, as described by Makovitzki et al. 41. For Nc-C16, the CMC is either 
below the peptide concentration tested in this study (i.e. < 10 µM) or the structure is stabilized in 
a different fashion, possibly existing only as a monomer. Solution-state NMR experiments on 
pure samples of Nc-C12 and Nc-C16 in the absence of lipids showed that both derivatives at ~1 
mM in aqueous buffer formed aggregates that did not yield any useful NMR signals (M. F. and 
R. W., unpublished data). However, when dispersed in DPC, Nc-C16 yielded well-defined NMR 
spectra. In addition, Dufour et al. 42 have studied linearized versions of the lipopeptide surfactin 
and found that C10, C14, and C18 surfactin had CMC values of 1113, 301, and 8 µM 
respectively. These values are consistent with our own observations and also support the Nc-C16 
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micellization. In principle, the acyl chain could also pack against the peptide at the monomer 
level provided a suitably hydrophobic binding surface was available as suggested by Makovitzki 
et al. 41. A helix projection of Nc (Fig. 1A) highlights a perfectly amphipathic helix with a sharp 
distinction between a hydrophobic face (only interrupted by Gly10) and a cationic face, where 
the acyl chain is attached to first residue placed in the middle of the cationic face. Nevertheless, 
Nc-C16’s apparent micellization suggests that the C16 chain engages in inter- rather than intra-
molecular packing. It is likely that the precise site of attachment of the acyl chain will dictate 
whether it is more favorable for the chain to dock against the peptide, engage with other acyl 
chains in an intermolecular micellar arrangement, or even combine the two types to form small 
micelles that also incorporate the peptide, as suggested for the lipopeptides elegantly developed 
by Privé and coworkers 43. For D-Nc, we do not observe any marked differences with regards to 
the CD spectra compared to wt Nc. This agrees with reports by Scolnik et al. 44 who only 
observe very subtle differences between for synthetic D- and L-polyglutamic acid by CD apart 
from the expected inversion of the signal.
It is worth considering how these aggregative tendencies may influence subsequent vesicle 
interactions: We have a system with two defined states, one monomeric where the peptide has a 
random conformation, the other most likely multimeric where the peptide has a -helical 
structure. Let us assume that the peptide initially inserts as a monomer into the lipid bilayer 
(even if it binds as a multimer it is likely to rearrange its higher-order arrangement in the bilayer, 
and possibly monomerize, due to the change in environment). In that case binding will need to be 
preceded by micelle dissociation above the CMC of the lipopeptide micelle (which is < 10 µM 
for Nc-C16 and between 40 and 200 µM for Nc-C12). Detergent micellar dynamics typically 
involve two relaxation processes, namely the dissociation of monomer from micelles (on the µs 
scale) and micelle break-up (on the minute scale depending on the biophysical properties of the 
detergent) 45. Thus, we do not consider it likely that monomer dissociation from micelles is rate-
limiting for the kinetics of binding of acylated Nc to membranes. Any changes in disruption 
kinetics are most likely to reflect changes in the binding to the membrane and/or structural 
rearrangements in this environment. Let us therefore address these issues.
Changes in secondary structure caused by addition of lipids 
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Nc and D-Nc folding in vesicles is strongly dependent on the lipid headgroup. Nc remains 
largely random coil in 100% zwitterionic lipids, but mixed lipids containing 20% DOPG induce
-helical structure. However, the increase in secondary structure does not in itself favour 
permeabilization but makes it less efficient. 
Since we know from our calcein release and fluorescence anisotropy studies that Nc binds at 
least as well to DOPC vesicles as to DOPC:PG vesicles, the differences in structure may reflect 
different arrangements on the vesicle surface and/or membrane traversion. One scenario could be 
that Nc is loosely attached to DOPC vesicles, allowing it to remain relatively unstructured and 
thus cover a larger surface on the vesicle, while in DOPC:PG vesicles Nc is buried at the 
headgroup-acyl chain interface, favoring an amphipatic -helix structure. This is consistent with 
our stopped-flow experiments with Dansyl-Nc where we observe a higher degree of interaction 
with DOPC:PG vesicles both prior to and after vesicle disruption. Our solid-state NMR 
observations also show that Nc mainly interacts with the lipid headgroups. Previously we 
observed that the closely related peptide Novispirin was able to bind to the positively charged 
surfactant LTAC to a more superficial extent than to the complementary SDS micelles, 
highlighting different levels of interaction 21. Other studies also indicate that binding and 
permeabilization can be separate processes, and that binding alone is not sufficient for membrane 
permeabilization. For example, the amyloid-β peptide can bind to both crystalline and liquid 
disordered phases but only permeabilize the liquid disordered state 46.
Acylated peptides are -helical in the presence of zwitterionic vesicles, suggesting that the 
acyl chain causes the peptides to adsorb to the vesicles in a manner that facilitates the formation 
of -helix. One could imagine that the acyl chains work as “anchors” that pull the peptides into 
the headgroup-acyl chain interface where it then folds into an -helix, supported by our PRE-
data which indicate deeper penetration into micelles by Nc-C16 than Nc wt (Fig. 9B). This 
anchoring effect may also explain our solid-state NMR observation where we not only observe 
perturbation of the lipid head groups but also effects in the central and tail parts of the lipids –
where -helical secondary structure would support membrane penetration (static or transient). 
Graham and Phillips 47 reported that adsorption of rigid molecules to lipid membranes caused a 
slower increase in surface pressure compared to flexible molecules. This, in combination with 
“plugging” effects mentioned below, could help to explain why we do not see an increased 
vesicle disruption because of the increased peptide rigidity induced by -helix formation. In 
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addition, the increased submersion into the lipid bilayer will make the acylated peptides less 
sensitive to the nature of the headgroup and will thus decrease the preference for zwitterionic 
lipids shown by Nc.
Changes in lipid specificity caused by acylation
In the steady-state fluorescence measurements of vesicle disruption, we observe that Nc
causes calcein release from DOPC vesicles at 12-fold lower concentration than those needed for 
disruption of DOPC:PG vesicles. Solid-state NMR data also reveal a stronger interaction 
between the peptide and the DMPC membranes than the DMPC:PG membranes. Peptide 
acylation increases the concentrations needed for vesicle disruption, and leads to a decreased 
preference for zwitterionic vesicles compared to partially anionic vesicles (Fig. 3D). However, 
this decreased functional efficiency does not reflect a lower degree of overall binding to vesicles, 
as we need less lipid to induce changes in secondary structure for both Nc-C8 and Nc-C12
compared to Nc. To explain this apparent discrepancy, we speculate that the peptide’s N-
terminal acyl chain to some degree is able to counteract membrane disruption. The observed 
faster release rates could then be explained by the higher surface concentration of peptide that 
has been able to accumulate up to this level without disrupting the membrane because of the 
“plugging” effects of the acyl chain which help retain membrane integrity (see model in Fig. 11). 
The “plugging” effect could very well be what we observe in the solid-state NMR spectra. It is 
clear that the C16 acylated Nc interacts with central parts of the lipid bilayer as seen in Figs. 10 
c,f. We note that from the present NMR data, we cannot distinguish whether it is the peptide 
itself or it is its acyl chains that interact with the central parts of the lipids. Data which could be 
interpreted in the same light have been observed for the lipopeptide surfactin where an increase 
in acyl chain length lowers the surface pressure of vesicles 48. In vivo these effects would 
presumably lead to a decrease in the haemolytic activity of the peptide as the outer leaflet of red 
blood cell is primarily composed of the zwitterionic phosphatidylcholine and 
phosphatidylethanolamine 49. 
It should be mentioned that the decreased preference of acylated Nc for zwitterionic lipids
differs significantly from the work of Dathe et al 50 and Wieprecht et al 51, who report an 
increased affinity towards zwitterionic vesicles as a result of increased hydrophobicity. However, 
in their studies they have made point mutations in order to increase the hydrophobicity, rather 
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than acylating the peptide. Although it has been reported that antimicrobial peptides composed 
solely of the D- enantiomer amino acids have the same antimicrobial effect 52; 53, we also observe 
a slight decrease in the permeabilizing ability of D-Nc towards neutral lipids, although it binds to 
lipids just as well as Nc does. As with the acylated variants, this emphasizes the separation of 
folding and function. 
Vesicle aggregation
The overshoot observed in our calcein release assay is presumably a scattering effect caused 
by vesicle aggregation. Apparently the aggregated vesicle aggregates are subsequently dissolved 
as we observe the overshoot to decrease over time. This is confirmed in our CLSM experiments 
where we in some cases clearly observe vesicle aggregation followed by vesicle disruption. 
Peptide induced aggregation of vesicles has been reported previously for antimicrobial peptides 
such as Cryptidin-4 and polylysine, measured by FRET and dynamic light scattering 54; 55; 56. The 
aggregation is believed to be driven primarily by preferential electrostatic interactions, bilayer 
deformation, and lipid head group dehydration 55; 57. We do observe a link between the 
aggregation and the acylation, since increasing chain lengths increase the aggregation (though 
Nc-C8 has reduced aggregation capability compared to non-acylated Nc). One explanation could 
be that the previously suggested plugging effect gives the peptide-lipid complexes time to 
interact and subsequently aggregate.
In a mixed population of vesicles charge interactions are the governing forces of peptide-
lipid interactions 
For the mixed populations of purely zwitterionic and zwitterionic-anionic vesicles, the 
peptides show a marked preference towards the (partially) negatively charged DOPC;PG vesicles 
over the zwitterionic DOPC vesicles. This preference differs from our calcein release 
measurements but does not contradict them. Rather, they simply reveal that long-range
interactions in solution, mediated by electrostatics, can be sufficient to trap peptides on or close 
to a membrane surface for subsequent folding and membrane interactions. Although the 
visualization of vesicle contents release by peptides and small molecules has been reported 
previously 58; 59; 60; 61, to our knowledge this is the first example of the microscope-based analysis 
of mixed vesicle populations. This allows us to compare the affinity of wildtype and modified
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peptides for a specific lipid composition in the presence of competing lipids, and thus ultimately 
model complex in vivo systems, such as the human digestive track, where the antimicrobial 
peptides are exposed to a diverse range of possible targets 62; 63. 
In summary, we present the following working model on how Nc and acylated versions 
interact with DOPC and DOPC:PG vesicles (Fig. 11): Nc attaches peripherally to DOPC vesicles 
since there is no significant change in the secondary structure upon binding although we still 
observe vesicle disruption. In the presence of DOPG, Nc is submerged more extensively in the 
bilayer most likely at the acyl chain headgroup interface, leading to increased α- helix structure 
and an increase in the fluorescence of the dansyl-labeled Nc prior to to vesicle disruption. The 
acylation of Nc pulls the peptide deeper into the DOPC vesicles as we have formation of α-helix. 
Nevertheless the insertion is different from that in DOPC:PG vesicles, since there are still clear 
differences in the vesicle disruption kinetics and concentrations needed for the two types of 
vesicles. The acyl chain helps to counter act the vesicle destabilizing effect of the peptide, 
leading to the need for higher concentrations of peptides to disrupt the vesicles, irrespective of 
the lipids used.
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MATERIALS AND METHODS
Chemicals
DMPC (1,2-Di-myristoyl-sn-Glycero-3-Phosphocholine), DHPC (1,2-Di-hexanoyl-sn-
Glycero-3-Phosphocholine), DMPG (1,2-Di-myristoyl-sn-Glycero-3-[Phospho-rac-(1-
glycerol)]), DOPC (1,2-Di-oleoyl-sn-Glycero-3-Phosphocholine) and DOPG (1,2-Di-oleoyl-sn-
Glycero-3-[Phospho-rac-(1-glycerol)]) were from Avanti Polar Lipids (Alabaster, AL). Protected 
amino acids, 1,2-ethane dithiole (EDT), triisopropylsylane (TIPS), Di-chloromethane (DCM), 
Dimethylformamide (DMF), N,N-Diisopropylethylamine (DIPEA), 1H-Benzotriazolyl)-1,1,3,3-
tetramethyl-uronium hexafluorophosphate (HBTU), octanoic, dodecanoic- and hexadecanoic 
acid, and O-(7-azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate
(HATU) were from Iris Biotech (Marktredwitz, Germany). Acetonitrile chromasolv gradient 
grade, trifluoroacetic acid (TFA), Sucrose 99.5 % purity and D(+)Glucose 99.5 % purity were 
from Sigma (St. Louise, MO). DiIC18(3) and Alexa488 hydrazide were from Invitrogen 
(Carlsbad, California). Calcein disodium salt was purchased from Fluka (Buchs, Switzerland).
DPC was purchased as DPC-d38 from Cambridge Isotope Laboratories Inc. (Andover, MA) and 
Gd-(DTPA-BMA) was generously provided by Klaus Zangger.
Peptide synthesis, acylation and purification
Synthesis of the acylated Nc peptides was carried out in two steps. Firstly, the Nc peptide 
(sequence KNLRR IIRKG IHIIK KYF) was synthesized on an automatic CEM liberty 
microwave assisted peptide synthesizer (Matthews, North Carolina) by solid-phase synthesis 
using standard Fmoc chemistry on Wang resin. Secondly, the fatty acid was attached to the N-
terminus of the resin-bound peptide also using Fmoc chemistry. Wang resin was used with the C-
terminal Phe residue coupled to the linker group at a concentration of 0.66 mmol Phe/gresin. The 
resin was initially swelled with DCM for 30 min, followed by 5 repeating washes with DMF. 
The Fmoc protective group was removed with 20% piperidine solvated in DMF. Fmoc-amino 
acids (Sigma) were coupled to the resin bound peptide in 4 times molar excess together with 4 
times molar excess of HBTU and 8 times molar excess of DIPEA solvated in DMF. The resin 
was washed with DMF and the procedure was repeated for each residue. The following side 
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chain protective groups were used for reactive amino acids: Lys: BOC, Asn: Trityl, Arg: PBF, 
Tyr: Tert butyl and His: Trityl. 
In the second step, Nc was manually acylated with either octanoic-, dodecanoic-, or 
hexadecanoic acid. The appropriate fatty acid, HATU and DIPEA were added to the resin bound 
peptide in 5, 5, and 10 times molar excess, respectively, and agitated for 1 h. The acylated 
peptidyl resin was washed, dried and cleaved from the resin with TFA, water, TIPS, and EDT in 
a 88:5:15:2 molar ratio. The reaction was allowed to proceed for 3 h before allowing the solvents 
to evaporate. Subsequently, the peptide was washed in tert-butyl-methyl ether five times, each 
time with a centrifugation step where the peptide was sedimented and the supernatant removed. 
The last remains of tert-butyl-methylether were evaporated before purification. The purification 
was done on a Dionex Ultimate 3000 HPLC system (Sunnyvale, California) with a Reverse 
Phase semi-preparative C5 column and an AJO-7371 guard column in an AJO-7220 guard 
column system. Prior to each purification, the column was equilibrated with 15% acetonitrile. 
After loading the peptide to the column, an initial step with 15% acetonitrile was run for 2 min 
followed by a gradient from 15% acetonitrile from 15% to 99.9% acetonitrile over a period of 30 
min. The column was allowed to run another 30 min at 99.9 % acetonitrile followed by a 
gradient from 99,9% acetonitrile to 15% acetonitrile over a period of 30 min. The eluent 
solutions all contained 0.1 % TFA. The fractions containing peptides were freeze-dried and the 
peptide dissolved in the appropriate buffer.
Synthesis of dansyl-Nc
Nc was synthesized as for the fatty acid derivatives using SPPS. In the second step, Nc was 
manually acylated with the dansyl moeity. Dansyl-chloride (Aldrich) and DIPEA were added to 
resin bound peptide in 5 and 10 times molar excess, respectively, and agitated for 1 h. The dansyl 
acylated peptidyl resin was washed, dried and cleaved from the resin as for the fatty acid 
derivatives to provide the N-terminal dansylated Nc.
Preparation of LUV liposomes
LUV´s (large unilamellar vesicles) containing calcein were prepared from stock solutions of 
lipids dissolved in methanol and dried overnight in a Heto VR-1 centrifuge vacuum drier. Lipids 
were then resuspended by vortexing in 20 mM Tris HCl, pH 7.5 containing 40 mM calcein 
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sodium salt, to a final concentration of 10 g/L (~14 mM), exposed to at least seven cycles of 
freezing in liquid nitrogen, followed by thawing in a 50oC water bath, before extrusion through a 
200 nm pore filter 12 times using a 10 ml thermo barrel extruder (Northern Lipids, Vancouver, 
Canada). The lipid solutions were run on a PD10 column pre-equilibrated with 20 mM Tris HCl, 
pH 7.5. Eluent fractions were gathered and tested by fluorescence measurements with and 
without the addition of Triton X-100 to test for calcein release. Those with the highest signal-to-
background ratio were selected for further use. All extruded vesicles were used on the same day 
that they were made.
Preparation of GUV liposomes
GUVs (giant unilamellar vesicles) were prepared by the electroformation method originally 
described by Angelova and Dimitrov 22. The GUVs were made using a home-built 
electroformation chamber partly built on the specifications published by Bagatolli and Gratton 23. 
GUVs were prepared from chloroform stocks containing 10 g/L lipid as well as 0,01 g/L DiIC18. 
The chloroform lipid stocks were spread on platinum electrodes with approximately 10µl on 
each. The chamber was placed at 50C for 2 h to evaporate any remaining solvents. The chamber 
was filled with a solution of 200 mM sucrose containing Alexa-488 or Alexa-633 hydrazide. The 
platinum wires were connected to a function generator (Digimess FG 100, Grundig Instruments, 
Nürnberg, Germany) and a low-frequency alternating field sinusoidal function with a frequency 
of 10 Hz and amplitude of 1.5 V was applied for 90 min followed by 30 min at 1 Hz and 
amplitude of 3 V. The platinum electrodes were gently washed by pipetting up and down to 
release loosely bound GUVs. To remove free fluorophor, the GUVs were run over a PD10 
column pre-equilibrated with 200 mM glucose. The eluent from the column was collected in 0.5 
ml fractions, samples were selected on the basis of absorption of free fluorophor and transferred 
to an eight-well microscopy chamber (Lab-Tek Brand Products, Naperville, IL). For mixed 
vesicle experiments the GUV´s were mixed in a 1:1 ratio in the microscopy chamber. GUVs 
were left overnight at 4C to allow them to sediment at the bottom of the viewing chamber prior 
to viewing. 
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Laser confocal microscopy measurements
Vesicles were equilibrated to room temperature on the microscope slide for 15-20 min before 
measuring. GUVs were observed with a LSM 510 scanning confocal microscope (Zeiss GmbH, 
Jena, Germany). Excitation of Alexa488, Alexa633 and DIIC18 was done at 488, 633, and 543 nm, 
respectively. Fluorescence emission was measured at 505-548, 650-700, and 558-612 for 
Alexa488, Alexa633, and DiIC18, respectively. 10µl of peptide solution was injected into the
microcopy chamber outside the field of vision, and the measurements started immediately 
afterwards with images recorded every 15 s. Typically no changes were observed for the first 10-
15 min after injection, probably due to slow diffusion of peptides into the field of vision in the 
viscous sucrose medium. Vesicle lysis was usually preceded by fluctuating vesicle movement 
associated with bulk solution changes, indicating the arrival of peptides diffusing into a lower-
viscosity solution. The fluorescence intensity inside GUVs and the average GUV size were 
quantified using the public domain program Image J (Image Processing and Analysis in Java). 
Manual calcein release assay
All measurements were conducted on an LS55 fluorimeter (PerkinElmer, Waltham, USA). To 
monitor the release of free calcein from the vesicles and the concomitant rise in fluorescence, the 
solution was excited at 490 nm, measuring emission at 515 nm every second using a slit width of 
2.5 nm for both monochromators. The vesicles were diluted in Tris buffer pH 7.5 to a 
concentration of ~ 0.05 g/L, yielding a maximum emission maximum signal of around 350 units 
under these settings. A 10 mm quartz cuvette with magnetic stirring was used and the vesicle 
solution was allowed to equilibrate for ~1 min before starting to record fluorescence. During the 
recording, peptide was injected and the fluorescence was followed until it reached a plateau (this 
typically took ~1 min). Spectra were normalized with regards to maximum fluorescence (the 
fluorescence level achieved when 1% of Triton X-100 is added) using the equation: 
Dye leakage (%)  100 *
F  Fo 
Ft  Fo 
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where F is the fluorescence intensity achieved by the peptides and F0 and Ft are fluorescence 
intensities without the peptides and with Triton X-100, respectively.
Stopped Flow measurements
Kinetic experiments were carried out on an Applied Photophysics SX-18MV reaction 
analyzer (Applied Photophysics, Leatherhead, Surrey) in fluorescence detection mode. For the 
calcein release measurements, the solution was excited at 490 nm and a 510-nm glass filter was 
used to measure emission intensity. The calcein vesicles and peptides were mixed in 10:1 
volume ratio and at least three measurements were averaged for each concentration. Final 
concentrations of lipid were around 50 µM while final peptide concentrations varied from 0.2 
µM to 72 µM. In measurements using Dansyl-Nc, the samples were excited at 335 nm and a 530 
nm glass filter was used. The lipid concentration was held constant at 20 µM while the peptide 
concentration was varied from 1 to 10 µM.
Secondary structural changes measured by CD spectroscopy
Circular dichroism studies were performed on a Jasco J-810 spectropolarimeter (Jasco 
Spectroscopic Co., Hachioji City, Japan) with a Jasco PTC-348W1 temperature control unit. 
Scan speed was set to 100 nm/min, slit width 2 nm. All experiments were carried out in 20 mM 
Tris-HCl pH 7.5, at 25C using a 1 mm quartz cuvette. The measurements were conducted as 
one-pot titrations with an initial peptide concentration of 200 µM and stepwise addition of lipids. 
After addition of each new lipid aliquot, the sample was allowed to equilibrate for at least 1 min 
before a spectrum was recorded. Samples at each concentration were measured in three scans 
and averaged to yield the final spectrum. Background spectra without peptide were subtracted
and the CD signal was corrected for dilution. 
Peptide lipid binding measured by fluorescence anisotropy
All measurements were done on an LS55 fluorimeter (PerkinElmer, Waltham, USA) in a 200 
µL Hellma quartz cuvette. The excitation was set to 335 nm and emission was measured at 515 
nm. Slit width was set to 7.5 nm for both the vertical and horizontal filter. For each sample the 
G-Factor was measured before measuring the anisotropy. Dansyl-Nc concentration was held
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constant at 25 µM and increasing amounts of lipid was added. The samples were mixed by 
pipetting and allowed to equilibrate for 2 min before measuring anisotropy.
Interaction of Nc variants with E. coli cells
E. coli BL21(DE3) was grown to exponential phase (OD600 0.7) in 250 ml LB media. The 
cells were harvested by centrifugation at 3000 g and washed 3 times in 10 mM sodium phosphate
pH 7.5 and 130 mM NaCl. The cell pellet was resuspended in 10 ml of this buffer and further 
diluted five-fold in the same buffer. 10 µL containing 0-10 µg of acylated or non-acylated Nc
was added to 100µl of this cell suspension and the samples were incubated for 2 h at 37C, with 
occasional mixing. Following the incubation, the supernatant was separated from the cells by 
centrifugation at 3000 g and checked for cell lysis by -galactosidase assay, which was 
performed essentially as described previously, with some modifications 24. In short, 50 µl of cell 
supernatant was transferred to microtiter plates in duplicates and 30 µl of 0.1M NaH2PO4, pH 7.5 
containing 33 mM MgCl2 was added. To some wells, 50 µL of buffer was added instead of cell 
lysate as blanks. Reaction was initiated by addition of 20 µL of substrate (o-nitrophenyl 
galactose, ONPG). The plate was placed in a plate reader (FLUOstar Omega, BMG Labtech) set 
at 37C and the OD410 was read at various time intervals, ranging from 15 min to 17 h. Blanks
were subtracted from each value. The obtained numbers from each time interval reading were 
plotted as a function of the amount of Nc peptide(s) added in µg.
Solution-state NMR experiments
NMR samples containing 1 mM Nc-C16 or 2 mM Nc were dissolved in 90 mM DPC-d38, 10 mM 
phosphate buffer, 0.05% sodium azide, 5% D2O, pH 6 to a final volume of 500 μL. All NMR 
measurements were conducted at 37 oC on a Bruker DRX600 spectrometer operating at a field 
strength of 14.1 T, equipped with a TXI(H/C/N) probe with triple-axis gradients. [1H, 1H]-
TOCSY spectra with 50 and 80 ms mixing time were recorded using a clean-TOCSY pulse 
sequence with a 15 kHz spin-lock and a WATERGATE water suppression25. 2QF-COSY, [1H-
13C]-HSQC in the aromatic and aliphatic regions and a 2D NOESY spectra with a mixing time of 
80 ms and WATERGATE water suppression25 were recorded. All NMR spectra were processed 
using Topspin version 1.3, and assignment was performed using the program CARA version 
1.5.526 while the NEASY subroutine of CARA27 was used for integration of the NOE cross 
Vad et al.         Activity, folding, and acylation of Novicidin
27
peaks. The program TALOS28 provided 13 φ/ψ backbone torsion angle restraints based on the Hα
/ Cα / Cβ chemical shifts and the CALIBA29 subroutine in CYANA was used to convert 
integrated cross-peak intensities from the NOESY spectra into distance constraints. The NOE 
upper distance constraints were combined with the angle constraints in the input for the structure 
calculation using the torsion angle dynamics program CYANA30. Structure calculations were 
subsequently started from 80 conformers with random torsion angle values and the 20 calculated 
structures with the lowest CYANA target function were selected for the final ensemble 
representing the tertiary structure of the peptide. The software program PYMOL version 0.9931
was used for structural analysis and visualization.
The PRE measurements of Nc-C16 were performed as previously described in detail32. The 
Nc-C16 NMR sample were titrated with Gd(DTPA-BMA)33 to final concentrations of 2, 5 and 
10 mM. Eight inversion recovery NOESY spectra with recovery delay times of 1, 50, 150, 400, 
700, 1200, 2600, 4000 ms were recorded for each titration point in order to obtain the T1
relaxation time.
Preparation of lipid bicelles for solid-state NMR spectroscopy
The NMR bicelle samples were made from DMPC, DHPC, and DMPG. All lipids except 
DMPG were solubilized in chloroform. Two different bicelle samples were made with 
DMPC:DMPG:DHPC molar ratios of 3.2:0.0:1.0 and 2.6:0.6:1.0, respectively. The lipids were
dried separately over a stream of nitrogen and left under vacuum over night. 200 µL of a 10mM 
sodium phosphate buffer pH 6.8 was added to the dry DHPC and briefly vortexed until the lipid 
was solubilized. The clear solution of DHPC was added to the dry powders of DMPC/DMPG 
and Nc, and subsequently vortexed in an ice bath for 20 min. After 3-5 freeze-thaw cycles, the 
sample was transferred to a 3 cm long 5mm (o.d.) NMR tube and sealed. All samples contained 3 
 0.2 mg peptide and 56 mg lipid.
Solid-state NMR experiments
All experiments were performed on a Bruker Avance 400 spectrometer (Bruker BioSpin, 
Rheinstetten, Germany) operating at 9.4 T corresponding to 400 MHz for protons. The 
spectrometer was equipped with a standard Bruker 5 mm triple-resonance MAS flatcoil probe, 
which for the present experiments were used for static-sample experiments in a 1H-13C double-
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resonance configuration. The 1H RF field strength was 35 kHz for the initial 90 pulse, while it 
was reduced to 20 kHz during cross polarization (CP; 3 ms contact period) as well as the t1
period of the PISEMA experiment 34. The 15N RF field strength was 20 kHz during CP and the 
t1–period of the PISEMA experiment. SPINAL-64 
35 was employed for 1H-decoupling during 
detection (20 ms). The PISEMA experiment employed 45 t1 increments, each using 64 or 100
scans. The sample was allowed to equilibriate for 5 s between each scan. Upon processing, a 
scaling factor of 2 /3 from Lee-Goldburg homonuclear decoupling in the indirect dimension 
was accounted for by increasing the spectral width accordingly and the intensity was adjusted 
according to the number of transients. The incubation temperature was 305K for samples 
containing only PC lipids and 303K for samples containing PG lipids.
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FIGURE LEGENDS
Figure 1
(A) Sequence of Novicidin and a helical projection highlighting its amphipathic character. (B) 
CD spectra of Nc and acylated derivatives in 50 mM PBS buffer pH 7.5: 40 µM wt Nc (filled
circles), 40 µM D-Nc (empty circles), 40 µM Nc-C8 (empty diamonds), 40 µM Nc-C12 (empty 
squares), 200 µM Nc-C12 (filled squares), 40 µM Nc-C16 (+), 40 µM Novicidin in vesicles 
containing 20% DOPG and 80% DOPC (x), and 40 µM Nc-C8 in vesicles containing 100% 
DOPC.
Figure 2
Development of CD spectra at 208 nm with the addition of increasing concentrations of (A) 
100% DOPC and (B) 20%DOPG and 80% DOPC to Nc wt (filled circles), D-Nc (empty circles), 
Nc-C8 (diamonds) Nc-C12 (filled squares) and Nc-C16 (+)
Figure 3.
(A) Time profile of calcein release by Nc and derivatives. Signal normalized relative to signal 
upon addition of Triton X-100 (see Materials and Methods). With the addition of Nc and 
acylated derivatives to calcein loaded vesicles three distinct calcein release release patterns are
observed in stedy-state fluorescence measurements. A slow release leading with the curve 
displaying second order characteristics (), a fast release with a fluorescence increase between 
0- and a 100 %(), and finally a fast release with an overshoot which would after ~1 min reach 
decrease to a 100% (). Injection occurs in all cases at 50s. (B and C) Nc, NcD and the acylated 
derivatives were added to calcein-loaded vescicles composed of (B) 100% DOPC and (C) 20 % 
DOPG and 80 % DOPC (data for Nc in 100% DOPC included for comparison). The normalised 
maximum fluorescence was plotted as a function of protein concentration. (D) The bars indicate 
the peptide concentrations needed for 50% calcein release (R50) from 100% DOPC vesicles (gray 
bars) and 20 % DOPG and 80% DOPC vesicles (black bars) and also the ratio between these two 
(striped bars).
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Figure 4: Degree of release of -galactosidase from E. coli by different concentrations of Nc and 
acylated variants hereof.
Figure 5: Anisotropy measurements of Dansyl-Nc in increasing concentrations of pure DOPC 
and 80:DOPC:20%DOPG. The vesicles were allowed to equillibrate for 1 min before each 
measurement. 
Figure 6: Stopped-flow analysis of Nc interactions with lipids. Upon addition of Dansyl Nc we 
observe an increase for the dansyl flourescence for both vesicles composed of DOPC (A) and 
20% DOPG 80 % DOPC (B) before an increase in the calcein fluorescence. The arrow A(I) 
indicates an initial small increase in dansyl fluorescence due to binding while arrow A(II) shows 
the simultaneous release of vesicle contents for DOPC vesicles. For the 20% DOPG 80 % DOPC
vesicles the arrow B(I) indicates a large fluorescence increase from the dansyl probe indiating 
Novicidin membrane insertion prior to vesicle disruption shown by arrow B(III) followed by 
another   increase in dansyl fluorescence B(II) which might be due lipid rearrangement.
Figure 7: Representative multicolour fluorescence images of Alexa 488 (green colour) loaded 
lipid vesicles with DiIC18 (red colour) incorporated in the membrane obtained by confocal laser 
scanning microscopy. In the presence of Nc and acylated derivatives, we observe three distinct 
modes of action, namely (A) vesicle leakage, (B) vesicle aggregation and (C) vesicle lysis. The 
relative preferences for the three modes of action are summarized in Table 2, 
Figure 8: CLSM images of vesicle contents release from DOPC (red, filled with Alexa 488) and 
20% DOPG and 80% DOPC (green, filled with Alexa 633 ) GUV´s after addition of Nc. Each 
image represent ~ a 2 min interval. Peptide was injected at t = 0. 
Figure 9. (A) Structure of Nc-C16 in the presents of DPC. Superposition of the 20 backbone 
conformers with the lowest cyana target function representing the 3D NMR structure. The 
bundle is obtained by superimposing the backbone Cα, C ,N atoms of residues 2-17. The carbon 
atoms of the acyl chain is clearly seen extending from the N-terminal part of the peptide. (B) 
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PRE values of Hα nuclei of Nc () and Nc-C16 () as a function of residue numbers. Error bars 
indicate variations in PRE values obtained from fitting several peaks.
Figure 10. Solid-state NMR spectra of novicidin and acetylated variants in pure and mixed lipids.
(a-f) Each panel describe four different bicelle samples containing either; pure lipid bicelle (red), 
lipid and wt Nc (green), lipid and C8-Nc (blue) and lipid with Nc-C16 (magenta). Each panel 
consists of an excerpt from 2D 1H-13C PISEMA spectra of DMPC:DHPC or 
DMPC:DMPG:DHPC bicelles as well as sum projections and traces along the position of the 
pure bnicelle for both the 1H dimension and the 13C dimension.(a-c) describe the spectral 
changes observed for zwitterionic bicelles. 
(d-f) describe the spectral changes observed for a mixture of zwitterionic and anionic bicelles. 
The focus is on three representative regions describing the lipid head group (a,d), the central part 
of the lipid molecule (b,e) and the lipid tail region (c,f). 
The location of the carbon atoms in the lipid molecule is indicated in (g).
Figure 11: A schematic model to illustrate why much less wt Nc is required compared to the 
acylated versions to cause the same degree of vesicle permeabilization. Wt Nc binds either the 
membrane-water interface (zwitterionic vesicles) or the headgroup - acyl chain interface (anionic 
vesicles), leading to membrane disruption. Acylated Nc binds at the headgroup - acyl chain 
interface, but the inserted acyl chain helps to counter the peptide induced membrane disruption.
TABLES
Table 1
Increase in ellipticity at 208 nm of Nc peptides as a function of lipid concentration (units of molar 
ellipticity per mg/ml lipid x 10-3).a,b
Peptide 100% DOPC 20% DOPG 80 %DOPC
Wt Nc -1.21 -8.98
D-Nc 1.21 27.57
Nc-C8 -6.56 -29.56
Nc-C12 -8.84c -11.87
Nc-C16 -0.58 -1.15
Notes:
a All data carried out in 20 mM Tris-HCl pH 7.5 at 25C. Fits based on data shown in Fig. 2.
b These values are not actual affinity constants (since the ellipticity generally increases linearly and 
does not level off to a plateau level over the concentration range tested) but serve to illustrate the 
degree to which different lipids can increase the secondary structure of the Nc peptides over the 
experimentally accessible concentration range.
c Data have been fitted to a parabolic equation to derive the slope at zero molar lipid.
Tables 1-4
Table 2: Summary of confocal laser scanning microscopy experiments with Nc and acylated 
derivatives, indicating the propensities of the peptides for three different kinds of vesicle 
interactions (illustrated in Fig. 7)a. 
Vesicle leakage
Peptide DOPC vesicles 20%DOPG vesicles
Wt Nc + +++
Nc-C8 - +
Nc-C12 - -
Nc-C16 + +++
Vesicle Fusion
Peptide DOPC vesicles 20%DOPG vesicles
Wt Nc + +++
Nc-C8 - -
Nc-C12 ++ +
Nc-C16 +++ +++
Vesicle lysis
Peptide DOPC vesicles 20%DOPG vesicles
Wt Nc ++ +
Nc-C8 +++ ++
Nc-C12 +++ +++
Nc-C16 ++ +
Notes:
a For practical reasons, all experiments were performed at pH 6 and at 15 oC. The degree of leakage, 
fusion and lysis was based on a relative comparison between the different samples.
Table 3. Summary of peptide induced-perturbation of CHn groups in the headgroup (C), central 
(C3), and tail (C14) region of zwitterionic (DMPC) and mixed zwitterionic and anionic 
(DMPC:DMPG) bicellesa
Peptide DMPC DMPC:DMPG (4:1)
Headgroup (C) Nc ++ +
Nc-C8 +++ ++
Nc-C16 +++ ++
Central (C3) Nc ++ -
Nc-C8 ++ +
Nc-C16 ++ ++
Tail (C14) Nc - -
Nc-C8 - -
Nc-C16 +++ +
Notes:
a See labelling of lipid functional groups in Fig. 10g
Table 4
Quality Criteria for the Calculated Nc-C16 Structures
number of distance constraints 271
- of which intraresidual 136
- of which sequential 69
- of which medium-range (2 ≤ Δres ≤ 4) 66
number of angle constraintsa 26
- of which φ 13
- of which ψ 13
CYANA residual target function 0.89 ± 0.04 Å2
distance restraints violated by more than 0.2Å 0
angle restraints violated more than 5o b 0
rmsd residues 2-17c 0.13 ± 0.08 Å
% of residues in Ramachandran plot 
- in most favored regions 91.5
- less favored regions 7.6
- generously allowed regions 0.9
- disallowed allowed regions 0
Notes:
a Only those derived from TALOS.
b Per molecule.
c For backbone atoms C', Cα and N, as calculated by CYANA from the pairwise rmsd values of each 
of the 20 structures against a mean structure.
d as calculated by PROCHECK_NMR.
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